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Abstract 
Studies were carried out at the molecular level on Bovine 
Viral Diarrhoea Virus (BVDV) and Border Disease Virus (BDV). 
The primary objective of this work was to produce a cDNA library 
containing BDV sequences. 	BDV growth was studied and the 
possibility of growth enhancement using Actinomycin D was 
investigated, with a view to maximising virus production for a 
cloning experiment. BDV was grown on a large scale and 25 
litres of virus in tissue culture fluid were produced. 	RNA was 
purified from this virus and used as a template in a cDNA 
synthesis experiment. 	Cloning of cDNA from the RNA was not 
successful, 	due to the lack of sufficient quantities of RNA as 
starting material. 	This stemmed from the extreme difficulty in 
producing enough virus, as BDV grows poorly and is difficult to 
purify. 
Although this primary objective was not achieved, 	other 
approaches were successful. 	The replication of BDV was studied 
in vivo by incorporation of 3H-uridine into infected cells. 	A 
time course of replication was produced. 
Genomic RNA in infected cells was detected by ethidium 
bromide staining in agarose gels, 	and in vivo labelling of 
virus RNA. 	The RNA was shown by gel electrophoresis and rate 
zonal sedimentation to be of the order of 12kb in size. 
Seven DNA clones produced from BVDV-NADL were used to assess 
homology between various pestivirus strains. 	One clone tested 
hybridised to BDV RNA in a dot-blot experiment. Northern blots 
using this probe confirmed the BVDV RNA to be 12kb in size in 
accordance with published data. 
The polymerase chain reaction was used to amplify sequences 
from BVDV and BDV. Five different pairs of oligonucletides were 
assessed for their ability to prime amplification of BVDV and 
BDV sequences, four pairs successfully amplifed BVDV-NADL 
sequences and one pair amplified BDV sequences. 
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Finally, 	computer assisted sequence comparison programmes 




REVIEW OF LITERATURE 
1.1 HISTORY AND CLINICAL DESCRIPTION OF PESTIVIRUS INFECTIONS 
Border Disease (BD) is a viral infection of sheep causing 
congenital disease and persistent infection. First described by 
Hughes et al (1959), 	evidence for a viral aetiology was 
established by in vivo transmission experiments (Gardiner and 
Barlow, 1972). All aspects of the disease have been discussed in 
a comprehensive review by Barlow and Patterson (1982). 	The 
causative virus has been classified, 	on the basis of physical 
and serological properties, 	in the genus Pestivirus of the 
Flaviviridae. 	The other two members of this genus are Bovine 
Viral Diarrhoea Virus (BVDV) which naturally infects cattle, and 
Hog Cholera Virus (HCV) whose natural host is the pig (Westaway 
et al, 	1985). 	A serologically unrelated virus, Rubella virus 
of man, (RUV) has been grouped with the Pestiviruses under the 
collective term non-arthropod borne (non-arbo) togaviruses, 	to 
distinguish them from the main genus of togaviruses, 	the alpha 
viruses, 	which rely on an arthropod vector. Non-arbo 
togaviruses share an ability to cross the placenta of an 
infected animal and infect the foetus. The consequences of such 
congenital infections have been comprehensively reviewed by Van 
Oirschott (1983) and an exhaustive comparison of all aspects of 
these viruses has been published by Horzinek (1981). 
The pestiviruses themselves have been the subject of several 
recent reviews (Littlejohns, 1989; Moennig, 1990; Collett et 
al, 1989), and their original classification as Togaviruses is 
now under debate (Moorman et al, 1990). 
The clinical manifestations of pestivirus infections vary 
enormously in type and severity (a fact which probably reflects 
their complex pathogenesis). This section deals with the main 
clinical aspects of infection by BDV, BVDV and HCV. 
1.1.1 Border disease 
Since the initial description by Hughes et al (1959) there 
have been many reports both from the UK and abroad of outbreaks 
of this disease (Dickinson and Barlow, 1967, Osburn et al 1972, 
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Acland et al 1972). 	Outbreaks are most clinically evident at 
lambing time, 	typified by abortions, stillbirths and the birth 
of affected lambs. 	Characteristic symptoms are: generalised or 
localised growth retardation giving a stunted appearance, 	an 
excessively hairy birthcoat, 	sometimes abnormally pigmented, 
and varying degrees of neurological defects due to 
hypomyelinogenesis of the central nervous system (CNS), which 
can produce body tremors in the newborn lamb. 	Recent studies 
suggest that this hypomyelination could be due to depressed 
levels of thyroid hormones in the foetus, 	as a result of 
persistent, 	non-destructive infection of the thyroid gland by 
BDV (Anderson et al, 	1987, 	1988). These symptoms led to an 
alternative name for BD affected lambs: 	"hairy shakers". These 
lambs show a general failure to thrive and many will die after 
weaning. 	Those that do survive show a gradual decline in 
symptoms with age. 	These recovered animals have been termed 
"recovered hairy shakers" (RHS) (Barlow and Paterson, 	1982). 
Some RI-IS sheep succumb to a spontaneous, 	acute and usually 
fatal disease which can develop at any time. These RHS sheep are 
viraemic for life. Some may succumb to a spontaneous acute and fatal disease. This 
disease has been termed "mucosal disease of sheep" because of its similarity to the 
same disease in cattle (discussed later). The main symptoms are diarrhoea and nasal 
and respiratory discharge (Barlow et al 1983). 	 The onset of this 
disease is sudden, 	its course rapid (about 10 days) and the 
outcome is almost always death. 
1.1.2 Bovine Virus Diarrhoea Virus (BVDV) 
Two clinically distinct diseases of cattle, bovine virus 
diarrhoea (Olafson et al 1946) and mucosal disease (Ramsey and 
Chivers, 1953) were shown to be caused by serologically related 
viruses (Gillespie et al, 1961). 	BVD is characterised by 
outbreaks of diarrhoea, 	but has a low mortality rate. 	Many 
infections are mild, if not subclinical. 	Associated with such 
outbreaks is a rise in the incidence of abortions and 
stillbirths, 	as with Border disease. 	Unlike BDV infections, 
calves infected in utero with BVDV and surviving to term do not 
have characteristic clinical symptoms (Nettleton, 1985). 
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Mucosal disease usually occurs in young cattle and is 
invariably fatal. Diarrhoea, 	nasal discharge, depression and 
erosions of the CI tract are features of this disease. As with 
the condition in sheep, the onset is extremely sudden and the 
course rapid. 	The pathogenesis of BVDV infections has been 
reviewed by Brownlie et al (1987a). 
1.1.3 Hog Cholera Virus 
This virus causes a very serious and contagious disease of 
pigs with a high mortality rate. 	Also known as 'swine fever', 
the disease shows many features of BVDV and BDV infections, such 
as the ability to produce acute, chronic or inapparent 
infections, congenital transmission and teratogenesis resulting 
in stillborn offspring. HCV infections have been reviewed by 
Liess (1987). 
1.2 PATHOGENESIS OF BDV AND BVDV INFECTIONS 
1.2.1 General 
Infection of adult sheep with BDV is virtually always 
subclinical. 	Following exposure to the virus, a transient 
viraemia occurs inducing high and persisting titres of 
neutralising antibodies, which cross-react with other pestivirus 
strains (Vantsis et al 1976). 
The most serious and far-reaching consequences occur when BDV 
infects susceptible pregnant ewes. 	Exposure of pregnant ewes 
results in the same immune response as in non-pregnant animals. 
Nevertheless, before the virus can be eliminated by the ewe it 
penetrates the placenta and infects the foetus. 	Safe from the 
maternal antibodies (to which the placenta is a barrier) the 
virus finds a favourable environment for replication in the 
actively dividing foetal cells, 	and is free to grow without 
restraint. 
The exact nature of transplacental transmission is not clear. 
The factors involved in establishment of an intrauterine 
infection are many and varied, and have been discussed at length 
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by Osburn (1988) and Pohlenz et al (1988). Both BDV and BVDV 
replicate well in placental tissue (French and Snowdon, 	1974, 
Snowdon et al, 	1975) and the current view is that the virus 
grows through the placenta. 	This produces lesions which, 
depending on their severity, may contribute to early foetal 
death. 	Although only non-cytopathic BVDV strains produce 
persistent infections after transplacental transmission, 
cytopathic strains of virus are able to cross the placental 
barrier (McClurkin et al, 	1984; 	Brownlie et al, 1989). The 
reasons for the difference in pathogenesis of the two biotypes 
once inside the uterus are unclear. 
The eventual outcome of a foetal infection depends on an 
interplay between several factors. 	The specific properties of 
the infecting virus strain, for example, 	virulence and 
cytopathogenicity, can influence the course of the infection. 
Likewise, 	the genotype of the host may modify the outcome, 
perhaps by its effect on the immune system (Barlow et al, 
1980). 	The major determining factor though, 	is the age at 
which foetal exposure occurs, 	because this governs how, if at 
all, 	the foetus will respond to the virus. Foetal response in 
turn influences the distribution and persistence of virus, 
which will determine the type and extent of foetal damage. 
The ovine gestation period is approximately 150 days and the 
foetus can first mount an immune response between 64 and 82 days 
(Fahey and Morris, 1978). For the sake of clarity the possible 
outcomes of foetal infection with BDV will be discussed in 
isolation and with reference to the immune-competence of the 
foetal host at the time of infection. 
1.2.2 Infection of the immune-competent foetus 
Exposure of a foetus in the last trimester of pregnancy 
follows much the same course as in an adult sheep. The virus is 
eliminated by the foetal immune response and normal virus 
negative lambs are born. These lambs generally have high titres 
of neutralising antibodies to their infecting agent, and cell 
5 
mediated reactions to the virus have also been suggested 
(Gardiner et al, 1983). 
1.2.3 Infection of the immune-incompetent foetus 
Exposure of a foetus to BDV before it can mount an immune 
response has a very much less predictable outcome. 
Abortion and stillbirth can occur following early infection. 
If the foetus survives it may be born with classical BD symptoms 
or be clinically normal. There is evidence in cattle that such 
clinically normal animals harbour BVDV within specific cell 
types of the brain (Trantwein et al, 1987; Pohlenz et al, 1988). 
Most crucially, lambs born after exposure to BDV during this 
period will be persistently infected with the virus. 
The birth of clinically affected "hairy-shaker" lambs has 
been most consistently observed following infections in the 
50-63 day period. The lack of foetal immune response means the 
virus spreads among the tissues, and accordingly, virus is 
readily isolated from tissues of BD lambs (Terpstra, 1981). 
Persistently affected lambs have no neutralising antibodies to 
the virus and appear to be immunotolerant to it. This will be 
discussed in more detail later. 
Occasionally, following infection at 50-55 days gestation, 
lambs have been born with severe brain malformation. Sacrificed 
lambs from the same experiment were shown to have severe lesions 
and inflammatory reactions in the CNS. The lambs which survived 
to term and had such malformations did not, however, display any 
of the classical signs of BD. Despite being exposed during a 
period when they were supposedly immuno-incompetent, these 
lambs had neutralising antibodies, and, presumably, no virus. 
The factors involved in producing this "alternative pathology" 
(AP) are not entirely clear - but virus strain characteristics 
such as virulence and antigenicity appear to be important. 	It 
has been suggested that a precocious immune response by the 
foetus may in part contribute to the lesions and inflammatory 
reactions characteristic of this disease (Barlow and Patterson, 
1982). 
1.2.4 The persistently infected animal 
As discussed earlier, persistently infected animals result 
from exposure of an immuno-incompetent foetus to BDV. These 
lambs have a persistent viraemia and no neutralising antibodies 
to the virus. Clinical signs may or may not be present and 
certainly cannot be relied upon to detect viraemic animals. 
Most importantly, these animals continuously shed infectious 
virus into the environment thus remaining a constant source of 
virus. They may also transmit virus vertically and produce 
viraemic offspring. Consequently they are of immense importance 
in the epidemiology of the disease. 	The elucidation of the 
mechanism(s) of viral persistence is therefore of great 
practical significance in this particular case, 	as well as 
representing a fascinating challenge more generally. 
To establish a persistent foetal infection the virus 
responsible should be of low virulence so as not to kill the 
foetus, and low cytopathogenicity so as to minimise foetal 
damage caused by destruction of cells. 	An ability to impair or 
evade immune function and/or replicate in cells of the immune 
system are also qualities proposed by Mimms (1982). Persistence 
of RNA viruses in the CNS has been discussed by Kristensson and 
Norrby (1986). 
In fact, virus recovered from persistently infected animals 
is invariably non-cytopathic, and only non-cytopathic strains 
produce persistently infected lambs after crossing the placenta. 
Exposure to an antigen during foetal life is a way of 
producing immunological tolerance to that antigen. The 
unlimited replication of the virus before the foetus can mount a 
response would result in high levels of viral antigens being 
displayed to the developing immune system, with a consequent 
tolerance to these antigens. Persistently infected sheep 
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immunotolerant to BDV have a normal unimpaired immune response 
to other antigenic stimuli. 	Thus, the tolerance of BDV is not 
likely to be due to a generalised impairment of immune function, 
but rather to an inability of the host immune system to 'see' 
BDV antigens. 	This is probably due to a combination of evasion 
of host response by the virus, 	and clonal destruction of BDV 
specific lymphocytes during development. 
The immune tolerance to BDV is specific but neither permanent 
or absolute (Terpstra 1981), as persistently infected animals 
may develop neutralising antibodies to BDV at some stage. 
Viraemia, however, remains present. 
In experiments designed to test the specificity of this 
immunotolerance, in RHS sheep, Barlow et al (1983) showed a 
startling and unexpected result. RHS sheep experimentally 
superinfected with a cytopathic heterologous virus (BVDV) 
remained healthy and produced neutralising antibodies to the 
superinfecting virus, which was largely eliminated. RHS sheep 
superinfected with a homologous cytopathic virus (BDV) became 
severely ill with a disease clinically and pathologically 
similar to mucosal disease (MD) of cattle. The superinfecting 
cytopathic virus was readily isolated from the tissues of these 
animals and no neutralising antibody was detectable. 
The conclusions drawn from these and subsequent experiments 
were firstly, 	that a persistent infection with BDV is a 
prerequisite for development of the MD-like syndrome, and 
secondly, 	that close antigenic similarity between the 
persistent and superinfecting viruses is necessary. 	It is 
unknown if the MD-like syndrome occurs naturally under field 
conditions. 
Mucosal disease has been studied far more extensively in 
cattle than in sheep, and experimental superinfection of cattle 
with biologically-cloned isolates of BVDV, as well as naturally 
occurring outbreaks, has produced results which may shed some 
light on the event(s) precipitating this disease. Brownlie et al 
(1984, 	1987a, 	1987b) have discussed this at length and a 
summary of current ideas follows. 
1.2.5 Pathogenesis of mucosal disease (MD) 
It is established that MD can occur only in persistently 
infected cattle (Roeder and Drew, 1984). 	A crucial question 
then, is what precipitates the disease. 	A hypothesis has been 
proposed by Brownile et al (1984) as follows: Initial infection 
of a pregnant cow occurs (before her foetus is immune-competent) 
with a NCP form of BVDV. 	The calf subsequently born is 
inimunotolerant to this BVDV strain. 
At some stage, 	the calf encounters a cytopathic form of the 
same virus strain and becomes superinfected. 	Because the calf 
is specifically immunotolerant to this strain the CP virus is 
free to replicate without restriction in the host, and on doing 
so produces MD. 	Although this situation may occur, 	recent 
results suggest that MD may also arise despite a neutralising 
antibody response to the superinfecting CP virus, 	although the 
comparative efficacy of neutralising in vivo and in vitro is not 
known (Westenbrink et al, 1989). 
To test this hypothesis, Nettleton 	(1987o) investigated 
the cytopathogenicity of BVDV isolates from natural outbreaks. 
CF virus was consistently associated with MD and with no other 
disease syndrome. 	Furthermore, 	superinfection experiments on 
persistently infected cattle showed that CP BVDV was capable of 
provoking MD, 	whereas NCP virus was not. 	Bolin et al (1985) 
reached similar conclusions. 
There is thus substantial evidence that superinfection by CF 
pestiviruses is a trigger for production of MD in both sheep and 
cattle. 	A further refinement of the hypothesis refutes a 
criticism made against it, 	which was based on the fact that 
some workers failed to produce MD by superinfecting with a CF 
virus. Superinfection experiments using antigenetically 
different CF viruses showed that the degree of relatedness 
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between the superinfecting CP virus and the original NCP 
persisting virus is important in determining whether MD is 
produced (Brownlie et al, 1987b). 	Thus there must be a close 
homology between CP and NCP strains for the disease to occur. 
These authors further suggested a time dependent probability of 
the disease developing, 	depending on the degree of homology 
between the persistent and superinfecting viruses. Corapi et al 
(1988) substantiated this model by demonstrating that antigenic 
similarity between the persistently infecting NCP virus and the 
CP virus isolated from fatal MD cases was a consistent finding. 
Having defined this working hypothesis, some questions remain unanswered. A 
CP virus is associated with specific molecular properties. 
How do those properties relate to the diseases associated 
with each type? Are the two types interconvertible? Where, in 
fact, do CP viruses arise from? Westenbrink et al (1989) found 
that the CP virus re-isolated from experimentally induced cases 
of MD, was different antigenically from the original strain of 
CP virus used to superinfect the animal. 	They suggested this 
may be due to a mutation of the superinfecting strain, mutation 
of the NCP persistently infecting strain to CP, or a result of a 
genetic recombination between the RNAs of the persistently and 
superinfecting virus strains. Evidence for RNA recombination is 
now well established (King et al, 1982) and a copy choice model for 
producing rearrangements in the pestivirus genome has been proposed (Meyers et al 
1991). 
Two possibilities exist for the origin of CP viruses 
preciritating MD. They can be introduced from outside a herd or 
arise from within. Brownlie et al (1987b) have discounted the 
former idea on the grounds that the chance of introducing a 
virus of suitable antigenetic similarity was very slight. Also, 
some MD outbreaks occur in closed herds. They thus propose that 
CP virus arises from a NCP virus, 	presumably by mutation, and 
spreads throughout the herd, which is immunotolerant to it. No 
direct evidence for mutation of this sort exists. 	However, the 
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same observations which led to the hypothesis of antigenically 
similar superinfecting strains, 	can also be invoked in support 
of the mutation theory. 
The very fact that only antigenically similar pairs of 
viruses are isolated from cases of MD suggests that one may have 
arisen from the other. Pairs of CP and NCP viruses from cases of 
MD have been compared at the protein level (Pocock et al, 1987) 
and found to be very similar. 
The first part of this introduction has dealt with both 
clinical discription and pathogenesis of BVD and Border Disease. 
The latter will review the properties of the viruses causing 
these diseases. 
1.3 PROPERTIES OF THE VIRUSES 
While the clinical and pathological aspects of pestivirus 
infections are reasonably well represented in the literature, 
there is a dearth of information on the actual properties of the 
viruses. Most of the information which is available relates to 
Bovine Viral Diarrhoea Virus (BVDV), and, to a lesser extent, 
HCV. The few reports concerning border disease virus (BDV) are 
limited to morphological and serological findings. 	At the 
present time, there is apparently only one report in the 
literature dealing with the molecular organisation of BDV 
(Moerlooze et al, 1990). 
1.3.1 Classification 
The family of togaviruses was established to accommodate 
small enveloped viruses with icosahedral symmetry and a positive 
sense RNA genome. 	Initially it consisted of two well-defined 
groups; the alphaviruses and flaviviruses, both of which require 
an anthropod vector. 	Horzinek (1981) initially coined the term 
pestiviruses as a generic name for HCV and BVDV, which, though 
sharing the structural properties of togaviruses, were 
antigenically unrelated to the existing genera. 
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Horzinek (1981) defined the togaviruses as follows: 
"Spherical 40-70nm in diameter and consisting of an isometric 
probably icosahedral, nucleocapsid, 	tightly surrounded by a 
lipoprotein envelope. 	The viral membrane contains host cell 
lipid and one to three virus specified polypeptides, one or more 
of which is glycosylated. 	The nucleocapsid is constructed from 
one non-glycosylated polypeptide containing a single colinear 
molecule of single-stranded RNA (molecular weight about 4 x i06  
daltons) which is infectious when extracted and assayed under 
appropriate conditions". 
Recently, the validity of such a structural classification 
has been questioned (Horzinek, 1987). Flaviviruses have recently 
been elevated to family status as disparity between their 
replication strategy and that of the alphaviruses has emerged. 
Molecular organisation of the genome and replication strategies 
are now considered more relevant for taxonomy than physical 
structure. Molecular information on the pestiviruses has 
revealed that they are more similar to flaviviruses than to 
alphaviruses and there is currently debate over their taxonomic 
status (Collett et al, 1989). 
1.3.2 Morphology and physicochemical properties 
A wide size range has been reported for BVDV ranging from 30 
to over lOOnm. 	Ritchie and Fernelius (1969) observed 50nm 
diameter particles. The more recent studies have tended to be in 
agreement, with one exception: Chu and Zee (1984) showed 
particles 120 +/- 30nm in diameter in infected cells. These 
particles consisted of a core structure surrounded by a membrane 
5-7nm thick, which possessed numerous projecting spikes 4-5nm in 
diameter. 	Contradictory reports regarding virus size have been 
published (Ohmann and Bloch, 1983; Gray and Nettleton, 1987). 
The former of these reports detailed oval and round particles 
40-55nm in diameter consisting of a core structure surrounded by 
a smooth membrane. 	Gray and Nettleton reported similar sized 
46mB particles with a core structure, 	associated with rough 
endoplasmic reticulum (RER). 	These authors also published the 
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first ultrastructural details of BDV, 	which appeared to be 
morphologically indistinguishable from BVDV. 
In the report by Ohmann and Bloch (1983) mature viruses were 
never observed free in the cytoplasm, but in distinct vesicular 
structures. They proposed that viral structural components never 
exist free in the cytoplasm and that morphogenesis takes place 
entirely within these vesicles. An important conclusion from 
their study was that mature BVDV virions do not appear to leave 
the host cell by "budding" or by cytolysis. Instead, they appear 
to escape by exocytosis, the virion containing vesicles fusing 
with the cell membrane to release their contents. Presumably, on 
cell destruction late in the growth cycle the vesicles will 
disintegrate and release the remaining virions. 
Border disease virus has been studied even less. Gardiner et 
al (1972) reported it to be27nxn in diameter. 	Later reports 
confirmed this and showed it was a morphologically similar 
particle to BVDV (Vantsis et al 1976; Harkness and Vantsis, 
1982; Gray and Nettleton, 1987). The hydrodynamic properties of 
both viruses are very similar. In comparative experiments, BD-2 
virus and BVDV (NADL) were centrifuged in isopycnic gradients. 
Both were shown to have a buoyant density of 1.108g/ml, BD-M 
possessed a buoyant density between 1.09 and 1.18g ml in 10-35% 
suctose gradients. This value was similar to that quoted for 
BVDV (NADL) under comparable conditions (Stott et al 1974). 
Laude and Gelfi (1979) showed that the buoyant densities of BDV, 
BVDV and HCV were all identical in sucrose gradients. 
BVDV has been shown to be sensitive to heat, (560C, 30 mm) 
ether and chloroform (Gillespie et al 1961; Tanaka et al 1968). 
It was shown to have a single-stranded RNA genome (Hafez and 
Liess, 	1972) which is directly infectious (Diderholm and 
Dinter, 1966a). 
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Similar sensitivities were attributed to BDV (Vantsis et al 
1976). 	No report has demonstrated the infectivity of the BDV 
RNA. 
Thus BDV and BVDV are indistinguishable on the basis of 
physico-chemical criteria. Along with HCV, 	they form a 
structurally homogeneous group within the Togaviridae (Laude 
and Gelfi, 1979). 
1.3.3 Virus-specified proteins 
Only limited information (Akkina 1983, 1990) is available on the protein 
composition of BDV, and the following discussion refers therefore to BVDV 
throughout. 
The first report of analysis of BVDV (associated) proteins 
was by Pritchett and Zee (1975). These authors analysed 
labelled polypeptides from virus-infected cells. 	Four 
reproducibly migrating electrophoretic zones were obtained, with 
molecular weights of 25K, 70K, 50-59K and 93-110K. Within each 
zone, distinct peaks were clear, which could have been separate, 
closely migrating proteins, 	though the authors concluded that 
this was unlikely due to the heterogeneous migration pattern of 
the peaks. 	They proposed instead that the peaks represented 
differences in carbohydrate moieties of the proteins. 
Mattaeheus (1979) demonstrated three major polypeptides of 
molecular weights 55K, 	44K and 34K, the larger two being 
glycosylated. 	Coria et al (1983) produced results in formal 
agreement with Pritchett and Zee (1975). Four polypeptides were 
detected, of molecular weights 25K, 54K, 66K and 75K, with the 
54K and 75K polypeptides being glycosylated. 	Akkina (1983) 
demonstrated five polypeptides specific for BVDV by radio-immune 
precipitation (RIP). 	These had molecular weights 115K, 80K, 
54K, 45K and 35K. These results were duplicated almost exactly 
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by Purchio et al (1984a) using the same method. 	The former 
report also contains the only known reference to the molecular 
structure of BDV - using BVDV antiserum in RIP, two BD specific 
proteins of 115k and 60k were detected. 	Peptide mapping 
analysis showed the BD and BVDV 115k proteins to be similar. 
The two most recent reports seem at first sight to have 
further complicated the issue, demonstrating eight and twelve 
putative viral proteins respectively (Pocock et al 1987; 	Donis 
and Dubovi, 1987a). However, at the lower end of the molecular 
weight range, they are in excellent agreement with each other. 
For ease of comparison the results from the publications 
discussed are summarised in Table 1.1 
Donis and Dubovi (1987a) used both direct analysis and RIP to 
detect BVDV proteins. 	By direct analysis they detected the 
twelve polypeptides detailed in Table 1.1. 	Their rationale was 
that visualisation of all BVDV proteins may be hampered by the 
specificity of the antiserum as encountered in RIP analysis. 
Unfortunately, in abandoning such specificity, there remains no 
means of positively identifing the visualised proteins as virus 
specified. 	Recognising this dilemma, 	the authors minimised 
host-cell protein synthesis as far as possible, by inhibitory 
treatments including actinomycin D and hypertonicity. Under such 
conditions, RIP failed to detect some polypeptide species shown 
by direct analysis. 	This may be interpreted either as 
successful discrimination of virus-specific proteins, 	or as 




BVD virus-specific polypeptides 
NADLb 
Strain 	NADLa 	C24V SingerC NADLcI NADLe singer Pestivirus 
165 
135 
93-100* 115 120 (gpll8) p125 
80 87 80 p80 
70 gp75 (gp75) 
66 gp69 (gp65) gp62 
50-59 	gp57 pg54 gp55 gp57 gp57 gp53 
gp44 (45) gp49 gp48 gp48 
34 (38) 37 37 
33 32 
25 26 gp23 (gp25) gp25 
19 p20  
*MW values x 1O3. Numbers in parentheses represent minor components. 
apritchett and Zee (1975), bMattaeheus  (1979), ccoria  et al (1983), 
dPurchio et al (1984a), epocock  et al (1987), f Donis and Dubovi (1987a,b), 
gCollett et al (1988b). 
Taken from V. Moennig, Vet. Micro., 23: 35-54 (1990). 
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An important point arising from this work is the danger in 
any sort of quantitation of results, even relative comparisons. 
The degree of labelling of a particular protein varied with the 
precursor used, i.e. 	different proteins were preferentially 
labelled with different precursors. Also, bias towards 
immunodominant epitopes by RIP may misrepresent the relative 
proportions of each polypeptide. 
In a companion paper to the above, the same authors describe 
analysis of BVDV glycoproteins by one and two dimensional gel 
electrophoresis (Donis and Dubovj, 1987b). They detected six 
virus-induced glycoproteins, the most abundant of which were 48k 
and 56 to 58k. The 56k protein migrated heterogenously in one 
dimensional gels. Following digestion with Endoglycosidase F, 
which removes oligosaccharide, 	this protein migrated as- a 
single-band of 52k, thus apparently losing 4-6k in carbohydrate 
side chains. 	This suggested differences in migration patterns 
are due to variations of glycosylation. 
The functional significance of most of the proteins 
identified is unclear. 	However, the 56K glycoprotein (which is 
the only protein consistently identified by all published 
reports) appears to be a constituent of the viral envelope, and 
involved in neutralisation (Donis et al, 	1988). 	The 48k 
glycoprotein has also been suggested as an envelope component. 
It is of course unlikely that all twelve proteins identified are 
virion structural components, 	even allowing for the fact that 
some may be glycosylation variants of others. 	Some may be 
non-structural virus-induced proteins, 	while others may have a 
orecursor/product relationship. Recent studies at the molecular level have 
shown the likely processing pathways of pestivirus polyproteins (Collett 1992). 
In summary, the results of reports to date on the structural 
and virus-induced polypeptides of BVDV are shown in Table 1.1. 
The variation in the observed molecular weights is probably due 
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to differences in experimental design and method combined with 
the use of different virus strains. 	In this context it is 
relevant to recall the results of Pocock et al (1987) who showed 
considerable variation in migration patterns in SDS PAGE of BVDV 
proteins from different virus strains. 
There seems, from Table 1.1 to be a general consensus of the 
following BVDV proteins: VP1 115K, VP2 80K, VP3 55K, VP4 48K and 
VP5 37K. 	There is also evidence for a small 25K protein. NCP 
Border disease virus apparently has a similar 120K protein, and 
proteins of 130K and 80K have been demonstrated in CP BDV 
infected cells (Dutia et al, 1990). 
Only by direct sequence analysis of the genome and in vitro 
translation experiments will all the possible protein products 
be unequivocally identified. This will be further discussed in 
considering the molecular biology of the virus. 
1.3.4 Antigenic relationships between pestiviruses 
The pestiviruses are serologically unrelated to any other 
members of the togaviridae, 	including RUV (Porterfield et al, 
1978). 
The serological relationship between HCV and BVDV has been 
studied by a variety of tests. 	A common soluble antigen (SA) 
was shown by immunoelectrophoresis (IEF) (Mattaeheus and Van 
Aert, 1971). This soluble antigen seems to be a non-structural 
viral glycoprotein which appears early in the infectious cycle, 
before the mature virions (Mattaeheus, 	1980). 	Its early 
appearance makes it likely to be a structural precursor or a 
virus encoded enzyme. 
Plant et al (1971) confirmed the relatedness of BVDV, BDV and 
HCV by immunodiffusion (ID). All pestiviruses cross react in 
immunofluorescence (IF) tests, 	probably due to the common SA. 
Neutralisation tests however are more stringent, and can 
distinguish BVDV and HCV, and also different strains of BVDV. 
Gillespie et al (1961) showed that different BVDV strains were 
antigenically close but distinguishable. 
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With the BD viruses, two strains, BD-M and BD-2, were shown 
to be more related to each other than to BVDV (NADL) and more 
related to NADL than to HCV (Laude and Gelfi, 1979). 
Nettleton (1985) investigated the relationship between 
several CP BVD strains, 	and CP and NCP BD strains and reached 
the following conclusions. In neutralisation tests, the BD-M 
strain was distinguishable from four BVDV strains to the extent 
that it may be designated as a separate serotype. 	This 
confirmed and extended the findings of Vantis et al (1976): all 
four BVDV strains were very closely related, but 
distinguishable. IF tests failed to distinguish any BD or BVD 
viruses tested, thus demonstrating a common antigen detected by 
this test which is not involved in virus neutralisation. 
Western blotting experiments detected a 77-81K protein in all 
BD and BVD strains examined. 	This was almost certainly the 
common SA of the pestivirus group. A smaller 35K protein was 
detected only in BVDV preparations with homologous antisera. 
This protein (VP5) has previously been suggested to be type-
specific (Mattaeheus 1981) and may possess epitopes involved in 
virus neutralisation. 
Peters 	et al 	(1986) used monoclonal antibodies in a 
preliminary characterisation of BVDV specified proteins. Several 
interesting results emerged from this study. Firstly, all CP and 
NCP BVD viruses along with HCV share a common epitope as shown 
by an antibody reacting with all of these. Secondly CP and NCP 
strains appeared to be antigenically distinct, and the epitopes 
concerned have been mapped to a 79K protein by western blotting. 
Furthermore, antibodies which failed to react with NCP BVDV 
(but reacted with CP) also failed to react with HCV which is 
NCP. No attempt was made to map the epitope concerned on HCV. 
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The most recent report has extended the use of monoclonal 
antibodies to classify BVDV strains on the basis of virus 
neutralisation tests (Bolin et al 1988). 	A panel of nine 
antibodies was used, 	all of which detected only the 56-58K 
glycoprotein. Three separate epitopes appeared to be involved 
in the neutralisation function. One was conserved between all 
strains examined and appeared to be the main one involved in 
neutralisation. 	Another was similarly broadly distributed but 
was only weakly involved in neutralisation. A third epitope, on 
this protein allowed the classification of groups of viruses. 
Apparently CP and NCP strains were not distinguished by their 
56K glycoprotein, 	and therefore not by neutralisation tests. 
Four groups of BVDV viruses were classified in this way, the 
NADL strain was the only member of its group. 	Thus the 56K 
virus membrane glycoprotein appears to be the main determining 
factor in antigenic variation. 
Bolin et al (1988), Bolin and Ridpath (1990) have studied the 
neutralising activity and protein specificity of antibodies 
induced by vaccination of persistently infected cows with a 
cytopathic (NADL) BVD virus. 	Antisera were collected during a 
period of 12 weeks following exposure of persistently infected 
animals to the NADL virus, 	and tested for their neutralising 
activity against various cytopathic (CP) and non-cytopathic 
(NCP) strains of BVDV. 	As expected, 	the resultant antisera 
neutralised some BVDV strains but not others, 	including the 
homologous NCP persistently-infecting strain. No subsequent 
clinical data were presented, 	but it would be interesting to 
know if superinfection by the non-neutralised strains was 
followed by clinical mucosal disease. 
These authors also studied the time course of appearance of 
antibodies specific for each BVDV protein, 	by radioimmune 
precipitation (RIP) of lysates of cells infected with various 
BVDV strains. The first antibodies to be produced against those 
strains which were neutralised were directed against the 56k 
protein. Antibodies to the 115K, 80K and 47K proteins were not 
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detected until 7 weeks after exposure. 	In contrast, when 
control animals free of a persistently infecting virus were 
exposed to NADL, antibodies specific for these proteins appeared 
within 2 weeks. 	The delay in generating antibodies to these 
proteins in persistently infected animals is probably due to 
their highly conserved nature, which would mean that they are 
not sufficiently different from those of the persistently 
infecting strain to overcome the immune tolerance of the host. 
This immune tolerance, 	however, 	is clearly not absolute; 
antibodies generated following exposure to the 115K protein 
detected after 7 weeks will also recognise the 115K protein of 
the persistently infecting strain. 	Furthermore, 	at 12 weeks 
after exposure to NADL, 	antibodies to the more significant 53K 
protein of the persistently infecting strain were detected. 
These antibodies did not possess neutralising activity. 	Thus, 
antibodies raised against one strain of BVD can react with the 
56K protein of a second strain, 	without neutralising this 
second strain. 	This implies that there are structurally 
conserved epitopes on the 56K protein which are of little or no 
importance for virus neutralisation, 	and/or that the 
neutralisation epitope(s) are altered in the second strain, 
allowing binding but not neutralisation. 
The work of Magar et al (1988) further supports this idea. 
These authors studied the reactivity of one monoclonal antibody 
(raised against NADL 56K protein) in immunofluorescence (IF) and 
neutralisation tests against a panel of BVDV strains. 	They 
found that BVD viruses (both reference and field strains) could 
be classified according to their reaction with this monoclonal 
antibody (Mab). One group were positive in IF and neutralisation 
tests, 	the second group were positive in both tests. The most 
interesting group, however, 	comprised strains which were 
clearly positive in IF tests but which were not neutralised by 
the Mab. 	This suggests that for these strains, the epitope is 
altered, such that the Mab can still bind (as shown in IF 
tests) but not with sufficient avidity to effect neutralisation .-
A second interesting result from these experiments was that the 
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degree of fluorescence varied (consistently) between strains in 
the IF test. 	This was suggested to be due to different amounts 
of expression of the 56K protein in different strains, 	and not 
differing levels of virus replication, 	since polyclonal 
antiserum produced uniformly bright staining of all strains. 
In summary, 	pestiviruses have substantial antigenic 
homology. 	A common soluble antigen (SA), 	which is probably a 
70K-80K non structural protein has been detected. 	NCP viruses 
appear to lack an 80K protein or have an antigenically different 
form of it. 	A 35K protein has shown limited evidence of being 
type specific, but the bulk of antigenic variation appears to 
occur in the 56k glycosylated membrane protein. 
1.4 VIRUS REPLICATION IN THE INFECTED CELL 
1.4.1 Growth in tissue culture 
The majority of studies on BVDV and BDV have used primary or 
low pass secondary cell cultures in which to propagate the 
viruses. 	A variety of cell types has been shown to be 
susceptible to BVDV (Horzinek, 1981). In particular, low pass 
secondary bovine embryonic kidney (BEK) cells have been widely 
used (Gillespie et al 1961) but bovine embryonic spleen or 
testis cells have been equally useful (Horzinek, 1981). 
BDV has been cultivated in both ovine and bovine cells, for 
example bovine embryonic testis or foetal lamb kidney (FLK) 
cells. One strain of BDV has shown poor growth in BEK cells but 
was grown successfully in FLK cells (Vantsis et al 1976). 
A major problem with the use of bovine and ovine secondary 
cultures is the sporadic occurrence of contamination by latent 
NCP pestiviruses. 	Foetal bovine serum used as a growth 
supplement has also been shown to be contaminated by 
pestiviruses. 	Various rates of contamination have been quoted, 
some as high as 100%. Heat inactivation can greatly reduce but 
not eliminate the problem (Nuttall, 1978). 
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The possibility of contamination by NCP pestiviruses should 
therefore be borne in mind when considering experiments 
conducted before recognition of the problem. Some workers have 
reported the use of pestivirus-free cell lines to grow BDV and 
BVDV (Laude and Gelfi, 1979, Potts et al 1982). 
The growth cycles of all three pestiviruses have been 
studied, but to a fairly limited degree. Nuttall (1978, 1980) 
has reported comparative growth studies between CP and NCP 
strains of BVDV in calf testis cells under presumed single cycle 
conditions. 	The kinetics of replication of both strains were 
similar; a lag phase of 6 to 8 hours followed by an exponential 
phase of up to 12 hours post infection with a subsequent 
plateau. 	During the exponential phase, 	the titre of the 
intracellular virus approximately equalled that of the released 
virus, 	when the plateau was reached, 	extracellular virus 
exceeded intracellular virus by about 0.5 log for the CF and 
l.Olog for the NCP strain. 
The overall yield per infected cell was 58 times less for the 
NCP strain, although the actual rate of replication was not 
appreciably slower. 	The maximum titre reached was about 10  
pfu/ml. 
This author also studied the effects of the drug actinomycin 
D (ACD) on the replication of BVDV, on the basis that this drug 
had been reported to enhance the replication of other RNA 
viruses (Heller, 1963). Surprisingly, CP BVDV replication was 
inhibited (by 30-100%), 	whether this inhibition was maintained 
throughout the growth cycle or confined to the time measured (20 
hours post infection) was not investigated. The former would 
seem most likely on the basis of the report by Aynaud (1968) who 
observed a similar enhancement of HCV replication during the 
exponential phase in cultures treated with ACD; 	but the 
enhancement was transient, and a final reduction in virus yield 
was observed. 
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The growth curves of a CP strain of BDV have been compared to 
those of two CP BVDV strains in foetal lamb brain cells 
(Nettleton, 1985). There were no significant differences in the 
growth curves, which were exponential until about 20 hours post 
infection, followed by a plateau which showed no signs of 
falling off by 120 hours post infection. 
Though CP strains of BVDV appear to replicate much better 
than the NCP ones (Nuttall, 1980) this does not apply to BDV 
where both strains grow at comparable rates (unpublished 
observations). 
One problem in studying togavirus growth, which has emerged 
from an extensive review on the subject (Horzinek, 1981) is the 
fact that infection of cells in a culture may be asynchronous, 
with a low number of cells becoming infected initially, 
regardless of the input m.o.i. 	This has been observed for RUV 
(Wong et al 1969) and EAV 	(Van der Zeijst, 1975 cited from 
Horzinek, (1981) among others. 	None of the studies on BVDV 
growth has included infectious centre assays at the initial 
stage to confirm the percentage of cells infected at the outset. 
Nuttall (1980) showed that 100% of cells were infected by 48 
hours post infection, but this would not guarantee single cycle 
conditions at the outset. 
Thus, studies on the kinetics of pestivirus replication have 
perhaps been substantially compromised by a poor efficiency and 
asynchrony of infection. 
1.4.2 Viral RNA synthesis 
Of the togaviridae, 	replication of both alphavirus and 
flavivirus, now flaviviridae, (Horzinek, 1987) is well defined 
and a number of studies have been done on RUV (Hovi, 	1972, 
Sedwick and Sokol, 1969, Wong et al 1969). 
Reports on BVDV RNA synthesis in the infected cell are few. 
Nuttall (1978) followed the synthesis of viral RNA by 
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incorporation of labelled uridine. By comparing the difference 
in incorporation between infected and uninfected cells, 	an 
estimate of the amount of virus-induced RNA synthesis was 
obtained. 	However, this did not discriminate between authentic 
viral replication and host cell transcriptional responses 
(either positive or negative) to infection. 
Viral RNA synthesis was first detectable 7 hours after 
infection. Having demonstrated the incorporation of label into 
viral RNA, this author surprisingly failed to detect such 
radiolabelled RNA in progeny virions. 	Moreover, in the latter 
half of the replication cycle, all the previously synthesised 
labelled RNA was abruptly degraded. The replication of positive 
stranded RNA viruses requires the synthesis of a negative 
template strand which is never incorporated into the virion. 
The author's suggestion was that all of the label had been 
incorporated into negative strands such as this, which were 
presumably degraded after serving their function. 
In a comparative study (Karrar, 1983) RNA synthesis of CP and 
NCP isolates of BVDV was examined. Maximum levels of synthesis 
occurred 12-24 hours after infection, and CP viruses showed a 
significantly higher level of RNA synthesis than NCP strains, 
though the incorporation of this labelled RNA into virus was not 
tested. 
Renard et al (1985) have demonstrated the incorporation of 
labelled uridine into a full length viral RNA by 12 hours post 
infection. 
There are no reports of BDV RNA synthesis published at this 
time. 
1.4.3 Cytopathogenicity 
The term "cytopathic effect" (CPE) describes virus-induced 
cell damage, 	whether morphological or biochemical. 	However, 
the mechanism by which a virus causes such effects still remains 
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obscure. 	CPE is typified by cytoplasmic vacuolation, pyknotic 
nuclei, cell rounding and detachment, and eventual cell death, 
though the type and severity of CPE depend on virus strain and 
cell type. BVDV and BDV strains have been classified according 
to their ability to produce these effects, 	and the distinct 
roles in pathogenesis assigned to CP and NCP strains imply that 
this division is a pertinent one. 
CPE produced by some strains of BVDV have been shown to be 
modified or eliminated depending on the cell system used 
(Fernelius and Lambert, 1969; 	Johnson and Rosenbusch, 1990). 
Similarly, certain BDV strains were CP for FLM cells but NCP for 
calf testis cells, 	(Laude and Celfi, 1979) and the failure to 
develop CPE was not due to a failure to replicate the virus. 
Thus permissiveness for viral replication does not invariably 
coincide with susceptibility to CPE. 
Despite the above variations, for most strains 
cytopathogenicity or its lack appears to be a stable phenotypic 
trait, 	the basis of which has not yet become clear. 	Few 
comparative studies on the virology of CP and NCP strains have 
been published, 	the majority of those that have deal with the 
clinical and pathological effects of each type. 	The main 
differences observed between CP and NCP strains will now be 
outlined. 
CP strains consistently show higher rates of replication than 
NCP strains. 	Nuttall (1980) showed a 58 fold increase in the 
yield of infectious virus per cell for CP BVDV strains. Cells 
infected with CP strains also showed strong fluorescence in IF 
tests whereas those infected with NCP strains stained poorly, 
also suggesting a higher concentration of viral antigens in the 
CP virus infected cells (Nuttall, 1978). A similar observation 
was made by Mahnel and Van Moreau (1984) who found strong 
fluorescent antibody staining of CP BVDV virus infected cells 
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but not with NCP virus infected cells. 	These authors also 
showed a distinct and characteristic growth cycle for each 
strain, 	the CF strain producing high amounts of virus in a 
short time and the NCP virus slowly rising over a longer time to 
reach a similar final titre. 	Karrar (1983) has demonstrated 
higher levels of virus-induced RNA synthesis in cells infected 
with CF BVDV than with NCP virus. 
A second difference in tissue culture is the ability to 
induce interferon synthesis. CP strains will induce interferon 
but NCP strains apparently lack this capacity, as judged by 
their inability to suppress heterologous superinfection 
(Diderholm and Dinter, 1966b). 
However, NCP BVDV can interfere with the replication of CF 
strains in tissue culture (Gillespie et al 1961). Such 
interference has not yet been conclusively demonstrated in vivo. 
The fluorescence studies already discussed imply that NCP 
strains of BVDV have a much lower rate of synthesis of viral 
antigens, and it has been shown that buffy coat cells from a 
persistently infected animal do not display viral antigens on 
their surface, despite replicating the virus (Nuttall, 1978). 
In vivo, such a mechanism may contribute to evasion of the host 
immune response. 
There have been few structural comparisons between the CF and 
NCP biotypes of BVDV. 	Pocock et al (1987) demonstrated the 
first biochemical difference between CP and NCP biotypes. 	All 
NCP types examined were characterised by the absence of an 87K 
protein which was always present in CF BVDV infected cells. 
This protein appears to be a derivative of a 120K protein and 
the authors suggest that NCP strains may have a defect in the 
processing of the 120k precursor, though a corresponding 
increase in the amount of this precursor in NCP virus infected 
cells was not shown. The absence of an 80K protein in NCP virus 
infected cells has since been confirmed by several reports 
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(Peters et al 1986; Donis and Dubovi, 1987a; Magar et al 1988) 
Donis and Dubovi (1987b) also confirmed the relatedness of the 
118K and 80K polypeptides, and demonstrated that the former was 
far more abundant in NCP virus infected cells than in those 
infected with CP virus. 
Previously it has been suggested that a mutation causes 
conversion of an NCP strain to a CP strain (Howard et al 1987). 
The processing of the 118K polypeptide by CP strains is not due 
to an extra proteolytic activity absent in NCP strains (Donis 
and Dubovi, 1987b). These authors therefore suggest that the 
difference in processing is due to the presence of a protease 
sensitive site in the 118K protein of CP strains, allowing 
degradation to the 80K protein by cellular proteases. 
Monoclonal antibodies can define structurally CP and NCP 
strains of BVDV (Peters et al 1986). 	This epitope has been 
mapped by western blotting to a 79K protein which is probably 
the same protein shown to be lacking in NCP strains by Pocock et 
al (1987) and Donis and Dubovi (1987b). 
Thus, the basis of cytopathogenicity is still largely 
unresolved. There seems to be a general consensus that CP 
BVDV strains replicate faster than NCP strains, though this is 
not necessarily reflected in higher virus titres from CP strains 
(Donis and Dubovi, 1987b). However, CP and NCP strains of BDV 
replicate at similar rates (unpublished observations). 
It has been postulated that faster replication results in the 
accumulation of double-stranded replicative intermediate RNA 
which is toxic for host cells. 	This view is supported by the 
fact that double-stranded RNA is a potent interferon inducer. 
CP strains induce interferon, whereas NCP strains do not. The 
biochemical difference, in which NCP strains lack an 80K protein 
present in CP strains, is interesting; 	if we accept that NCP 
strains do have a lower replication rate, 	then it could be 
suggested that lack of the 80k protein is a rate-limiting 
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factor, 	and that this protein is therefore involved in 
replication of the viral RNA. 	Donis and Dubovi (1987b) have 
proposed a similar hypothesis in which the 118k protein has a 
negative regulatory effect on transcription or the 80k protein 
enhances it. It is equally possible that both mechanisms occur. 
Thus, the classification of pestivirus strains as CP and NCP 
seems to represent a natural dichotomy within the group, which 
is pivotal in determining the behaviour of the virus in vivo and 
in vitro. 	The molecular basis of the distinction has been 
defined for some strains of BVDV (Meyers et al 1991). 
1.5 MOLECULAR BIOLOGY OF PESTIVIRUSES 
Until recently, there was a great lack of information 
regarding the molecular biology of pestiviruses, probably due to 
the extreme difficulties involved in obtaining the large amounts 
of pure virus necessary for analysis. 	Only BVDV, and recently 
HCV, have been fully characterised at the molecular level and 
the following discussion will be largely confined to BVDV. 
1.5.1 Characterisation of the genome 
The genome of BVDV was first shown to consist of RNA in 1966. 
This RNA was shown to be directly infectious (Diderhoim and 
Dinter, 1966a). 
Prichett et al (1975) published the first attempt to 
characterise the BVDV genomic RNA. These authors investigated 
whether size heterogeneity of the virus was reflected in a 
similar (physical) heterogeneity of the RNA. 	Purified virus 
containing labelled RNA was prepared, and the nucleic acid was 
analysed by isopycnic centrifugation and polyacrylamide gel 
electrophoresis. By both techniques one major and two minor RNA 
species were detected, the sedimentation coefficients in high 
ionic strength were 38s, 31s and 24s, corresponding to 
molecular weights of 3.22, 2.09 and 1.22 x 106kd respectively. 
The two minor components were suggested to be incomplete 
genomes as the sum of their molecular weights approximately 
equalled that of the major component, although they could have 
been degradation products. 
Felmingham and Brown (1977) showed that extracted RNA from 
purified virions was homogenous, banding at 40s in sucrose 
gradients. They also showed this RNA to be single-stranded. 
RNA isolated from infected cells, however, apparently revealed a 
20s component in addition to the 40s one. 	Size analysis on 
polyacrylamide gels showed these RNAs to be 3.6 and 7 x 106kd. 
The larger RNA was double-stranded as judged by its resistance 
to RNAase, and the authors suggested it represented a 
replicative form of the virus. 
Other authors dispensed with the analysis of purified virion 
RNA and instead analysed RNA synthesis in the infected cell. 
Purchio et al (1983) detected a single 8.2kb RNA in cells 
infected with BVDV, 24 hours after infection. The size was 
determined using formaldehyde agarose gels. Sedimentation 
properties of this infected-cell-specific RNA were analysed in 
formaldehyde gradients and a sedimentation coefficient of 33s 
was obtained. 
Recently, the genomic RNA of the Osloss strain of BVDV has 
been cloned and sequenced (Renard et al 1985, 1987a,b,c). RNA 
from purified virions was shown to be 12.5kb in size and lacked 
a poly A tail. RNA from infected cells showed a similar size. 
No subgenomic RNA was identified. 
These authors prepared a cDNA library and eventually obtained 
clones which were characterised by restriction mapping and cross 
hybridisation, 	and shown to span the entire BVDV genome. 
Sequencing of these clones provided the entire nucleotide 
sequence of the genome (Renard et al 1987a). 
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The genome length was 12490bp. Two large open reading frames 
(ORFs) were identified which were non-overlapping. The first ORF 
does not commence with the first AUG in the sequence. 	The 
second ORF is separated from the first and terminates before the 
end of the RNA leaving a 3' non-coding region. 	The two ORFs 
must code for large polyproteins which are processed to give the 
viral polypeptides. 	The predicted amino acid sequence of these 
polyproteins was analysed by hydrophobicity plots. The first 
polyprotein begins with a highly charged positive region 
corresponding to a protein of about 28K which is suggested to be 
the virus capsid protein. 	This is followed by two putative 
membrane glycoproteins of 45-50K (in their unglycosylated form). 
Thus the first polyprotein appears to code for the structural 
proteins of the virion. 	The second reading frame is less 
distincti 	nd was suested to code for the non-structural 
proteins. It is now recognised that Osloss has only one long ORF, and not two. 
Following the report of the cloning of the BVDV-Osloss 
sequence, a second group have reported the cloning and 
sequencing of the NADL strain of BVDV (Collett et al 1988c). 
This group prepared RNA from cells infected with BVD NADL and 
purified the viral RNA by taking advantage of its secondary 
structure. By using a lithium chloride precipitation technique, 
the viral RNA was retained in the supernatant fraction, with 
only some low molecular weight RNAs as contaminants. 
The purified NADL RNA was shown to be 12-13kb in size as 
determined by its migration on methyl mercuric hydroxide gels, 
confirming previous reports. 	The RNAs of other CP and NCP 
strains of BVDV showed identical electrophoretic mobilities. 
Sequencing of the cDNA clones provided the entire nucleotide 
sequence of the NADL strain. 	This sequence contained only one 
long open reading frame (ORF) in contrast to the 2 ORFs reported 
for Osloss. 	This ORF consisted of 3988 codons, potentially 
coding for a 449K giant polyprotein. The amino acid sequence of 
this polyprotein produced by translation of the ORF was analysed 
in a companion paper to the above (Collett et al 1988b). Fusion 
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proteins from each representative area of the genome were 
synthesised, and antibodies to these fusion proteins were used 
in immunoprecipitation analyses to identify the authentic BVDV 
proteins. 	In this way 83% of the genome was assigned a coding 
function. 
The first protein appears to be a 270 residue protein rich in 
proline and lysine residues, and presumed to be the virus capsid 
protein. 	The next segment codes for a 116K precursor which 
yields 3 glycoproteins gp53, 	gp48 and gp25. 	gp53 is the 
presumed membrane glycoprotein with important neutralisation 
sites. 
The next identification region is that coding for p125 which 
in cytopathic strains is processed to p80 and p54. The final 
part of the coding sequence specifies a 133k protein which is 
processed to p58 and p75. 	p75 is the presumed viral RNA 
polymerase, or at least a component of it. 
As discussed previously, 	pestiviruses appear to be more 
closely related to flaviviruses than to togaviruses. 	Like 
pestiviruses, flaviviruses also have a genome of positive sense 
containing one large ORF. 	Comparison of the NADL nucleotide 
sequence with several flaviviruses over the entire genome 
revealed virtually no homology. Comparison of the overall amino 
acid sequences of the translated ORFs also failed to reveal any 
extensive homology (Collett et al 1988a). 	However, comparison 
of the organisation and features of the protein coding regions 
was more rewarding. 	The order of gene products appears to be 
very similar in both viruses, ie capsid protein, glycoproteins, 
followed by non-structural proteins ending with the viral RNA 
polymerase. 
The sequences of two HCV strains have also recently been 
reported (Moorman et al, 	1990; 	Meyers et al, 1989) and the 
homology to the BVDV strains is quite high, around 85% at the 
amino acid level. 
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1.5.2 Expression of the Osloss genome 
The 8.2kb RNA described by Purchio et al (1984b) has been 
translated in vitro using a reticulocyte lysate system. 	On 
denaturing the RNA, a large spectrum of polypeptides was 
translated ranging from 50K to 150K. 	None of these 
co-electrophoresed with authentic viral proteins. 	Isolating 
polysomes from BVDV infected cells however gave translation 
products of 115K and 80K which did co-migrate with viral 
proteins. 
Renard et al (1987b) have expressed virtually the entire 
coding sequence of this virus as B-Galactosidase fusion proteins 
in E. coil. The immunoreactivity of only one of these fusion 
proteins has been reported. 	This particular fusion protein 
represents the start of the second ORF. It was unreactive with 
all BVDV antisera This may be due to the structure of the 
fusion-protein, epitopes normally displayed on the mature virus 
protein may become inaccessible when they form part of the 
fusion protein. 
Alternatively, 	this particular protein may be poorly 
immunogenic in vivo. This seems unlikely since antisera raised 
against the fusion protein were clearly positive in ELISA, IP 
and IF tests using BVDV infected cells. 	Antisera against the 
fusion protein identified a 36K and 76K in IP and western 
blotting respectively. 	The 76K protein is the major band 
detected by IP using sera from infected animals. 	It is a 
non-structural protein as judged by its failure to co-purify 
with virus in sucrose gradients. 	None of the antisera raised 
against the fusion proteins was able to neutralise the virus. 
In summary then, the first ORF may code for the structural 
proteins in the form of a large precursor which is then 
processed to produce mature polypeptides of 28K, 48K and 50K, 
the latter two being glycoproteins. Summing their molecular 
weights and adding an average 5K to each glycoprotein (to 
account for co-translational glycosylation) gives a size of 
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approximately 136K for the precursor. A protein of around this 
molecular weight has been detected in infected cells (Donis and 
Dubovi, 1987a). 
It is proposed that the non-structural proteins are derived 
from the second ORF, which is larger than the first one. The 
largest protein so far detected in BVDV infected cells is 165K 
which presumably represents the non-structural precursor. 	The 
first part of this precursor appears to become a 76K non-
structural protein, possibly involved in viral RNA replication. 
1.5.3 Conclusions and comparisons 
Although the sequences of four pestivirus are now known, 
virtually nothing is known of their replication strategies and 
control mechanisms. 	Presumably the non-structural proteins are 
involved in the synthesis of the minus template strand and in 
processing of protein precurors, but no such roles have yet been 
assigned. The timing and appearance of each protein is largely 
undefined and the regulatory processes controlling the 
expression of the viral genes are totally obscure. 
However, recent work on amino acid sequence comparisons has 
revealed that the p125 protein of BVDV contains domains with 
motifs characteristic of both serine protease type enzymes and 
helicases (DNA unwinding proteins). Even more interestingly, 
the positioning of these domains on the p125 protein is such 
that after the processing to p54 and p80 which occurs in CF BVDV 
strains, both the protease and the helicase are present on the p80 region (Bazan 
& Fletterick 1989; Gorbalenya et al 1989). 
In addition, the BVDV genomic RNA has been postulated, on the 
basis of circumstantial evidence, 	to have a complex and 
extensive secondary structure. This structure has not yet been 
predicted from the sequence data. 
Another puzzle which may be solved by determination of 
further sequence data from different BVDV strains is whether or 
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not actual physical recombination can occur between pairs of 
persistently infecting and super-infecting viruses in vivo. This 
has been suggested to occur on the basis that some CP strains 
have been reported to be altered in their properties (both in 
pathogenesis and protein composition) following superinfection 
(Brownlie et al, 	1989). 	Analysis at the nucleic acid level 
could define this very precisely - if this is occurring it has 
considerable epidemiological implications regarding the 
antigenic variation of these viruses. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
This chapter covers all the basic techniques used throughout 
this work, but some more detailed methods will be found in the 
appropriate chapters. 
2.1 TISSUE CULTURE 
Cells: 	The cells used were semi-continuous cultures of foetal 
lamb muscle (FIX), bovine turbinate (BT) and embryonic bovine 
trachea (EBTR). 
Cultures were established and propagated using standard 
techniques (Paul, 1970). Briefly, tissues were coarsely chopped 
then disaggregated using 0.25% trypsin, filtered through gauze 
and washed in tissue culture medium. 	Cells were seeded at lml 
pcv per lOOmi medium, incubated for 24hrs, then the medium was 
changed. Cultures were allowed to reach confluence and were 
subsequently split 1:3 when necessary. 
Cultures were used between pass 	5 and pass 20, 	after which 
growth rate and susceptibility to virus infection were reduced. 
All cell stocks used were shown to be free of contaminating 
pestiviruses by an indirect immunofluorescence test (IFT). Cell 
cultures were also checked periodically every 5 passes by IFT, 
as described previously (Gardiner et al, 1983; Nettleton et al, 
1987). 
Tissue culture medium and solutions 
1 x Hanks balanced salt solution (Hanks BSS) 
mg/l 
MgSO4; 7H20 	 200 
MgCl2; 6H20 	 100 
CaC12; 2H20 	 140 
NaCl 	 8000 
Na2PO4; 71120 	 3000 
KH 
2 
 PO 4 
	
60 
KC1 	 400 
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1 x phosphate buffered saline 
mg/i 
NaCl 	 8000 
KC1 	 200 
Na2HPO4 	 1150 
200 
1 x isotonic saline 
NaCl 	 8500 
Medium E199 
E199 lOx liquid with Earles salts (modified), without sodium 









Distilled water to 500 ml 




lOx 50m1 lx 
29.5g/i 60m1 3.55g/1 
80g/1 3m1 0.48g/l 
	
0. IM 	 5m1 	 1mM 
10,000u/ml 	 5ml 	 lOOu/ml 
lOg/i 	 Sml 	 0.lg/1 
* 10% serum for growth medium 
2% serum for maintenance medium, a further 3m1 sodium bicarbonate to 
give 0.9g/l. 
* Serum used was Foetal Bovine Serum (FBS) from Northumbria 
Biologicals (batch 37826), 	shown to be free of BVD virus and 
antibodies to BVDV. 	The serum was heat inactivated for 30 mm, 
56°C. 
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In some later experiments horse serum (non heat-inactivated) 
from Tissue Culture Services Ltd (batch 480) replaced FBS. 
IMDM 
IMDM (powder) Iscoves modified Dulbecco's Medium, 	with 
L-glutamine, with 25mM Hepes buffer, without sodium bicarbonate, 
without alpha-thioglyceral, without beta-mercaptoethanol (Gibco 
Labs). 	Ix stock was prepared as specified in Gibco catalogue. 
For use pencillin (100,000u/ml) was added to a concentration of 
lOOu/ml, 	streptomycin (log/i) was added to 6.lg/l. Sera, 	as 
detailed above, were added to concentrations of 5% for growth 
medium and 2% for maintenance medium. 
2.2 VIROLOGY 
2.2.1 Virus strains 
The two main pestivirus strains used throughout this work 
were the BDV strain G1480 (non-cytopathic) and the BVDV strain 
NADL (cytopathic). 	Occasionally other strains were used in 
specific experiments and these will be detailed in the 
appropriate chapter. 
BDV-G1480 was isolated at Moredun from a precolostral blood 
sample taken from a new born lamb with clinical symptoms of 
Border Disease. 	The lamb's mother had been infected 
experimentally at 52 days gestation with the Moredun strain of 
BDV isolated originally from a pool of brain tissue (IIB brain 
pool) from newborn lambs clinically affected with BD (Barlow et 
al, 1980). 	It was passaged five times in foetal lamb kidney 
(FLK) cells including three passages at terminal dilution. This 
master stock was adjusted to 10 TCID50/ml and stored in 20m1 
aliquots at -70°C. 
BVDV-NADL was originally isolated from the spleen of an 
animal which died from BVD at the National Animal Diseases Lab, 
Iowa, USA. 	It was obtained from the American Type Culture 
Collection and kindly supplied by Dr. P.L. 	Roeder, 	Central 
Veterinary Laboratory, 	Weybridge. The virus had been passaged 
seven times in bovine cells and was passaged a further twice 
then stored as a master stock of titre 4 x i06 TCID50/ml in 4ml 
aliquots at -70°C. 
Working stocks of both strains were grown as required. 
2.2.2 Virus growth 
Viruses were grown on 100% confluent cell monolayers. BDV was 
grown in FLM cells. 	BVDV was grown in bovine cells (BT or 
EBTR). Depending on requirements, 	virus was grown in plastic 
tissue culture flasks (various sizes) or in glass roller bottles 
surface area 1500cm 
2
(Jencons). 	All cultures were sealed and 
incubation was in a non-CO2 atmosphere at 370C. 
Confluent monolayers were washed twice with warm Hanks BSS. 
The virus inoculum was added at the appropriate multiplicity of 
infection (moi) generally 0.01 TCID50/cell and in a minimal 
volume, 20ml per roller bottle, for example. The cultures were 
incubated at 37°C for lhr with occasional agitation, 	then the 
inoculum was removed and maintenance medium was added. 
Incubation of CP viruses was continued at 37°C for 2-5 days, 
depending on virus strain and degree of cytopathic effect (CPE) 
at harvest. NCP viruses were harvested after 4-5 days. 
2.2.3 Virus harvesting 
The sources of infectious virus were: the tissue culture 
supernatant and the cell monolayers. For BVD-NADL the 
distribution of virus has been shown to be approximately 10 fold 
higher in the supernatant than in the cellular fraction 12hrs 
post infection (pi) (Nuttall, 1980). 	For BD NCP virus the 
distribution is approximately equally divided between the two 
compartments (P. Nettleton, personal communication). 
During this work, infectious virus was harvested from tissue 
culture supernatant only, 	and the cells were further processed 
to yield viral RNA. 
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Procedure: 	The tissue culture fluid was removed from the 
cultures and clarified by centrifuging at 9000rpm, 30 min at 4°C 
in a Beckman Ja-14 rotor for the Beckman J2-21 high speed 
centrifuge. 	This clarified supernatant was sampled for 
titration and aliquots stored as working stocks as required. 
Supernatants not used immediately for virus isolation were 
stored at -70°C until required. 
Various methods were tested to find the most efficient 
procedure for concentrating supernatants and purifying virus. 
These are discussed fully in Chapter 3, but the usual means of 
isolating intact virus from supernatant was to centrifuge the 
supernatant at 25K, 16hrs at 40C in an SW28 rotor. 
2.2.3 Assay of infectious virus 
Tissue culture supernatants were assayed for either 
cytopathic or non-cytopathic virus by an end point titration 
method. Serial ten-fold dilutions of samples were made in 
serum-free medium and titrated in 96 well microtitre plates. 
Four wells each containing 25u1 volumes were used per dilution. 
The appropriate host cells in lOOul of growth medium were added 
in the form of a suspension containing 2 x 10 cells per lOOul 
per well and the plates were sealed and incubated at 37°C for 5 
days. 	The titration end point was determined for CP viruses by 
the microscopic examination of cultures for cytopathic effects. 
For NCP viruses the end point was determined by an 
immunoperoxidase staining procedure as detailed below. 	In both 
cases the titration end point results were calculated and 
expressed as Tissue Culture Infective Dose/ml (TCID50/ml) 
(Lenette and Schmidt, 1979). 
Immunoperoxidase test for detection of NCP virus (Smith et al 
1988) 
Following 5 days incubation, the plates were emptied, gently 
washed with warm physiological saline and air-dried. Cells were 
fixed to the plates in 95% acetone in distilled water at -20°C 
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for 30 mm. 	The plates were then air dried, 	washed once more 
in saline and blotted dry. 
Fifty microlitres of an optimal dilution of gnotobiotic lamb 
serum with a high level of neutralizing antibody to BDV were 
added to each well and incubated at 37°C in a moist atmosphere 
for 30 mins. 	Plates were then washed four times in warm wash 
fluid and blotted dry. 
Fifty microlitres of the 2nd antibody: 	donkey anti 
sheep-horseradish peroxidase conjugate from the Scottish 
antibody production unit (SAPU) were added to each well and the 
plates incubated 30 min as before. The four washes in warm wash 
fluid were repeated and the plates blotted dry. 
Freshly prepared substrate AEC (see Appendix 1) was added 
(50ul) to each well. Colour development occurred after 30 mm - 
1 hr at room temperature. 	The reaction was stopped by washing 
plates once in tap water. 
2.2.4 Trichloroacetic acid (TCA) assay of incorporation of 
uridine into cellular RNA 
Cells (FLM) were grown on the inside of stoppered glass test 
tubes in E199 growth medium containing 2uCi/ml H uridine. 
Medium was aspirated from the tubes and the monolayers washed 
twice with ice cold PBS. 	0.5ml of lysis buffer was added to 
each tube (Lysis buffer: 0.5g NP40, 0.017g NaCl, 0.03g MgCl2, 
lid Tris pH8.6, 100l 1120).  Tubes were vortexed thoroughly for 
10 seconds. 
lOml ice-cold 5% TCA were added, mixed and the tubes 
incubated at 4°C for 5 mm. 
The contents were then filtered through a Whatman glass fibre 
filter using a vacuum pump attached to a conical flask with a 
funnel attachment. 
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The filter was washed twice in ice-cold TCA, once in absolute 
ethanol, air dried and placed in a scintillation vial. Counts 
were obtained over 1 minute in PPO scintillator fluid on a 
Scintillation Counter. 
2.3 DNA TECHNIQUES 
2.3.1 Standard solutions 
All solutions were sterilised by autoclaving at l5lbs/inch2  
for 20 min unless otherwise indicated. 
1 x TE: 	 10mM Tris HC1, 1mM EDTA adjusted to pH 
8.0 with concentrated HC1. 
1 x TNE: 	 100mM NaCl 
10mM Tris HC1 pH8.0 
1mM EDTA pH8.0 
50 x TAE: 	 2M Tris base, 	1M CH3COO Na, 	50mM 
EDTA, stock solution adjusted to pH8.3 
with glacial acetic acid. 
20 x SSC: 	 3M NaCl, 0.3M sodium citrate, 	stock 
solution adjusted to pH7.0 with 5N 
NaOH. 
50 x Denhardts solution: 1% (w/v) Ficoll, 1% (w/v) polyvinyl 
pyrrolidone, 1% (w/v) BSA (Pentax 
fraction V), filtered through 0.45uni 
filter and stored -20°C. 
Ethidium bromide: 	l0mg/.y1 in H 
2 
 0 stored in light-proof 
bottle. 




Phenol: 	 Redistilled from solid. 	Distillate 
was equilibrated with 1M Tris-HCl p118.0 
and stored under a layer of TE buffer. 
8-Hydroxyquinoline was added to 0.1% 
(w/v). Aliquots were stored at -200C. 
Chloroform: 	 chloroform and isoamyl alcohol (IAA) 
24:1 	mixture 	stored 	at 	room 
temperature. 
Phenol/Chloroform: 	1:1 mixture of the above. 
Formamide: 	 Deionised by adding lg/ml of ion 
exchange resin (Dowex AGx G8) and 
stirring for lhr. The formamide was 
filtered through Whatman No. 1 paper 
and stored at -700C in small aliquots. 
Glassware and Dlasticware 
All glassware used in nucleic acid work had been washed, 
rinsed twice in double-distilled water and sterilised by 
autoclaving (15lbs/in2 20 mm). Further treatment was necessary 
for glassware to be used in RNA work: see Section 4. Pipette 
tips were sterilised by autoclaving as above. 
Bacterial growth media 
L-broth: 	 lOg/l Difco Bacto tryptone 
4g/l Bacto yeast extract 
lOg/l NaCl 
pH 7.2 
L-agar: 	 As above plus 15g/l Difco agar. 
Antibiotics: 	Ampicillin (500x) stock solution, 25mg/ml in 
water. Use at SOug/ml. 
Chioramphenicol: (200 x) 34 mg/ml stock 
solution in 70% ethanol. Use at 170ug/ml. 
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2.3.2 Phenol extraction of DNA 
Generally done in 1.5m1 microfuge tubes. 	An equal volume of 
phenol/CHC13/IAA mixture was added to the DNA solution. 	The pH 
of the equilibration buffer was 8.0. 	The mixture was vortexed 
thoroughly for 5 sec and the phases separated by a brief 1-2 mm 
spin in a microfuge. The upper aqueous phase containing the DNA 
was removed and retained. 	The organic phase was then 
re-extracted with an equal volume of TE buffer and this was 
pooled with the first aqueous phase. 
2.3.3 Ethanol precipitation 
DNA was precipitated from solution by the addition of 0.5 
volume of 7.5M ammonium acetate and 2 volumes ethanol. The 
tubes were spun immediately for 20 min to pellet the DNA 
(12000rpm in a microfuge (MSE) or high speed centrifuge 
depending on the volumes). Occasionally, when the DNA was at a 
very low concentration (< 0.lug/ml) and recovery was critical, 
the ethanol/nucleic acid mixture, was stored at -20°C for 30-60 
min before pelleting. The pellets were washed with 70% ethanol, 
dried in a vacuum desiccator and resuspended in the desired 
volume of TE buffer. DNA was stored in TE at 4°C. 
Restriction endonuclease dipestion of DNA 
DNA was digested in a total volume of 10-50u1. The reaction 
mixture contained DNA, 10 x restriction buffer, restriction 
enzyme and water. Incubation was at 37°C for 1-2hrs. The BRL 
REACT buffer system was used, along with the appropriate 
enzymes. 	Reactions were generally loaded directly onto an 
agarose gel for analysis without further purification. 
2.3.4 Preparation of competent cells and transformation with 
plasmid DNA 
The method used was based on that of Chung et al (1989). 
The bacterial strain used was E. 	coil JM109, 	Genotype: 
(lac-pro), thi, supE44, 	recAl, and Al, gyr A96, hscl, R17 
1 	 9  /F, tra D36, proAB, lac/, lacZLTIJ. 
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A fresh overnight culture was diluted 1/100 into L-broth and 
the cells incubated with shaking at 37°C (225rpm) until the 0D600  
= 0.3-0.4. 
The cells were pelleted lOmins at 4000rpm 4°C, resuspended in 
1/10 volume of ice cold TSS and mixed gently. 	O.lml of this 
suspension was then added to a chilled polypropylene tube 
containing lul (0.01-ing) of plasmid DNA and mixed gently. 	The 
tube was incubated on ice for 30-60mm. 	0.9m1 of L-broth with 
lOmrl glucose was added and the cells incubated at 37°C with 
shaking (225rpm) for an hour, 	to allow expression of the 
antibiotic resistance gene. 	0.lml of the culture was plated 
directly by spreading on L-agar plates containing the appropriate 
selective antibiotic 
TSS: L broth + 10% (w/v) PEG 8000 
5% (v/v) Dimethylsulfoxide (DMSO) 
2Oml MgCl2  
pH 6.5 
2.3.5 Large scale preparation of plasmid DNA 
500m1 of L-broth plus anipicillin (25ug/ml) were inoculated 
with 20m1 of an overnight culture in a 2-litre flask, 	and 
incubated 16hr at 37°C with vigorous shaking. 
The cells were pelleted at 4000rpm for 15min at 4°C and the 
culture medium allowed to drain from the pellets. The pellets 
were washed in ice cold TNE and pelleted as above. 
The pellet was resuspended in lOmi Lysis buffer (25mM 
Glucose, 	25mM Tris HCl pH8.0, 10mM EDTA) to which lysozyme had 
been freshly added to a concentration of 2mg/mi. The suspension 
was stored at room temperature for 5mm., 20ml freshly prepared 
solution 2* were added and the contents mixed thoroughly by 
inverting the bottle. 	The mixture was allowed to stand at room 
temperature for 10mm. lSml of ice cold solution 3* were added 
and the contents mixed by vigorous shaking then stored on ice 
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for 10mm. 	The lysate was then centrifuged at 10000rpm for 30 
min and the supernatant filtered into a fresh bottle. 	0.6 
volumes of isopropyl alcohol were added, 	mixed well and left 
for 10min at room temperature. 
The DNA was recovered by centrifugation at 12K for 30min at 
20°C. The pellet was rinsed with 70% ethanol and dried by 
evaporation at room temperature. The pellet was dissolved in 
8m1 of TE. 
* Solution 2: 0.2N NaOH, 1% SDS 




Purification of plasmid DNA on continuous CsCl density gradients 
Eight grams of solid CsC1 were added to the 8m1 of DNA 
solution (final volume = lOml). 	0.8ml of a lOmg/ml ethidium 
bromide solution was added and mixed with the CsC1 solution. The 
final density of the solution was 1.55g m1 1 (refractive index = 
1.3860) and the ethidum bromide concentration was approximately 
740ug/ml. 
The mixture was transferred to a Beckman quick-seal 
polyallomer tube using a wide gauge needle and disposable 
syringe. 	The tube was filled with light paraffin oil and heat 
sealed. The density gradient was spun in a Ti 70 rotor 
(Beckman) for 48hrs at 40000rpm. 
After centrifugation the gradient tube was viewed under UV 
light, to visualise the DNA bands. 	The lower, plasmid band was 
collected through the side of the tube using a syringe and a 19g 
needle. 
The plasmid DNA was placed in a lOmi polypropylene tube and 
the ethidium bromide was removed by four extractions with an 
equal volume of n-butanol. 	The CsC1 was removed by dialysing 
against several changes of TE buffer overnight. 	The 
concentration of plasmid DNA was measured by checking the 
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0D260/280 of the solution and the DNA was precipitated by 
ethanol, 	resuspended to the desired concentration in TE, 
aliquoted and stored at -20°C. 
2.4 RNA TECHNIOUES 
2.4.1 Precautions to minimise RNAse activity 
All glassware for RNA work was washed and sterilised as for 
normal laboratory glassware then soaked in a 0.1% (v/v) solution 
of diethyl pyrocarbonate (depc) in water overnight and 
sterilised by autoclaving. 	Where possible the use of sterile 
disposable plasticware was preferred, as this was assumed to be 
RNAse free. 
All solutions for RNA work were prepared from separate 
bottles of dried chemicals, depc was added to 0.1% v/v and the 
solutions left overnight at room temperature then autoclaved. 
Tris solutions were prepared using sterile depc-treated water, 
because the addition of depc to Tris causes its decomposition. 
Depc is unstable in the presence of water and rapidly 
decomposes to ethanol and CO2. For this reason depc was 
purchased in small (25ml) bottles, stored at 40C in a 
dessiccator jar, and any excess was discarded after 1 month. 
All RNA work was carried out wearing gloves to avoid 
contamination with RNAases from the skin. 
2.4.2 Solutions for working with RNA (prepared under RNAase free 
conditions). 
RNA extraction buffer. 4M Cuanidinium isothiocyanate, 0.1M Tris 
C1pH7.5 	 - 
B-mercaptoethanol 17. 
5.7M CsCl in 10'J1EDTA 
TE/SDS 	10mM Tris pH7.6 
1mM EDTA 
0.1% w/v SDS 
TNE/SDS 10mM Tris pH7.6 
1mM EDTA 
100mM NaCl 
0.1% w/v SDS 
2M LiCl2 
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2.4.3 Phenol extraction 
Phenol was equilibrated with ACE buffer (10 mM NaOAC pH5.1, 
50mM NaCl, 5mM EDTA) An equal volume of phenol was added to the 
RNA solution, 	mixed well and the phases separated by 
centrifugation at 10000rpm for 5mm, 	or in a microfuge. 	The 
aqueous phase was re-extracted with a phenol/CHC13/IAA mixture 
as for DNA. 	Phenol extractions were carried out on ice unless 
SDS was present in the sample. 
2.4.4 Ethanol precipitation 
RNA was precipitated from solution by the addition of 0.1 
volume of 3M sodium acetate and 3 volumes of ice cold ethanol. 
The mixture was chilled at -20°C or -70°C for a minimum of 
30mm. 	The precipitate was collected as for DNA precipitation. 
The pellets were rinsed in 70% ethanol and resuspended in 
TE/SDS. 
Storage: Long term storage (> 1 month) of RNA was in 70% 
ethanol as a precipitate at -70°C. Short term storage was as 
either a precipitate or an aqueous solution containing 0.1% SDS 
at -20°C. 
2.4.5 Isolation of RNA using guanidinium salts followed by 
CsC1 gradient purification (Chirgwin et al, 1977). 
From a confluent cell monolayer rinsed well with Hanks BSS: 
RNA extraction buffer was added directly to the monolayer in the 
flask and the cells scraped off with a rubber policeman. The 
viscous lysate was transferred to a tissue homogeniser tube and 
homogenised for 1mm. The homogenate was centrifuged at 4000rpm 
for 5min at 4°C. It was then layered onto a cushion of 5.7M 
CsC1 in a Beckman polyallomer tube. Depending on the volume, 
either SW55 or SW40 tubes were used. 	The CsC1 cushion occupied 
a maximum of 0.25 volume of the tube. Centrifugation was at 30K 
for 24hrs (SW40) or 40K for 16hr (SW55) at 200C, in a Beckman L8 
ultracentrifuge. 
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Following centrifugation, the supernatant was carefully 
removed down to the level of the cushion. The upper portion of 
the tube was cut off using a red hot scalpel blade and the 
remaining fluid drained off. The pellet was rinsed with 70% 
ethanol dissolved in TE/SDS and transferred to a microfuge tube 
for ethanol precipitation. 
RNA was also isolated from frozen virus pellets in SW28 tubes 
by adding the RNA extraction buffer directly to the frozen 
pellet and continuing as above. 
2.4.6 Rate zonal sedimentation of RNA through sucrose density 
gradients 
For this work the gradients used were 10-30% continuous 
preformed sucrose gradients. 
Gradient preparation: 	stock sucrose solution was 60% (w/w) 
prepared in TNE/SDS using RNAse-free highly pure sucrose (BRL). 
Dilutions from this stock were made to give 10% w/w and 30% w/w 
solutions. The dilution was non-linear, see below. 
	
Volume of 60% 	 3 
Desired final 	stock sucrose diluted 	Density (g/cm ) 
concentration to 1 litre (ml) 
10% 	 134 	 1.0381 
30% 437 1.1270 
(Taken from Meth Enzymol, Vol. 45) 
Gradients were poured light end first into Beckman SW40 
polyallomer tubes, using a three channel peristaltic pump. 	All 
pump tubing, gradient tubes and apparatus had been soaked in 
0.1% depc in water, then rinsed with depc treated water prior to 
use. Gradients were used within 30min of preparation. 
The RNA samples were dissolved in lOOul TNE/SDS and heated to 
650 for 15min prior to loading on the gradient. 
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Centrifugation of the gradients was performed at 20°C 
20000rpm for 20hr, and the rotor decelerated without braking. 
Following centrifugation, tubes were carefully removed and 
the gradient was fractionated by upward displacement using 40% 
sucrose solution pumped into the bottom of the tube. 	The 
gradient was collected in 0.5ml fractions while the OD was 
measured. 	The desired fractions were pooled and precipitated 
with ethanol. All fractionation equipment had been depc treated 
prior to use. 	The gradient profile was seen as a spectro- 
photometric trace. 
2.5 GEL ELECTROPHORESIS 
2.5.1 Horizontal agarose gel electrophoresis of DNA 
Buffers: Running buffer: 1 x TAE Ethidium Bromide (EtBr) looug/rnl 
Sample loading buffer: 5 x TAE, 50% (v/v) glycerol 
0.5% w/v xylene cyanol 
0.5% w/v bromophenol blue 
The optimum percentage of agarose in the gel was determined 
by the size range of the DNA to be separated, as recommended in 
Sambrook et al (1989). 
The agarose was dissolved in running buffer to the desired 
concentration by heating in a microwave oven. After cooling to 
50°C the solution was poured into a gel casting tray (11 x 14cm) 
(BRL). When set, the gel was placed in the gel tank (BRL mini 
gel apparatus) and covered with running buffer. 	The samples 
were mixed with 0.2 volumes of loading buffer and loaded into 
the wells. 	Gels were run at 60-80v for 1-2 hrs or 15v 
overnight. 
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2.5.2 Formaldehyde-agarose gel electrophoresis of RNA 
All solutions and glassware were RNAase free as described 
in Section 2.4.1. 
Buffers: 10 x MOPS/EDTA: 0.2M MOPS [3-(N-morpholino) 
propanesulfonic acid] 
50mM sodium acetate 
10mM EDTA 
Running buffer: 1 x MOPS/EDTA 
Sample buffer: 	0.75m1 deionised formamide 
0.15u1 x MOPS 





0.8u1 10% (w/v) bromophenol blue 
Gels were prepared in running buffer as for DNA agarose gels, 
and allowed to cool to 50°C. Formaldehyde was added to a 
concentration of 0.66M and the gel was poured into an 11 x 14cm 
tray and allowed to set for lhr in a fume hood. 
The RNA samples were prepared for electrophoresis by 
precipitating with ethanol, redissolving in 1-2u1 of 25mM 
EDTA/0.1% SDS and mixing with lOul of sample buffer. After 
heating at 650C for 15mm, lul of 1mg/mi EtBr solution was added 
and the samples were loaded onto the gel. Electrophoresis was 
generally performed at 60v for 2-3hrs. 
2.5.3 Alkaline agarose el electrotthoresjs of DNA 
Buffers: 1 x running buffer: 	50mN NaOH 
1mM EDTA pH8.0 
6 x sample loading buffer: 300mN NaOH 
-6mM EDTA 
18% Ficoll (type 400; 
Pharmac ia) 
0.15% bromocresol green 
0.25% xylene cyanol 
51 
The desired amount of agarose was dissolved in water and 
allowed to cool to 60°C. NaOH was added to 50mM and EDTA to 
1mM. 	The gel was poured and allowed to set as described in 
Section 2.5.1. It was placed in the electrophoresis tank and 
sufficient lx running buffer added to cover the gel to a depth 
of 2mm. 
The samples to be electrophoresed (in 1120) were prepared by 
adding EDTA to 10mM followed by 0.2 volume of 6 x sample loading 
buffer. 	Electrophoresis was performed until the dye had 
migrated approximately 2/3 of the way into the gel. 
The gel was soaked for 30min in 7% TCA then mounted on three 
layers of 3MM paper, covered in Saran wrap and dried in a 
commercial gel dryer (Biorad) without heat for 2 hours. 	The 
dried gel was then autoradiographed. 
2.5.4 Visualisation and photography of nucleic acids in gels 
Ethidium bromide was included in the gel and the running 
buffer for ordinary agarose gels, and in the sample for RNA 
gels. 
Gels were viewed on a short wave liv transilluminator and 
photographed using a Polaroid camera, Type 667 film under a 
red/orange filter. Exposure time was generally 0.5sec at f4.5 
2.5.5 Recovery of DNA from agarose gels 
The desired bands were eluted from the gel and the DNA 
purified by one of two methods either by using 'Geneclean' 
according to the manufacturers instructions (Stratech Ltd) or by 
electroelution as described by Sambrook et al (1989). 
2.6 NUCLEIC ACID HYBRIDISATION ON FILTERS 
2.6.1 Preparation of RNA dot blot filters 
Filters were nitrocellulose (Schleider and Schuell) or nylon 
(Hybond N, 	Amersham). 	Gloves were worn at all stages of 
handling filters. The filter was moistened for 15min in 
distilled water, 	transferred to 20 x SSC for 30min and then 
applied to a commercial blotting manifold (Hybridot or 
hybrislot). 
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The RNA sample was denatured in a volume of lOOul containing 
7.5% formaldehyde and 6 x SSC in TE buffer, by heating to 65°  
for 15min before chilling on ice. 
The sample was then applied to the manifold under a gentle 
vacuum such that lOOul sample took approximately 5mins to blot. 
The filter was removed and air dried on 3MM (Whatman) paper for 
30mm. 	The RNA was fixed to nitrocellulose filters by baking 
under vacuum for 2hrs and to nylon filters by brief (2mm) 
exposure to short wave UV light. 	Filters not used immediately 
were stored between sheets of 3MM paper wrapped in Saran Wrap. 
2.6.2 Preparation of northern blot filters 
RNA samples were run on a formaldehyde gel as described in 
Section 2.5.2. RNA markers (BRL RNA ladder) were included on 
the gel and the gel was photographed under UV directly without 
destaining. 	The gel was then soaked in 10 x SSC for 2 x 20mm 
periods. 
Filters used were as described in the previous section. The 
filter to be used was pre-wet in distilled water for 5min then 
transferred to 10 x SSC for 5mm. It was applied to the gel and 
blotted by capillary action using 10 x SSC as the transfer 
buffer, essentially as described in Sambrook et al (1989). RNA 
transfer was allowed to take place over 16hrs. 	The fixing of 
RNA to the filter, and storage was as described in the previous 
section. 
2.6.3 Preparation of DNA probes by random priming (Feinberg 
and Vogelstein, 1984). 
This method allows the labelling of isolated DNA fragments to 
high specific activities. 	Linear double-stranded DNA purified 
from agarose gels as described in Section 2.5.5 was used as the 
template in the reaction. 	The optimum size of template is 
lOO-300bp. 
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Using 32P as label, the resulting probe is only stable for 
around 4 days, so it was impractical to prepare excessive 
amounts. 	The amount of template in the reaction was determined 
by the eventual amount of probe needed for the hybridisation 
reaction (see below) 
Typical hybridisation reactions: 
Hybridisation 
Area 	volume 	 Probe 	Template* 












Northern filter 100cm 2 25ul 
	
500-1000ng 250-500ng 
* Assumes the amount of labelled probe produced is double the 
amount of input template, though labelling double-stranded template 
effectively halves the specific activity of the available probe. 
Reagents: 2M Hepes pH 6.6 
Solution 1: 	1.25M Tris pH8.0 
0.125M NaCl 
500u1 each dATP, dCTP and dTTP 
Random primers: 90 OD units/ml of random hexamers 
(Pharmacia) 
Oligo-labelling 2M Hepes (250): Random primers (150): 
buffer (OLB): 	solution 1(100) 
Bovine serum albumin (BSA) (10mg/ui) 
dCTP 2.5mM 
The correct amount of template DNA in lOul distilled water 
was boiled for 3mm, the volume restored to iOul, then chilled 
on ice. The following components were added: 4ul OLB, 2u1 dCTP, 
lul BSA, 2u1 32PdCTP and 5 units large fragments of E. coil 
polymerase. 	Between 1o6 and 1O7 of label were used per ml of 
hybridisation buffer. 
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The resulting 20u1 reaction was incubated at 37°C until 
approximately 70% incorporation of label was achieved (generally 
2-3hrs) 
The probe was purified from unincorporated labelled dCTP by 
ethanol precipitation using ammonium acetate. 	It was 
resuspended in SOOul of TE buffer and used immediately in a 
hybridisation reaction or stored at -20°C. 	Between 106  and lO 
cpm/ml of hybridisation fluid were used. 
2.6.4 Preparation of RNA probes 
32P-labelled single-stranded RNA probes were prepared by 
run-off transcription from a T7 promoter. 	The insert to be 
transcribed was contained in the transcription vector pGEM4. 
Details of this vector are to be found in Chapter 5. 
The template was plasmid DNA which had been linearised by 
digestion with a restriction enzyme at a site downstream from 
the T7 promoter. The reaction was carried out in a 20u1 volume. 
All solutions and equipment were treated to minimise RNAse 
activity as described in Section 2.4.2. 
The reaction was carried out in 40mM Tris-HC1 p118.0, 10mM 
MgC12 10mM Dithiothreitol (DTT), 4mM spermidine, 10mM NaCl and 
50ug/ml BSA. The template DNA was added to the above buffer 
along with ATP, GTP and CTP each to a final concentration of 
0.5mM. Generally, 0.5ug of template was used. 20uCi of 32 P-UTP 
were added followed by 10 units T7 RNA polymerase (Pharmacia). 
The reaction was incubated at 37°C for lhr. Remaining DNA was 
removed by diluting the reaction to 200ul and adding 10 units 
DNAse 1 (Pharmacia) then incubating a further 15 mins at 37°C. 
The RNA probe was purified by phenol extraction and ethanol 
precipitation, then by chromatography on a 10cm x 1cm Sephadex 
G50 column followed by a further ethanol precipitation. 	The 
probe was redissolved in TE buffer containing 0.1% SDS and 
either used immediately or stored frozen at -20°C. 
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2.6.5 Hybridisation and washing procedures 
Hybridisation fluid: 50% formamide 
5 x Denharts solution 
4 x SSC 
0.1% SDS 
100ug/ml denatured salmon sperm DNA 
Filters prepared as described in Section 2.6.1 were 
pre-hybridised in the above fluid for a minimum of 4hrs at 420C. 
This and the subsequent incubation with probe took place in 
minimal volumes in sealed vessels. 	Examples of typical 
hybridisation volumes are given below 
Filter size 	Volume hybridisation fluid Hybridisation vessel 
	
5cm2 	 lml 	 lOml polypropylene tube 
10cm 2 4ml 50m1 polypropylene tube 
100cm2 	 lOml 	 200ml screw top roller jar 
Continuous movement of the buffer over the filter during 
pre-hybridisation and hybridisation was provided by incubating 
the tubes or jars on a roller apparatus (or rotary shaker for 
1041 tubes). 
After the pre-hybridisation the required amount of probe was 
added directly to the hybridisation fluid. Double-stranded DNA 
probes were first denatured by boiling. Incubation continued at 
42°C for up to 16hrs. This was the standard hybridisation 
procedure, variations on this method are described in Chapter 5. 
Following hybridisation the probe and hybridisation solution 
were removed and either stored for re-use or disposed of. 	The 
filter was washed as follows, with agitation. 
2 x 5 min in 2 x SSC 0.1%SDS at room temperature 
2 x 30min in 0.1 x SSC 0.1%SDS at 55-60°C 
Again, variations on these standard washes are described in 
Chapter 5. 
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The washed filters were wrapped in Saran Wrap and 
autoradiographed. They were not allowed to dry if they were to 
be re-probed. Probe could be stripped by washing 2 x 30min in 
distilled water at 70°C. 
2.6.6 AutoradioEraDhv 
Detection of 32P radiolabelled material was performed using 
X-ray film in cassettes. 	Gels were dried and covered in Saran 
Wrap, wet filters were sealed in Saran Wrap. 	The package was 
placed in direct contact with the X-ray film and exposed at 
-70°C using a single intensifying screen on the opposite side of 
the film to the gel or filter. 
2.7 POLYMERASE CHAIN REACTION 
Both DNA and RNA templates were used in the Polymerase Chain 
Reaction (PCR) to amplify sequences. 	The specific protocols 
used are detailed in Chapter 6. The amplifications were 
performed using the Techne PHC-1 Dri block thermocycler and 
"Amplitaq" Taq polymerase enzyme (Perkin Elmer Cetus). 	RNA 
templates were converted to single strand cDNA using murine 
moloney leukaemia virus (MMLV) reverse transcriptase (GIBCO/BRL) 
prior to amplification. 
PCR amplification buffer (lOX): 500mM KC1 
100mM Tris pH8.3 
25mM MgCl2  
2mg/ml gelatin 
Primers: Custom-made synthetic oligonucleotides used as PCR 
primers were obtained as aqueous solutions from Oswell DNA 
Service, University of Edinburgh. 
2.7.1 Precautions 	to minimise contamination by irrelevant 
DNA sequences 
All solutions and equipment were sterile and reserved for PCR 
work. Stock solutions were prepared using pipettes reserved for 
that purpose, aliquoted under sterile conditions and stored at 
-20°C. Different pipettes were used to handle post-
amplification reactions and these reactions were never handled 
at the same time as pre-amplification reactions. 
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2.8 COMPUTING TECHNIQUES 
The University of Wisconsin Genetics Computer Group (UWGCG) 
sequence analysis software packages, mounted on a VAX/VMS 
operating system were used. 	Details of the particular programs 
used are described in Chapter 7. The EMBL/GENBANK sequence data 
libraries were also accessed. 
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CHAPTER 3 
GROWTH AND REPLICATION OF BORDER DISEASE VIRUS 
3.1 INTRODUCTION 
Large amounts of purified BDV were a necessary pre-requisite 
for this project. 	Before embarking on large-scale virus 
cultivation, however, studies were performed on the kinetics of 
virus growth and replication in order to optimise the amount of 
virus obtainable. This chapter first describes briefly previous 
studies on pestivirus growth, 	then presents and discusses 
results in which viral infectivity and RNA synthesis were 
measured over a period of time. 
Previous reports have discussed the growth cycles of all 
three pestivirus species (Aynaud, 1968; Nuttall, 1978, 1980; 
Nettleton, 1985). 
The growth curves of a cytopathic (CP) strain of BDV were 
compared to those of two CP BVDV strains in foetal lamb brain 
cells (Nettleton, 1985). 	No significant differences between 
strains were detected. Growth was exponential until about 20hrs 
post infection (pi) followed by a plateau. 
Nuttall (1978, 	1980) reported comparative growth studies 
(assaying infectious virus) between CP and NCP strains of BVDV. 
She concluded that although the rate of appearance of infectious 
virus was the same for both strains, 	the final yield was less 
(about 50 times) for the NCP strain. The effect of the drug 
Actinomycin D (AcD) on BVDV replication was studied. Virus 
infectivity was measured at 20hrs post-infection (pi) in the 
presence of 0.5-2.Oug/ml AcD for both CP and NCP strains of 
BVDV. 	Replication of the NCP strain was enhanced by 20-100%. 
Whether this effect was maintained throughout the growth cycle 
was not reported. 	Aynaud (1968) observed a similar enhancement 
of NCP HCV replication during the exponential phase in 
AcD-treated cells but this was a transient effect and a final 
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final reduction in virus yield was observed after treatment with 
AcD. 
Reports on the kinetics of RNA synthesis of the pestiviruses 
are few. Nuttall (1978) followed the synthesis of BVDV RNA by 
incorporation of 3H-labelled uridine. An estimate of viral RNA 
synthesis was obtained indirectly by comparing results from 
infected and mock-infected cells. However, this would not have 
discriminated between authentic viral RNA synthesis and host 
cell transcriptase responses, 	either positive or negative to 
viral infection. Viral RNA synthesis peaked at 10-llhrs pi, then 
incorporation fell rapidly. 	Labelled RNA could not be detected 
in progeny virions, suggesting that early RNA synthesis was not 
producing mature genome copies for packaging. In another study, 
(Karrar, 1983) the RNA synthesis of CP and NCP strains of BVDV 
was compared. Synthesis peaked after 12-14hrs, and CP strains 
showed a significantly higher final level of RNA synthesis, 
though the rates were similar. Again this author did not report 
the detection of the resultant labelled RNA in progeny virions. 
Experimental 
The experiments described fall into two sections, the first 
is a study of virus growth as measured by infectious virus 
released, 	and the second describes the measurement of RNA 
synthesis during virus infection by incorporation of tritiated 
(H) uridine into RNA. 
Initially experiments were performed to determine the effect 
of the drug AcD on BDV growth. If there was enhancement of the 
growth of the NCP strain as described for BVDV (see above) then 
this would be useful to increase virus yields during large scale 
growth. 
3.2 ACTINOMYCIN D AND VIRUS GROWTH 
Methods 
Virus growth curves were obtained under various conditions of 
treatment with AcD, to determine the optimum time of treatment 
relative to infection, length of treatment and concentration of 
AcD to be used. 
Cultures of FLM cells in 25cm2 flasks were infected with 
virus as described in Chapter 2, 	Section 2.2. 	The culture 
supernatant was sampled every 8 hours over a 72hr period, and 
the samples were assayed for extracellular virus titre by an 
inimunoperoxidase test. 
Actinomycin D was prepared as a lmg/ml stock solution in PBS, 
filter sterilised and stored at -20 C in the dark. Appropriate 
amounts of this stock were added directly to virus growth medium 
as required. 
3.2.1 Results 
Time-course of production of infectious BDNCP virus at 
various AcD concentrations 
Duplicate lOml cultures were set up and sampled as described 
above. AcD was added to the maintenance medium at the 
concentrations shown and was present throughout the 72hr period. 
The results of titration at different times are shown in Table 
3.1 and Fig 3.1 shows a plot of the results at 0.Olug/ml AcD. 
The presence of AcD does not appear to have any significant 
effect on virus growth at concentrations less than 0.Olug/ml. At 
0.Olug/ml the drug enhanced the rate of virus production during 
the exponential phase, 	but this effect was transient, and an 
overall reduction in final titre by a log was observed. 
Comparison of the effects of AcD on CP and NCP BDV strains 
lOmi cultures were set up for both cytopathic (BDV-M) and 
non-cytopathic (G1480) BDV strains. 	AcD was included in the 
maintenance medium at 0.Olug/ml and 0.05ug/ml. 	The control 
flasks had maintenance medium without AcD. All cultures were 
set up and sampled in duplicate. 	Sampling was every 8hrs for 
72hrs and the extracellular virus was assayed as described in 
the previous experiment. Results are presented in Table 3.2 and 
Figure 3.2. 
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Table 3.1 Growth of BDNCP virus over 72hrs at various AcD 
Concentrations 
AcD concentrations (ug/mi) 
Time (hrs) 	0 	0.001 	0.005 	0.01 
8 2.6 2.6 2.6 2.6 
16 2.8 3.3 3.3 3.8 
24 3.1 3.8 3.3 4.8 
32 4.1 4.3 4.3 5.6 
40 5.1 5.3 5.3 5.8 
48 6.3 6.3 5.8 5.6 
56 6.3 6.3 6.0 5.6 
64 6.3 6.6 6.0 5.6 
72 6.8 6.3 6.0 5.2 
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Figure 3.1 Growth of BDNCP virus over 72hrs in the presence 
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Table 3.2 Growth of CP and NCP strains of BDV in the presence of 
AcD 
AcD Concentration (ug/tnl) 
0 	 0.01 	0.05 
Time (hrs) Virus type: CP 	NCP 	CP 	NCP 	CP 	NCP 
8 1.6 2.3 2.6 2.6 2.3 2.6 
16 2.8 3.3 4.3 3.8 3.8 4.3 
24 3.8 4.1 4.8 4.8 4.8 4.8 
32 4.8 4.8 5.3 5.8 5.6 5.8 
40 5.6 5.3 5.3 5.8 5.6 5.8 
48 6.3 6.3 5.3 5.6 5.3 5.2 
56 5.8 6.3 5.3 5.6 4.6 5.2 
64 5.3 6.3 5.1 5.2 4.2 4.6 
72 5.8 6.1 4.8 5.2 4.2 4.6 
Values are log10 of mean TCID50 measurements from duplicate 
cultures 

Figure 3.2 Growth of cytopathic (CP) and non cytopathic (NCP) 
stains of BDV at different AcD concentrations. The 
top graph represents normal growth of both strains 
in the absence of AcD. 
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The growth curves of CP and NCP strains of BDV are not 
significantly different from each other in the absence of AcD, 
or in the presence of AcD at 0.Olug/ml. 	At 0.05ug/ml the drug 
appears to allow slightly better replication of the NCP strain 
throughout the growth cycle. As in the previous experiment AcD 
reduced final titres of virus for both strains, this effect 
increased at the higher (0.05ug/ml) AcD concentration. Thus 
both CP and NCP strains of BDV show similar growth responses to 
AcD; the replication rate is enhanced during exponential phase, 
the peak titre is unaffected but the final titre is reduced by 
0.5-1 log. The initial enhancement of growth was the same for 
the two concentrations of AcD tested, but the final reduction 
was greater at the higher concentration. This is in contrast to 
the results reported for BVDV where the responses of the CP and 
NCP strains to AcD were completely different (Nuttall, 1980). 
Effect of time of addition of AcD on the growth of BD NCP virus 
In these experiments the effects of adding AcD to the 
cultures pre- and post-infection were examined. 
Firstly, the effect of pre-treating host cells with AcD was 
examined. Cultures of FLM cells were pre-treated with AcD for 1 
and 5hrs at 0.01 and 0.05ug/ml. Monolayers were washed 
thoroughly, infected with BDNCP as described previously then 
maintenance medium lacking AcD was added and sampled every 8hrs. 
All cultures were set up and sampled in duplicate. The results 
are shown in Table 3.3 and Figure 3.3. 
As can be seen, pre-treatment of cells with AcD at 0.Olug/ml 
prior to infection resulted in an increased initial rate of 
virus production, reaching similar ti-tres as untreated cultures. 
However, unlike the previous two experiments this time no final 
reduction in titre was observed after AcD treatment. 
The rate of enhancement was similar whether cells were 
treated for 1 or 5hrs. 	Therefore 0.Olug/ml for lhr was 
sufficient to achieve the effect. 
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Table 3.3 Growth of BDNCP in cultures pretreated with AcD 
Concentrations of AcD ug/ml 
0.01 0 0.05 
Length of 
Time (hrs) 	Pretreatment lhr 5hr 0 lhr 5hr 
8 2.6 2.8 2.3 2.8 2.8 
16 3.8 3.8 2.8 4.1 4.2 
24 4.6 4.8 3.2 5.3 5.1 
32 5.8 5.6 4.1 5.8 5.6 
48 6.2 6.3 5.2 6.3 6.3 
56 6.3 6.2 6.3 6.1 6.2 
64 6.2 6.3 6.3 6.3 6.3 
Values are log10 of the mean TCID50 measurements from duplicate 
cultures 

Figure 3.3 The effect of pre-treating host cells with AcD 
prior to virus infection. 
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Addition of AcD to virus infected cultures 
AcD was added to virus infected cultures 12hrs after 
infection, at concentrations of 0.01, 0.05 and O.Sug/ml (Figure 
3.4, Table 3.4). 
An interesting effect was observed at the lower 
concentrations - a very high rate of initial virus production 
was observed after AcD addition, 	this appeared to be 
concentration dependent. Cultures containing 0.Olug/ml AcD 
continued to produce virus until the final titre was equal to 
that of untreated cultures. 	Cultures containing 0.05ug/ml, 
although having a higher initial rate of virus production, 
showed a final virus titre of more than 1 log less than the 
control. 	This was perhaps due to a toxic effect of the drug on 
the cells. 
3.2.2 Conclusions 
Actinomycin D was shown to increase the rate of virus 
production during the early stages of infection with CP or NCP 
strains of BDV. However, there was also a concomitant lowering 
of the final titre achievable, unless AcD treatment was given 
for a short period pre-infection, or else 12hrs after infection. 
In no case did AcD increase the final titre of infectious virus 
over that of the untreated control cultures. 
Thus AcD did not appear to be of use for increasing virus yield 
during large-scale virus production. 






0.01 	0.05 0.5 
8 2.1 2.3 	2.3 2.6 
16 2.8 3.6 4.1 2.3 
24 3.3 4.6 	5.2 3.8 
32 4.1 5.2 6.3 2.6* 
48 5.3 6.3 	5.3 0* 
56 6.1 6.1 5.2 0* 
64 6.2 6.3 	5.2 0* 
Values are log10 of mean TCID50 measurements from duplicate 
cultures. 
* Cells in these cultures had died at the time of measurement, 
presumably due to toxic AcD effects 
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Figure 3.4 Effect on BDNCP virus growth of addition of AcD to 
cultures 12hrs after infection. AcD was added 
where indicated by the arrow. 
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3.3 VIRUS REPLICATION IN THE INFECTED CELL 
The aim of these experiments was to quantitate the kinetics 
of synthesis of BDNCP RNA during infection, 	and to provide 
information on the best time to harvest viral RNA from infected 
cells. 
3. 3.1 Experimental 
The approach was to monitor the incorporation of the labelled 
precursor 3H-uridine into RNA during viral infection of cells. 
Actinomycin D was used to minimise incorporation of label into 
host cell RNA. By comparing incorporation of label in infected 
and uninfected cells an indirect measure of the amount of viral 
or virus-induced, RNA synthesis could be obtained. Conditions 
had to be established such that the availability of the labelled 
precursor was not rate-limiting in order that the amount of 
incorporation directly reflected the amount of RNA synthesis. 
Potential reasons for label being rate-limiting were: 
the label is not available inside the cell, because the 
intracellular pool of uridine is not yet labelled to 
equilibrium. 	This can be prevented by pre-labelling the cells 
for the time it takes for the intracellular labelled and 
unlabelled uridine pool to reach equilibrium. 
The label is available intracellularly but is preferentially 
incorporated into host cell RNA. This can be prevented or 
minimised by treatment with AcD. 	The time of addition of label 
relative to AcD treatment also needed to be optimised. 
3.3.2 Results 
Determination of the time taken to label the intracellular 
uridine pool to equilibrium 
15 tube cultures of FLM monolayers were incubated at 37°C 
(static) in E199 maintenance medium containing 3H-uridine at 
2uCi/ml. 	At the times indicated cultures were harvested in 
triplicate and assayed for the incorporation of the label into 
[1J 
TCA-insoluble material as described (Chapter 2, 	Section 2.6). 
Results are shown in Figure 3.5. Points are the mean of 
triplicate measurements. 
The incorporation rate slowed after 1-2hrs, suggesting that the 
intracellular labelled and unlabelled uridine concentration is 
at equilibrium from this time. 	Pre-labelling the cells for lhr 
should therefore be sufficient to ensure a constant 
intracellular concentration of label. 
Determination of the timing and extent of inhibition of host RNA 
synthesis by AcD 
Uninfected monolayers of FLM cells were incubated in the 
presence of 3H-lJridine and AcD at various concentrations over a 
24hr period. Cultures were harvested in duplicate at the times 
shown and assayed for 3H-uridine incorporation. The results were 
expressed as % reduction in incorporation as compared with an 
untreated control culture. The results are shown in Figure 3.6. 
At all AcD concentrations, the effect is at its peak 2hrs 
after treatment. 	Complete suppression of host cell RNA 
synthesis was not achieved in this or subsequent experiments. 
The best that could be achieved was 75-80% suppression after 24 
hrs treatment with AcD at lug/ml. From the data presented in 
Figure 3.6 the optimum AcD treatment was deemed to be 0.lug/ml 
for 2hrs, 	which gave around 70% suppression of host cell RNA 
synthesis. 
3H uridine incorporation in BDNCP infected. AcD.-treated cells 
2ml tube cultures were infected with BDNCP and the 
inoculum washed off after lhr. 	Cells were then incubated in 
maintenance medium containing AcD at lug/ml for 2hrs followed by 
addition of 3H uridine for 2hrs. Thus measurement of 3H uridine 
incorporation could only be made from 4hrs post infection. 
Initially cultures were assayed (in duplicate) 18hrs after 
infection and compared with uninfected cultures treated in the 
same way. The results are shown over. 

Figure 3.5 Determination of the time taken to label the 
intracellular uridine pool to equilibrium using 3H-
uridine (2uCi/ml). 








Figure 3.6 Time taken for AcD to exert an effect on RNA 
synthesis of uninfected FLM cells. 	Results are 
expressed as % 	reduction in 3 H uridine 
incorporation as compared to an untreated control 
culture. 








0 	 1 	 2 	 3 	 4 
Time (hrs) 
—0— 0.01 	- •- 0.05 	- A- 0.1 	- - 0.5 
(AcD) ug/mi ug/nil ug/mi 
WO 
Culture 	 Mean CPM/culture 
No AcD uninfected 	 12723 
AcD treated uninfected 	 213 
AcD treated BDNCP infected 	 175 
Thus there was no viral RNA synthesis detected after 18hrs, 
possibly because the labelled RNA had all been incorporated into 
progeny virions and released into the culture supernatant. The 
supernatant was not assayed for this. 	The next experiment 
assayed 
3 
 H uridine incorporation in infected cells over a period 
of 20hrs starting from 4hrs pi as described above. 
Time course of 
3 
 H uridine incorporation in BDNCP infected cells 
Cultures were infected and treated with AcD as described in 
the previous experiment. Duplicate cultures were assayed for 3H 
uridine incorporation at the times indicated. Results are shown 
in Table 3.5, Figure 3.7. 
Thus viral RNA synthesis is already under way by 4.5hrs pi, 
and rises rapidly to peak about 12hrs pi. 	The sharp decline 
which follows could either be due to release of this labelled 
fraction as whole virions, 	or as toxic effects of AcD on the 
cells. 	A similar sharp fall in RNA synthesis has been reported 
for BVDV (Nuttall, 1978). 
3.3.5 Attempts to detect labelled penomic RNA in virions 
Using 3 H uridine as a precursor, attempts were made to 
label directly the virus genomic RNA, then purify the labelled 
RNA for analysis. The experiment was set up as follows: 
Cultures of FLM monolayers in 100cm2 flasks were infected 
with BDNCP at an nioi of 1.0 TCID50/cell for lhr. They were then 
incubated in medium containing AcD at lug/ml for 2hrs, 	then 
0.1mCi of 3H uridine was added to each culture and the cultures 
incubated for 24hrs. 	The medium was collected and clarified by 




Culture 4.5 5 6 8 10 	12 	16 
No AcD 11175 11785 12098 12239 11462 	101073 
Uninfected 
lug/ml AcD 386 307 319 294 342 	- 
Uninfected 
lug/ml AcD BDNCP- 562 783 1131 3423 8936 	11521 	903 
infected 
Figure 3.7 RNA synthesis in BDNCP-infected, AcD-treated cells 
as measured by 3 H uridine incorporation. Points are 
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was pelleted from the supernatant at 25K for 16hrs in a Beckman 
sw28 rotor. The (invisible) pellets were resuspended in TNE and 
assayed for TCA insoluble counts and infectivity. 	The results 
are shown in Table 3.6. 	Clearly there is no labelled RNA 
present in the virus fraction. 	A second experiment produced 
similar results, ie infectious virus was recovered from the 
supernatant but it did not contain labelled RNA. 
This failure to detect labelled RNA in the virus fraction was 
also encountered in experiments with BVDV (Nuttall, 	1978). The 
suggested explanation was that the label was incorporated into a 
template RNA fraction on which the genomic RNA would later be 
transcribed. 	The template RNA would then be degraded. This 
would explain the sudden disappearance of labelled RNA in 
infected cells after 12hrs, in the previous experiment. 
Thus attempts to identify and analyse the BDV genomic RNA by 
i 	
3
n vivo labelling using H uridine were not successful. The next 
chapter discusses other approaches to the analysis of this RNA 
including further in vivo labelling attempts using 32 P 
orthophosphate. 
3.4 LARGE SCALE PRODUCTION OF BDV 
3.4.1 Introduction 
The amount of BDV required for this work was estimated on the 
basis of a report of BVDV cloning (Renard et al, 1985). 	This 
report described the purification of 5ug viral RNA from 3 litres 
of tissue culture supernatant containing virus at 108  TCID50/ml. 
Thus 3 x loll  TCID50 yielded only Sug purified viral RNA. A 
major problem encountered with pestiviruses is that they grow 
poorly in tissue culture. This is especially true of BDV which, 
at the time of these experiments, grew to a maximum titre of 
only 106  TC1D50/ml. 	By the criteria above, we would need 3001 
to produce Sug BDV genomic RNA. A practical figure of 20-301 
was decided as the target amount of supernatant to be produced. 
This should yield up to 0.5ug of viral RNA assuming a titre of 
106  TCID50/ml. 
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Table 3.6 Assay of extracellular virus for 3H labelled RNA 
Titre TCID50/l 	 cpm/ml 
From unlabelled control 	From 3H labelled 
Fraction 	 culture 	 culture 
Supernatant 	 5 	 6 
prepelleting 2 x 10 2 x 10 
(2Oml) 
Virus pellet 	 3 x 106 	 437 
(lml) 
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The strategy was to have BDV in continuous production in 
glass roller bottle cultures of FLM cells, 	over a period of 30 
weeks producing 1 litre of virus supernatant per week. The 
supernatant was clarified (9000rpm in Beckman Ja-14 rotor for 
30mm) and titrated then stored at -70°C until the total amount 
of supernatant had been amassed. 	The supernatants were then 
concentrated to a manageable volume, 	and virus spun directly 
out of suspension (25k 16hrs in Beckman sw28 rotor). Experiments 
described in the next section detail the design of the 
concentration and purification steps. 
3.4.2 Experimental 
FU'! cells were grown to 100% confluence in "Jencons" glass 
roller bottles and infected with BDNCP G1480 master stock as 
described in Chapter 2, Section 2.2. The inoculum was left on 
the cells, with rolling for lhr, then removed. 200m1 
maintenance medium were added and the cultures incubated with 
rolling for 5 days. Supernatants were clarified at 9K 30min and 
a 5ml sample removed for titration by immunoperoxidase staining. 
100ml of one culture was stored as inoculum at -70°C. Table 3.7 
shows results over a six month period of virus production, this 
was approximately half of the final amount of virus. There were 
many problems encountered at this stage and the pooled titre of 
the supernatants averaged 10 TCID50/ml, over a log down on the 
optimum attainable. From this table there was a total of 6 x 
10 TCID50 of virus after 6 months. Virus production continued 
until 1 x 1010  TCID50 had been obtained, in a total volume of 25 
litres. 
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Table 3.7 Batch titrations of BDNCP virus during bulk growth 
Batch date Volume (ml) 	Titre (log10 TCID50/ml) Total virus 
24/02/88 200 2 x 1O4  4 x 10 
2/03/88 400 2 x 1O5  8 x 10 
8/03/88 100 4 x 10 4 x 10 
9/03/88 2000 4 x 10 8 x 106 
17/3/88 1000 7 x 10 7 x 10 
17/3/88 500 1 x 106 5 x 10 
30/3/88 500 7 x 10 3.5 x 
10  
18/4/88 2000 2 x 1O4  4 x 10 
18/4/88 500 4 x 10 2 x 
10  
3/5/88 500 2 x 106 1 x 10 
25/5/88 1500 1 x 10 1 x 108 
7/06/88 500 1 x 
10  5x 108 
12/06/88 500 1 x 10 5 x 10 
17/06/88 1500 7 x 10 1 x 10 
28/06/88 400 7 x 10 3 x 108 
4/07/88 1500 1 x 106 1.5 x 10 
12/07/88 800 1 x 10 8 x 106 
2/8/88 800 4 x 10 3 x 10 
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3.4.3 	Concentration and purification of BDV. Comparison of 
methods 
Three methods of virus concentration were evaluated on a 
small scale to determine the most suitable method of 
concentration of the 251 of tissue culture supernatant. The 
methods compared were concentration by ultrafiltration, 
polyethylene glycol (PEG) precipitation, and ammonium sulphate 
precipitation. 	Three litres of BDNCP supernatant were 
pooled, clarified and split into 3 x 1000ml, 1000ml per method. 
The methods are detailed below, and the results shown in Table 
3.8. 
Ultrafiltration 
The 1000ml of virus suspension was prefiltered through a 
O.22JTflcartridge filter to remove cellular debris which would 
block the system. 	Two Amicon hollow fibre cartridges (1000 
molecular weight cut-off) were connected to a peristaltic pump 
and the virus suspension pumped through. 	The waste and the 
concentrate were sampled for titration. The process took 
approximately 3-4hrs. 
Ammonium sulphate precipitation (Felmingham and Brown, 1977) 
1500ml of sterile saturated (NH4)2SO4 in TNE were added to 
1000ml of virus suspension. The contents were mixed thoroughly 
and immediately decanted into centrifuge bottles and spun at 9K 
4°C for 30mm. The supernatant was sampled, and discarded and 
the pellet was resuspended in ice cold TNE at 1/20 of the 
original volume. 	This concentrate was sampled then stored at 
-70°C. 
Polyethylene glycol (PEG) precipitation (Magar and Lecomte, 
1987) 
250m1 of 50% (w/v) PEG 6-8000 (in TNE) were added to 1000ml 
of virus suspension. This gave a final concentration of 10% w/v 
PEG. 	The mixture was left at 4°C overnight with vigorous 
stirring, then spun at 9K, 30mm, 4°C, to collect the 
precipitate. 	The supernatants were sampled and discarded and 
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the pellets resuspended in 1/20 volume of ice-cold TNE. The 
concentrate was sampled and stored at-70°C. 
Results of virus concentration: Table 3.8 
Ultrafiltration TCID50/ml Volume (ml) Recovery 
Starting supernatant 7.2 x 10 1000 
Prefiltered supernatant 4 x 1O5  1000 53% 
Waste from ultrafiltration 4 x 10 - 1000 
Concentrated supernatant 4 x 10 110 6% 
(NH4) 2SO4 precipitation 
Starting supernatant 7.2 x 10 1000 
Waste supernatant 2 x 10 2500 
Virus concentrate in TNE 2.2 x 106 50 15% 
PEG precipitation 
Starting supernatant 7.2 x 10 1000 
Waste supernatant 2 x 10 1250 
Virus concentrate in TNE 1 x 10 50 70% 
The ultrafiltration apparatus was clearly faulty. 
Thus PEG precipitation gave a far-superior recovery of virus 
to the other two methods tested. 	In addition it was simple to 
perform, and this was therefore chosen as the method of 
concentrating the 251 of stored virus supernatant. 
Determination of optimum purification procedure 
In previous reports on BVDV (Felmingham and Brown (1977), 
Prichett and Zee (1975), Purchio et al (1983)) the virus had 
been purified by sucrose gradient sedimentation. Some of these 
reports describe rate zonal sedimentation to band virus, but 
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this has the disadvantage that the band tends to be diffuse, 
due to the large range of densities of pestivirus virions 
(Horzinek, 1981). In the following experiment different 
sedimentation procedures were compared for efficiency of virus 
recovery. 
A. Direct pelleting of virus from concentrate 
20m1 of PEG-concentrated virus in TNE were spun at 25K for 
16hr at 4°C in an sw28 rotor (Beckman). The pellet was 








1 x 10 
8 x 10 7 
80% 
Volume (ml) Total 
	
20 	2x108  
2 1.6x108  
B. Centrifugation through discontinuous sucrose gradients before 
pelleting 
Sucrose gradients were 3ml each of 35% and 20% sucrose (w/w) 
in TNE in an SW40 tube. These were overlaid with 5m1 of virus 
concentrate in TNE and spun at 20K 2hrs. This should pellet 
cellular material while leaving the virus at the interface 
between the two sucrose concentrations. The fraction was then 
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C. Rate zonal banding of virus 
Pellets of virus obtained in procedure A were resuspended in 
TNE and layered onto a 10-40% continuous sucrose gradient in 
TNE. 	The gradients were spun at 25K 4°C for 20hrs in an SW40 









8 x 10 - 
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Volume 	(ml) 	Total 
500 4xl07  
1 	lxlO 7  
Thus a single pelleting out of suspension gave by far the 
best recovery. It was felt that the recoveries from the gradient 
purifications were too poor to justify their use and it was 
decided simply to pellet the virus directly out of the PEG 
concentrate, 	since the most crucial factor was the amount of 
virus obtainable, rather than its purity. 
3.4.2 Large scale concentration and purification of BDV 
Twenty-five litres of tissue culture supernatant containing 
BDV had been stored at -700C following virus harvest as 
described in Chapter 2, 	Section 2.3. 	Two litre batches were 
defrosted at room temperature, pooled and sampled for titration. 
These were precipitated overnight by PEG, and concentrated as 
described previously. The PEG concentrate in TNE was then spun 
at 25K 20hrs at 4°C to pellet the virus out of suspension. 
Virus pellets were immediately frozen at -70°C until all of the 
251 had been processed. 	The pellets were now ready for the 
isolation of viral RNA. 
Titres are shown below. 
Large scale purification of BDNCP virus 
Fraction 	 Mean pooled titre Volume Total virus Recovery 
Culture supernatant 	5 x 10 	 251 	1 x 1010 
PEG concentrate 	 5 x 106 	1250ml 	6 x 10 	60% 
At an estimated 80% recovery of virus during the next direct 
pelleting stage, there should be approximately 5 x 10 total 
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virus in the frozen pellets. Working on the results obtained by 
Renard et al (1985), where 6 x 1010  TCID50 of BVDV yielded lug 
of virus RNA, this amount of BDV should yield a maximum of 80ng 
of RNA. 
3.5 SUMMARY 
The growth of BDV was studied in the presence of AcD to 
assess this drug's usefulness in enhancing BDV growth on a large 
scale. Although AcD did enhance BDV replication during the 
initial stages of an infection there was no evidence that it led 
to any increase in final virus titre. It was not therefore used 
in large scale BDV growth. 	However, it did prove useful in 
experiments studying the replication of viral RNA in vivo. 
These experiments failed to detect labelled precursor in mature 
virion RNA, but were able to show early synthesis of an AcD-
resistant fraction of RNA, presumably viral. 
Large scale production of BDV was difficult owing to the poor 
replication of virus in tissue culture and the consequent large 
volumes of culture fluid required. Twenty five litres of 
culture supernatant yielded approximately 5 x 10 TCID50 of 
virus after PEG concentration and virus pelleting. 	The virus 
was stored at -70°C until use. 
CHAPTER 4 
ISOLATION AND ANALYSIS OF BDV GENOMIC RNA AND ITS USE IN eDNA 
CLONING 
4.1 INTRODUCTION 
The genome of pestiviruses has been shown to consist of a 
single molecule of positive stranded RNA. 	Until relatively 
recently the size of this genomic RNA remained unclear. Renard 
et .al (1985) published a report sizing the BVDV (Osloss strain) 
RNA at 12.5kb. The NADL strain of BVDV was shown to have an RNA 
of similar size (Collett et al, 1988c), as were several other 
BVDV strains (Collett et al 1988a). 	HCV genomic RNA has also 
been reported to have a length of around 12kb (Moorman et al, 
1990). 	There have been no reports in the literature concerning 
the size of the genomic RNA of BDV. 
It has also been suggested that pestivirus genomic RNAs have 
extensive secondary structure. 	This idea arose from their 
sedimentation data, for which values between 24s and 40s have 
been reported. 	Experiments by Collett et al (1988c) revealed 
that the BVDV RNA has properties which would be consistent with 
areas of secondary structure, including the binding of the RNA 
to CF-11 cellulose, resistance to mild RNAase treatment, and 
solubility in 2M LiC1. . This last property was exploited by 
Collett's group to purify BVDV RNA from infected cells. 	This 
chapter begins with a section on the use of these techniques to 
prepare BDV RNA from infected cells. The next section describes 
attempts to prepare 32P labelled RNA from BDV virions labelled 
in vivo, and the last section describes the purification of BDV 
RNA from virions on a large scale, prior to cDNA cloning. 
4.2 ISOLATION AND ANALYSIS OF BDV RNA FROM INFECTED CELLS 
When Collett et al (1988c) published a method describing the 
purification of BVDV RNA from infected cells, it was decided to 
utilize the cell monolayers from the large scale virus 
production (Chapter 3, Section 4) as another potential source of 
BDV genomic RNA. The problems encountered with this approach 
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were again related to the poor replication of virus in tissue 
culture, additionally the very large size of the RNA molecule 
renders it extremely susceptible to degradation by Rt'TAses. The 
RNA of pestiviruses is also difficult to purify from cell-
associated fractions, presumably because its secondary structure 
results in a diffuse sedimentation pattern. 
4.2.1 Experimental 
RNA was prepared from 10 roller cultures of FLM cells 
infected with BDNCP (G1480). This was done in two batches. The 
cells were removed from the glass by trypsinisation in 
trypsin/versene 1/5 at 37°C. Cells were washed twice in ice 
cold TNE and pelleted at 4°C. 	The pellets were resuspended in 
TNE containing 0.1% SDS, and the suspension was extracted with 
phenol as described in 2.4.3. 	Following two ethanol 
precipitations this total cytoplasmic RNA fraction was dissolved 
in 2M LiC1. /1% SDS in 10mM EDTA. 	The RNA was left overnight at 
-20°C to precipitate the bulk of the cellular fraction. 	The 
solution was centrifuged at 12K for 30min in a Beckman Ja-20 
rotor in Corex tubes, at 4°C. The supernatant was decanted into 
a fresh tube and precipitated with 3 volumes of ethanol. The 
invisible pellet was resuspended in 20u1 depc-treated water, 
ready for electrophoresis on a denaturing formaldehyde gel. 	A 
control RNA fraction was prepared in the same way from 
uninfected FLM cells. 	The RNAs were run on a denaturing 
formaldehyde gel (Chapter 2, Section 5.2) alongside size markers 
to determine the molecular weight. 	The results are shown in 
Figure 4.1. 
Although ethidium bromide staining of RNA in formaldehyde 
gels is poor, 	a faint high molecular weight band was visible 
from the virus infected cells (track 4). This was assumed to be 
the BDV genomic RNA on the basis of its size and the absence of 
a similar band in the negative control (track 3). 
Unfortunately, limited amounts of material prohibited a DNAase 
digest on the high molecular weight fraction to eliminate the 
possibility that it was contaminating DNA. 
Figure 4.1 Denaturing agarose gel electrophoresis of the LiCl 
soluble fraction of RNA from BDNCP infected cells. 
The gel was 0.75% agarose. 
Tracks: 1. 0.5ug RNA ladder (BRL) 
0.5ug 28s/18s rRNA markers (mouse liver) 
LiCl supernatant RNA fraction from 
uninfected FLM cells 
LiCl supernatant fraction from BDNCP 
infected FLM cells 
mom  
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Estimation of the molecular weight of BDV genomic RNA 
A standard curve was plotted of log mol wt vs mobility, 
using the RNA ladder molecular weight standards (BRL). 	This 
plot is shown in Figure 4.2. The migration point of the high 
molecular weight RNA was 40mm as indicated by the arrow. From 
this it was deduced that this RNA was 12.5-13kb in size. 	This 
is in agreement with sizes of other pestivirus RNAs (Moorman et 
al, 1990; Collett et al, 1988b; Renard et al, 1985). The yield 
of this viral genomic RNA (as deduced by the intensity of liv 
fluorescence) was approximately 50ng from ten infected 
monolayers (1 x 108  cells), 	thus it was not judged to be a 
feasible route to preparative amounts of viral RNA, as we would 
have needed 10 times this amount and time was limiting. 
4.3 PRODUCTION OF LABELLED BDV IN VIVO USING 32P 
Despite unsuccessful attempts to produce progeny virion RNA 
labelled with the precursor 
3  H uridine it was decided to attempt 
a further in vivo virus labelling experiment, this time using 
The 	rationale was that firstly, 	by using 
32 
 P 
orthophosphate in the culture medium, a much higher specific 
activity could be achieved than with 
3
H, which may allow 
incorporation of label into virus particles. 	Secondly, the 
sensitivity of detection of 32P labelled material is vastly 
superior to that of 3H labelled material, 	and given the 
low levels of virus genomic RNA available this increased 
sensitivity might allow detection of labelled virus RNA. 
4.3.1 Experimental 
The same criteria applied as for the 3H labelling experiment 
(Chapter 3, Section 3) in that the label had to be available 
inside the cell, ie the intracellular pool was at equilibrium, 
and that host cell incorporation of label into RNA was minimised 
by AcD. 	However, the precursor used in this experiment was 
Figure 4.2 Standard curve to determine the molecular weight of 
the large RNA shown in Figure 4.1. 	Plot of log 
molecular weight of RNA standards (BRL) vs mobility 
in the gel. 	The position of the high molecular 
weight RNA is indicated by the arrow. - 
This corresponds to a molecular weight of approximately 4.5 x 10 
kd. Assuming one nucleotide to average m wt 330, this is equivalent 
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inorganic 32P orthophosphate, 	which will produce highly 
labelled cells and virus, 	since it will be incorporated into 
every phosphate-containing compound, 	notably DNA during 
cellular division, although cell growth is minimal in confluent 
cultures. Nevertheless, all material will be highly labelled 
and difficulties may arise in purifying the labelled virus RNA 
away from the enormous background of cellular labelled material. 
Four confluent cultures of FLM cells grown in 75cm2 flasks 
were used in the experiment. Two cultures were infected with BD 
NCP as described previously, and two were left as uninfected 
control cultures. 
One infected and one uninfected culture were labelled with 
32 P as follows: cultures were incubated in 25m1 phosphate-free 
32 
maintenance medium to which carrier free P orthophosphate had 
been added, at 0.5mCi/flask. 	Maintenance medium was phosphate 
free E199 medium (GIBCO custom-made medium) with 2% dialysed FBS 
and 5ug/ml AcD. 	Cultures were incubated for 40mins in the 
presence of label. The highly radioactive supernatant medium 
was processed as for virus harvesting (Chapter 2, Section 2.3) 
and discarded into cold carrier phosphate solution. 	The 
unlabelled culture was harvested in parallel and a sample was 
taken for titration, to indicate the amount of virus present. 
"Virus pellets" from infected and uninfected cultures were 
processed to yield RNA and the proportion of labelled RNA was 
determined. 	Pellets were resuspended in TNE containing SDS 
(0.1%) and proteinase K at 200ug/ml and incubated 37°C 30mm. 
This digest was extracted twice with phenol and once with 
chloroform, 	and ethanol precipitated. 	The precipitated 
material was resuspended in TE/SDS (0.1%) and the proportion of 
TCA insoluble counts was measured. 
A sample of this labelled RNA fraction was run on a 
denaturing formaldehyde gel (Chapter 2, Section 5.2) and another 
sample on a 10-30% sucrose gradient which was fractionated and 
the fractions precipitated and counted using Cerencov counting. 
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4.3.2 Results 
Titration of unlabelled, infected control cultures 
This was done by an immunoperoxidase titration as described 
in Chapter 2, Section 2.3. Assuming that the label has no effect 
on virus replication, then these figures should reflect the 
titre of the labelled virus culture. The results are summarised 
in Table 4.1. 
Incorporation of 
32 
 P into TCA insoluble material 
Virus pellets from infected and uninfected cultures were 
resuspended in TNE, 	0.1% SDS with proteinase K at 200ug/ml. 
After incubation at 37°C, 	30 mm, this digest was extracted 
twice with phenol, 	once with chloroform and precipitated with 
ethanol. 	The precipitate was resuspended in TNE, 0,1% SDS and 
the proportion of counts insoluble in 5% TCA was measured. 	The 
results are shown in Table 4.2. 
Denaturing gel electrophoresis of the labelled RNA 
Infected and uninfected labelled RNA fractions were run on a 
formaldehyde gel. The gel was dried and an autoradiograph 
produced as described in Chapter 2, Section 6.6. The results are 
shown in Figure 4.3. 
Sucrose gradient profiles of 32P labelled RNA from BDNCP 
infected and uninfected cultures 
Sucrose gradients were prepared, run and fractionated as 
described in Chapter 2, 	Section 4.6). 	2 x 10 
5 
 cpm of 32P 
labelled RNA from an infected and uninfected culture were run on 
parallel 10-30% continuous gradients. 	The run conditions were 
20hrs at 20,000rpm at 20°C in an sw40 rotor (Beckman). 	0.5m1 
fractions were collected, 	ethanol precipitated and resuspended 
in 50u1 TE. 	25u1 were spotted onto a filter and counted in PPO 
scintillator fluid for 1 minute. 	The gradient profiles are 
shown in Figure 4.4. 
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Table 4.1 
Titration of unlabelled control cultures 
Titre 	Volume 	Total 
Culture supernatant after 5 6 
clarifying 1 x 10 	25m1 2.5 x 10 
Culture supernatant after 4 5 
pelleting 1 x 10 	25ml 2.5 x 10 
Virus pellet 1 x 
10 	2.Oml 2.0 x 106 




Incorporation of label into the TCA insoluble fraction 
Infected culture Uninfected culture 
Total cpm 	 599 5052 	 348 579 
TCA insoluble cpm 	 870 351 	 30 711 
% incorporation 	 14% 	 9% 
Thus i 5 
	 50 
x 10  TCID of virus from above yielded RNA labelled with 
8 x 10 cpm. 
Figure 4.3 Autoradiograph of 32 P labelled RNA prepared from 
BDNCP infected and uninfected cultures by labelling 
in vitro. (Cellular 28s and 18s fractions are 
indicated by the arrows) 
Track: 1. 4 x 10 cpm from the uninfected culture 
5 x 10 cpm from the BDNCP culture 
5 x 10 cpm from the uninfected culture 




Figure 4.4 Gradient profile of 32 P labelled RNA from BDNCP 
infected cells labelled in vivo. 
Gradient profile of RNA from 32P 









I"i  6 8 1 12 14 16 18 20 
gradient fraction 




BDNCP was grown to a titre of 1 x 10 TCID50/ml in phosphate 
free medium containing 32P orthophosphate for 40hrs. Harvesting 
the virus from these cultures yielded 1 x 106  TCID50. From this 
virus pellet RNA was prepared and the incorporation of label 
into the TCA insoluble fraction was measured. The RNAs of both 
the infected and uninfected cultures were highly labelled, 	as 
expected since orthophosphate is a non-specific precursor. 
Allowing for this background, 1 x 106  TCID5Ø of virus yielded 8 
x 105cpm of labelled RNA. When RNA was analysed by denaturing 
formaldehyde gel electrophoresis a large amount of contaminating 
cellular material was obvious both in infected and uninfected 
cultures. 	There appears to be slightly higher molecular weight 
material visible in the infected RNA sample but this did not 
appear as a discrete band. 	In this infected sample, 	labelled 
material was present up to 10kb. 	The same RNA samples were 
analysed by rate zonal sedimentation through sucrose density 
gradients and a small peak was present solely in the infected 
fraction around the 35s region of the gradient. 
On the basis of these experiments it is probable that the 
BDNCP genomic RNA was demonstrated. However, lack of material 
meant that DNAse digestion controls were not performed to 
eliminate the possiblity of contaminating DNA. 	It is also 
possible that the high molecular weight fractions observed in 
gradients are aggregates of cellular rRNA since a discrete band 
was not obtained. 
4.4 LARGE SCALE PRODUCTION OF BDV GENOMIC RNA FOR USE IN cDNA 
REACTIONS 
RNA was to be prepared from the 5 x 10 TCID50 of BDNCP 
stored as frozen virus pellets. This RNA would then be purified 
by rate zonal sedimentation through sucrose density gradients. 
The problem was the lack of detection system available for BDV 
RNA. The amount of RNA obtainable (80ng) would be far too small 
to permit a spectrophotometric gradient profile. 	The only 
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option appeared to be to use a suitable probe to hybridise 
across the gradient, however, no probes showed unequivocally 
specific hybridisation to BDV RNA. 	It was therefore decided to 
use a parallel RNA purification from BVDV-NADL virions to which 
there were numerous specific DNA probes available. The NADL RNA 
was then fractionated on a parallel gradient with the BDNCP 
preparation, 	and the labelled probe was hybridised across the 
NADL gradient to detect the virus RNA-containing fractions. The 
equivalent fractions from the BDNCP RNA gradient were then 
pooled and assumed to contain whatever BDNCP RNA was present. 
This relied on two assumptions: 
that the BDNCP RNA is approximately the same size as the 
BVDV-NADL RNA, and 
that the BDNCP RNA had not been substantially degraded. 
4.4.1 ExDerimental 
Approximately 6 x 10 TCID50 of BVDV-NADL were spun from PEG 
concentrated tissue culture supernatant at 20k for 16hrs. 
The virus pellets were stored at -70°C until required. 6 x 10 
TCID50 of BDNCP which had been grown on a large scale (Chapter 
3) were used as the source of BDNCP RNA. RNA was prepared from 
both sets of virus pellets by thawing the pellets directly into 
Guanidinium isothiocyanate RNA isolation buffer, 	and purifying 
through a 5.7M CsCl cushion as described in Chapter 2, Section 
4.5). 	The RNA pellets were precipitated with ethanol and 
redissolved in sucrose gradient loading buffer (1 x 7E pH 
7.5/0.1% SDS). Low salt concentrations were used throughout the 
gradients to minimise RNA secondary structure. The BVDV-NADL 
RNA was loaded onto one 10-30% continuous sucrose gradient (in 
TE/SDS) and the BDV sample onto a parallel gradient. 	Gradients 
were spun at 20,000rpm for 20hrs in an SW40 rotor (Beckman). 
Both gradients were fractionated into 0.5m1 fractions. 	The BDV 
fractions were stored at -20°C. 	The BVDV-NADL fractions were 
ethanol precipitated and redissolved in lOul depc-treated H 2 
 0 
ready for denaturation and analysis by hybridisation. 
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Hybridisation of NADL-specific probes across the RNA gradient 
The samples were denatured in formaldehyde at 65°C for 15mm 
and loaded onto a nitrocellulose membrane using a slot-blot 
manifold (Chapter 2, Section 6.1). Blots were dried and fixed 
at 80°C for 2hrs under vacuum. They were pre-hybridised for 2hrs 
as described in Chapter 2 and then hybridised using 50% 
formamide at 42°C overnight. The probe was an antisense RNA 
probe produced by in vivo transcription of a small 192bp 
segment of the BVDV gene for the p80 protein. (For further 
discussion of this probe see Chapter 5.) The blot was washed at 
high stringency using 0.1 xc58 0.1% SDS at 60°C for 2 x 30 mm, 
and exposed to x-ray film with intensifying screens at -700C for 
2hrs. The results are shown in Figure 4.5 
The high molecular weight fractions showing a good signal 
were presumed to contain the NADL RNA. The equivalent fractions 
(20-24) of the BDV RNA gradient were pooled, precipitated and 
stored under ethanol at -70°C until required for cDNA synthesis. 
4.5 cDNA SYNTHESIS 
4.5.1 Introduction 
The difficulties involved in producing cDNA clones of 
pestivirus sequences are considerable. 	To a great extent the 
success of any cDNA cloning experiment depends on the amount and 
the quality of the input RNA for the template. 	Pestivirus 
growth in tissue culture is poor, leading to low virus yields 
and furthermore virions are difficult to purify from cellular 
material (Laude, 1979). This means that the source of virion RNA 
is extremely limited for all pestiviruses. 
The second problem associated with producing high quality 
pestivirus RNA for cloning concerns the RNA itself. 	The 
pestiviral genomic RNA is 12.5kb in length, 	and its size makes 
it extremely vulnerable to attack by ribonucleases. 	It also 
seems to have an extensive secondary structure which may prevent 
certain areas of the genome being available for reverse 
Figure 4.5 Autoradiograph showing slot-blot hybridisation of 
probe pBV4/p80 to 0.5m1 fractions of a sucrose 
gradient containing RNA from BVDV-NADL infected 
cells. 
Sample 23 was assumed to be a false negative due to loss of sample. 
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transcription, 	in particular the termini of the RNA. 
Furthermore, pestivirus RNA is not polyadenylated and therefore 
cannot be purified using oligo-dT chromatography: 	the starting 
preparations of RNA will therefore be fairly crude. Thus the 
scarcity, 	fragility and inherent structure of these viral RNAs 
have alt conspired to prevent any success in cDNA cloning until 
relatively recently (Renard et 1985). 	There are now several 
reports of BVDV and HCV cloning and none of BDV. 
4.5.2 Strategies for cDNA production and cloning 
The initial decision was whether to purify viral RNA from 
total infected cellular RNA or from purified or semi-purified 
virions. 	Both approaches have been used with success. Moorman 
et al (1990) and Collett et al 	(1988b) have both taken the 
intracellular RNA approach while Rumenapf et al (1989), Brock et 
al (1988) and Renard et al (1985) have all used RNA purified 
from extracellular virions which were pelleted from tissue 
culture fluid. 
Having isolated the template RNA the next decision was how to 
prime synthesis of the first strand of cDNA. Since the 
pestivirus RNA has no poly-A tail there are 3 options. A poly A 
tail could be added synthetically. This approach was used by 
Brock et al (1988) and Renard et al (1985). Their reason for 
using this approach was presumably because they planned to clone 
by homopolymer tailing, which requires the poly dT/dA stretch 
produced by oligo dT priming. This seemed an unnecessarily 
complicated approach involving many manipulations of a scarce 
and fragile RNA. 	The other means of priming was using random 
hexanucleotides or site-specific oligonucleotides. 	The latter 
had the advantage of allowing selective cloning of areas of 
interest, but needed exact sequence data in order to design 
primers. 	The simplest and most suitable method appeared to be 
random priming of first strand cDNA using hexanucleotide 
primers. 	This method sacrificed selectivity in an already 
heterogenous RNA population, 	since cellular RNA will co-purify 
with the pestivirus RNAs. However, the method had been used 
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successfully by several groups (Rumenapf et al, 1989; Renard et 
al, 1985, Collett et al, 1988c, Moorman et al, 1990) and it was 
decided on as the method of choice. 	First strand cDNA would be 
converted to a double-stranded molecule by the standard method 
of Gubler and Hoffman (1983). 
The next decisions concerned the cloning strategy. The 
options were: linker ligation or adaptor ligation involving 
attachment of linkers/adaptors to double stranded blunt-ended 
cDNA, or simple blunt ended ligation into a blunt-ended vector. 
The homopolymer tailing method of cloning was not available 
because it requires a poly dT/dA stretch on the cDNA produced by 
oligo dT priming. It was decided to simply blunt end the double 
stranded cDNA and clone this directly into a blunt-ended 
restriction site in the vector. 	This would avoid risks of loss 
of the small amounts of cDNA produced on 80ng of template. 
Fewer manipulations should result in conserving the small amount 
of cDNA produced. 
The vector chosen for cloning was Bluescribe. This is a 2kb 
plasmid vector which allows easy colour selection of 
recombinants. 
Bluescribe would be digested with SmaI to produce a blunt-
ended vector and ligated to the blunt-ended cDNA. Clones would 
be selected by colour and grown for screening. Since we had no 
BDV specific clones, the initial screening stage would involve 
a plus/minus screen using cDNA produced from total RNA from 
virus infected and uninfected cells. A flow summary of the 
cloning approach is shown in Figure 4.6. 
4.5. 3 Experimental 
First strand cDNA synthesis was performed using cloned 
MMLV-RT enzyme lacking RNAse H activity (BRL) (Gerard et al, 
1990). 	The BDNCP RNA was mixed with 0.8ug of random 
hexanucleotide primers (Stock 	0.8mg/ml) (Pharmacia). 	The 
mixture was adjusted to 14u1 with water, heated to 70°C for 10 
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min then chilled on ice. The first strand reaction components 
were added as follows; 	5 x reaction buffer (supplied with 
enzyme) to lx, 	O.1M dithiothreitol (DTT) to O.OlM, 	dNTPs to 
0.5mM each, lul of RNA guard (Pharmacia) and 200 units of MMLV 
RT. 	The final volume was 25u1. 5u1 were removed and incubated 
in the presence of 32P dCTP (2uCi). The remaining 20u1 were not 
labelled. 	Incubation of both reactions was at 42°C for lhr. 
The 20u1 reaction was then diluted into a second strand reaction 
mixture (-. 150u1) as follows: 
91.8u1 H 2 
 0 
32u1 5 x second strand buffer 
3ul 10mM dNTP mixture 
6u1 0.1M DTT 
5uCi 32P dCTP 
4u1 (40u) E. coil DNA p01 1 (Pharmacia) 
1.5 units RNAse H (BRL) 
The reaction was incubated for 2hrs at 16°C. 10 units of T4 
polymerase were added and incubated a further 30min at 37°C. 
Figure 4.6 Experimental strategy for production of BDNCP eDNA 
clones. 
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Starting material - 5 x 10 TCID50 of frozen BDNCP virus pellets 
Prepare virus RNA from pellets and purify through CsC1 
Further purify virus RNA on sucrose gradients alongside BVDV RNA 
in a parallel gradient 
Fractionate BVDV gradient and identify virus RNA fractions by 
probe hybridisation. Pool and precipitate the corresponding 
fractions from the BDV gradient 
Commit half this BDV RNA to a 1st strand cDNA synthesis reaction 
using murine moloney leukemia virus reverse transcriptase 
(MMLV-RT) and random hexanucleotide primers 
Second strand cDNA synthesis using DNA pol I and RNAse H 
Blunt end cDNA using T4 polymerase 
Direct blunt-end ligation of the cDNA into SmaI cut Bluescribe 
vector 
Select recombinants by colour and grow for screening 
Produce cDNA probes using 32P and reverse transcriptase on total 
cellular RNA from infected and uninfected cells. Probe colonies 
with these probes in a +/- screen. 
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Estimation of yield of cDNA 
The small (5u1) reaction was labelled with 2uCi. lul of this 
was diluted 1/10 into carrier DNA (lOng/ml salmon sperm DNA) and 
lul of this was spotted onto a Whatman glass fibre disk. Counts 
were measured before and after TCA washes (5 x lOsecs in 10% 
TCA). The incorporation of label was 4%. Theoretical yield of 
cDNA is 13.2ug (40n moles of dNTP in 20u1 reaction). 	Actual 
yield - 13.2 x 0.04 	0.5ug cDNA. 
Second strand yield 
Incorporation of label was 5%. 
Yield of second strand - 0.05 x (13.2 - 0.5ug 1st strand) 
0.63ug second strand cDNA produced 
cDNA cloning 
It was decided to attempt to clone "blind" the products of 
the second strand synthesis reaction, because the amounts of 
cDNA, if present, 	were far too small to allow the reaction to 
be analysed on gels. 
Preparation of Bluescribe vector for cloning 
Sug of Bluescribe vector was digested with SmaI restriction 
enzyme as described in Chapter 2. The digested vector was 
extracted twice with phenol chloroform and precipitated twice 
with 2.5 volumes of ethanol. 	The pellet was resuspended in TE 
p118.0 at 0.lmg/ml. 
Ligation 
The expected efficiency of direct blunt-ended ligation into 
SinaI cut Bluescribe was tested using control blunt-ended DNA 
fragments produced by Hae III digestion). The control blunt-
ended DNA was adjusted to 0.lug/ml in TE. 
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Ligations were set up as follows: 
0.lug vector (unphosphatased) 
0.lug blunt-ended fragments 
lul 10 x T4 ligase buffer 
(250mM Tris 50mM MgCl2 5mM ATP) 
3.75ul 40% PEG 8000 
lul 5mM ATP 
Adjusted volume to lOul with 1120  and incubated at 16°C 
overnight. 
The ligation reactions were diluted and transformed into 
competent E. coli JM109 cells. Transformation was carried out 
as described by Chung et al (1989). 	Transformation efficiency 
of 	closed circular plasmid DNA was between 5 x 10 
7  and 1 x 10 8  
colonies per microgram of DNA. 	Transformants were selected as 
described below. 
Selection of transformants and recombinants 
Selective medium consisted of L-agar containing 50ug/ml 
Ampicillin, 40ug/ml X gal and 5mM IPTG. Cells containing non-
recombinant plasmid gave rise to blue colonies while 
recombinants gave rise to white colonies. 
Ligation efficiency 
Ligation/transformations were set up as decribed above. 
Results are shown below. 
Ligation results 
Plate 	Received 	Blue colonies White colonies 
1 No DNA 0 	 0 
2 	lpg uncut BS 	 89 0 
3 lOpg uncut BS 500 	 0 
4 	100pg uncut BS 	> 2000 0 
5 100pg self ligated BS 	25 	 0 
6 	lOOpg 	BS 	 18 10 
+ lOOpg Hael fragments 
Each plate contains 1/10 of the transformation mix. 
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The self-ligated vector reactions appears to contain 100-fold 
less covalently closed circular plasmid than the control, as 
does the Hael ligation reaction. Thus for both intra- and 
inter-molecular ligation of blunt ends, efficiency appears to be 
approximately 1% , although a linear plasmid was not transformed as a control. 
Ligation and transformation of putative BDNCP blunt-ended cDNA 
Assuming 1% ligation efficiency as described above. 	Input 
DNA was lOOng of vector and half of the total 2nd strand 
synthesis reaction. 	The ligation reaction was set up and 
transformed and recombinants selected, all as described in the 
preceding section. 
Results - Table 4.3 
Transformation efficiency was 2.5 x 10 and the ligation 
efficiency was again around 1%. Unfortunately no recombinant 
colonies were obtained from the BDNCP cDNA ligation. 	This 
experiment was repeated with the last batch of the cDNA 
reaction, but no recombinant colonies were obtained. The 
reasons for this failure are not clear, the system appeared to 
be working as judged from the controls, and the problem seemed 
therefore to be inherent in the cDNA reaction. Either there was 
too little, if any, second-strand cDNA present (as suggested by 
the alkaline gel results) or what was there was unclonable 
perhaps due to poor efficiency of blunt-end production. 
4.6 SUMMARY 
Based on published results with BVDV (Renard et al, 	1985) 
the theoretical yield of pestivirus RNA from pelleted virions is 
lug viral RNA from 1 x loll  TCID5Ø of virus. Although we had 
only a total of 5 x 10 TCID50 of BDNCP virus a cDNA synthesis 
and cloning experiment was attempted. The theoretical yield of 
BDNCP RNA was 80ng. 	This was split into two batches and two 
attempts at cDNA synthesis were performed. 	On both occasions 
some high molecular weight products were detected in the first 
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Table 4.3 





1 	No DNA 0 	 0 
2 	lOpg uncut ccc BS 50 	 0 
3 	Self ligated BS lOOpg 30 	 0 
4 	BDNCP cDNA/lOOng linear BS 400 	 0 
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strand reactions but nothing was visible on an autoradiograph of 
the second-strand reaction. Despite this, the products of each 
second-strand reaction were ligated to linearised unphosphatased 
bluescribe vector in a simple blunt-ended ligation without using 
linkers or adaptors. The ligation and transformation reactions 
were successful but yielded no BDNCP recombinants. 	This was 
judged to be due either to lack of material or of failure to 
produce a clonable blunt-ended second-strand product. The most 
likely explanation is that there was never enough starting 
material at every stage, 	and this resulted in a failure to 
produce recombinant BDNCP clones. 
CHAPTER 5 
SPECIFICITY OF CLONES IN HYBRIDISATION STUDIES 
5.1 INTRODUCTION 
A range of cloned cDNAs representing BVDV sequences were 
available. Details on these clones are given in the following 
section, and where the clones map on the BVDV genome is shown in 
Figure 5.1. 
This chapter describes experiments to test six different BVDV 
cDNA clones for their ability to hybridise to the RNA of various 
BD and BVD virus strains. 	The purpose was to yield information 
on the extent and position of homology between strains and 
species. Additionally, this was undertaken to search for a BVDV 
clone which hybridises with BDV RNA, thus providing a potential 
probe for use in screening a BDV cDNA library, and which could 
also be of use to monitor BDV RNA purification. 
Since there was almost no molecular information available 
concerning BDV, there was little idea of the extent of homology 
between BVDV and BDV. 	At the time of these experiments there 
was no sequence information available for HCV either, 	although 
there has since been publication of HCV sequences (Moorman et 
al, 1990, Meyers et al, 1989). Further discussion on sequence 
comparisons can be found in Chapter 7 of this thesis. 
5.2 BVDV cDNA CLONES 
Clones 35. 50 and 75 
These were three cDNA clones produced at the Moredun 
Institute, 	Edinburgh in an earlier attempt to clone BVDV 
sequences (A. 	Herring, 	unpublished). 	Using the BVDV-NADL 
strain as a source of RNA, 	a cDNA library was constructed in 
pUC8, 	the cDNA was cloned into the Sma-1 site of the plasmid. 
The library was screened with total cDNA probes constructed from 
virus-infected and uninfected cells in a plus/minus screen. 
Several clones were then screened by removing their inserts, 
Figure 5.1 Position of BVD clones on the NADL genonie. Not to 
scale. 
KEY 
BVDV GENOMIC RNA 
p20 	p62 	p53 	p54 	 p80 	 p58 	1 	p75 ::] 
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2 
1 	pN24 	(1319 - 2479) 	 4 	pEV4/p80 (5644 - 7949) 
2 	p503 	(1800 - 3200) 	 5 	35 	(9874 - 10053) 
3 	50 	(3008 - 3167) 	 6 	75 	(11634 - 11831) 
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labelling and hybridising to infected and uninfected total-cell 
RNA preparations. 	The three resulting positive clones were 
designated 35, 	50 and 75. 	Each of these clones contains a 
short insert: clone 35 is 180bp long, clone 50 is 160bp long and 
clone 75 is 198bp long. 
These clones have been sequenced (M. 	Sweeney, 	Warwick 
University, 	personal communcation) and mapped on the BVDV 
genome. 	Clone 50 is derived from the sequence for a structural 
glycoprotein (p62/p53), whilst both clones 35 and 75 map to the 
last segment of the non-structural coding sequences (p58/p75). 
For details see Figure 5.1. 	Thus it might be expected that 
clone 50 would show a more restricted hybridisation pattern than 
the other two. 
Clones pN24 and P503 
These clones were kindly supplied by M. 	Sweeney at the 
University of Warwick. 	They were also derived from a cDNA 
library constructed from the NADL strain of BVDV. The inserts 
are cloned into the EcoRl site of the plasmid "Bluescript". 503 
was isolated using clone 50 described above, and is also 
positioned in the structural glycoprotein region of the genome. 
The insert is 1.4Kb long. pN24 is also derived from this region 
and overlaps p503. Its insert is 1.2kb long. 
Clone pBV4/p80 
This clone was kindly supplied by Dr. M.S. Collett, Molecular 
Genetics Inc., Minnesota, USA. 
It too is derived from BVDV-NADL sequences. It consists of a 
2.3kb insert cloned into the SrnaI site of the "Gemini" 
transcription vector pGEM-4 (Promega Biotech). The insert spans 
the entire p80 region of the BVDV genome. 	Clone pBV4/p80 is 
illustrated in Figure 5.2 Antisense RNA transcribed from the T7 
promoter was used as a probe. 
Table 5.1 presents a summary of the BVDV clones used. 
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Table 5.1 Summary of BVDV clones 
Insert Position on 	Protein 
Clone 	Vector 	size 	BVDV genome represented 	Source 
35 	pUC8 180bp 	9874-10053 p58  
50 	pUC8 160bp 	3008-3167 p53 
75 	pUC8 198bp 	11634-11831 p75  
p503 	Bluescribe 1.4kb 	1800-3200 p62  
pN24 	Bluescribe 1.2kb 1319-2479 	p62  
pBV4/p80 pGEM4 	2.3kb 	5644-7949 	p80  
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Figure 5.2 The clone pBV4/p80, showing unique restriction 
enzyme sites and the two sites used to linearise 
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The experimental strategy was to grow a selection of BVDV and 
BDV strains and isolate total cellular RNA from the infected 
cells. As the virus RNA fraction of this total RNA is too small 
to be detected, let alone quantified, extracellular virus titre 
is the only indication of its presence. 	Therefore throughout 
these experiments the amount of input viral RNA could not be 
standardised. 	The detection procedure used was a dot-blot 
hybridisation assay as described in Chapter 2, Section 6.1. RNA 
from virus-infected cells was dotted onto a membrane and probed 
with various probes. A panel of strains was used to test seven 
different probes. 
5.3.1 Growth of virus strains for RNA isolation 
The virus strains are described in Table 5.2. 	Virus 
infection of tissue culture cells was as described (Chapter 2, 
Section 2.2). However, in these experiments the extracellular 
virus was not required other than for titration purposes, and it 
was clarified, aliquoted and stored at -70°C as virus stock. The 
infected cell monolayers were washed in Hanks BSS then lysed 
directly into guanidiniuin isothiocyanate solution for RNA 
isolation as described in Chapter 2. Two 225cm2 flasks 
containing 100ml.of medium were used for growth of each strain. 
The RNA was purified through a CsCl gradient and stored under 
ethanol until required. 	The extracellular virus titre for each 
strain grown is shown in Table 5.3 
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Table 5.2 Virus strains 
Species 	Strain 	Cytopathogenicity 	 Origin 
BVDV NADL CP 
BVDV Osloss CP 
BVDV 8085 CP 
BVDV B816 CP 
BVDV C24V CP 
BVDV G982 NCP 
BDV G1480 NCP 
BDV G2048 NCP 
BDV JH2876 NCP 
BDV L991 NCP 
BDV D861 NCP 
BDV Weybridge NCP 
BDV R2727 NCP 
BDV G1305 NCP 
BDV A1870 NCP 
BDV BDV-M CP 
See Chapter 2 
Acute MD case (Highlands) 
Acute MD case (Borders) 
17 month-old bull with sight 
defect (Dumfries and Galloway) 
See Chapter 2 
Clinically normal survivor of 
BD abortion outbreak 
(Strathclyde) 
BD lamb (England) 
BD lamb (Cheshire) 
"Hairy Shaker" lamb (Cumbria) 
Reference strain from CVL, 
Weybr idge 
BD lamb (England) 
"Hairy Shaker" lamb (Grampian) 
BD lamb (Aberystwyth) 
Vantsis et al (1976) 
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Table 5.3. Virus titres from cultures used in dot blots 
Virus 	Strain Titre TCID50/ml 
BVDV 	NADL 2 x lO 
Osloss 4 x 106 
8085 5 x 10  
B816 2 x 10  
C24V 1 x 10 7 
G982 2 x 10  
BDV 	G1480 4 x 10 6 
C2048 5 x 10 
L991 4 x 10 
R2727 2 x 10 
D861 1 x 10 
Weybridge 7 x 106 
JH2876 6 x 1O4  
G1305 2 x 10 
A1870 2 x 10 
BDV-M (CP) 1 x 10 
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5.3.2 Preparation of dot blots 
The RNA preparations were quantified on an ordinary agarose 
gel (not shown). 	They were adjusted to about lug/lOul. 
Approximately 0.5ug of total cellular RNA was used per dot, but 
in some cases where virus titre was known to be low, this amount 
was increased to 1-5ug/dot in an attempt to standardise the 
amount of viral RNA available for hybridisation to the probe. 
The negative control RNA was 0.5ug/dot of uninfected FLK or BT 
cell RNA. 	In these experiments BVDV-NADL infected cell RNA was 
used as a positive control since all the clones tested were 
derived from this strain. 
Harvesting of cultures infected with cytopathic (CP) strains 
took place when the CPE was only just becoming evident. To have 
let it proceed further would have reduced the number of infected 
cells containing viral RNA. Non-cytopathic (NCP) virus infected 
cultures were harvested after 72hrs. Lack of information about 
the kinetics and mechanism of replication of both biotypes made 
it impossible to define exactly the time at which there would 
have been the maximum amount of viral plus-stranded RNA in the 
cell. 
5.3.3 Production of probes 
Probes 35, 50 and 75 were prepared as follows. The inserts 
were removed from the pUC8 vector by digesting the plasmid with 
the restriction enzymes EcoRl and Hindlil. The inserts were 
purified on a 2% agarose gel, (not shown). The insert band was 
excised from the gel and purified from the agarose by 
electroelution as described in Chapter 2. Electroelution was the 
preferred method of purification because the inserts were so 
small. 	The purified inserts were adjusted to lug/4u1, and were 
labelled using 32P dCTP in a random-primed labelling reaction as 
described in Chapter 2, Section 6.3. Probes were used directly 
or stored for a maximum of 1 week. 
Probes p503 and pN24 were prepared by digesting the plasmids 
with EcoRl. In the case of pN24 this gave a clean excision of 
the 1.2kb insert but in p503 an insert site for EcoRl means that 
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two fragments were produced at 800bp and 600bp. The larger one 
was chosen as a probe. The indicated fragments were excised 
from the gel and the DNA purified by "Geneclean", Chapter 2, 
Section 5.5. The purified inserts were then labelled with 32 P 
dCTP as described above to produce double-stranded DNA probes. 
The last probe tested was an antisense RNA probe produced by 
transcription from the T7 promoter of pBV4/p80. 	Two RNA probes 
of different lengths were prepared as described in Chapter 2, 
Section 6.4. 	The potential length of probe was determined by 
the site at which the plasmid was linearised. 	In these 
experiments a 192bp RNA probe was produced on a plasmid template 
linearised by the enzyme Dral, 	and a 2.3kb (full length) RNA 
probe was produced on a template plasmid linearised by HpaI. 
Both probes were labelled using 32P UTP. 
5.4 RESULTS 
5.4.1 Hybridisation pattern of clones 35. 50 and 75 
In this experiment RNA from cells infected with a panel of 
BVD and BD strains was dotted onto replicate nitrocellulose 
membranes and probed with 32P-labelled double-stranded DNA 
probes from clones 35, 50 and 75. Duplicate hybridisations were 
carried out at 420C in 25% and 50% formamide for 16-24hrs, 	and 
the probes were at a concentration of approximately 6 x 106  cpm 
in 5m1 of hybridisation buffer. 	For the actual hybridisation 
protocols see Chapter 2, 	Section 6.5. One set of filters from 
each hybridisation was given a moderate stringency wash (1 x 
SSC/0.1% SDS 2 x 30min at 550C) and the other set was given a 
high stringency wash (0.1 x SSC/O.l% SDS 2 x 30min at 60°C) then 
dried. 	An autoradiograph was produced from the filters as 
described in Chapter 2, 	Section 6.6. The results are shown in 
Figure 5.3. These results are after a moderate stringency wash. 
Increasing the washing stringency reduced the intensity of the 
signal but did not change the pattern. 
Clearly all three probes performed as expected with the 
positive and negative control RNAs (from BVDV-NADL infected and 
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Figure 5.3 Autoradiograph of dot blot hybridisations of clones 
35, 50 and 75 to cellular RNA of infected cells. 
A Standard stringency: 50% formamide 
B Low stringency: 25% formamide 
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B816 (BVD CP) 	8. 	G2048 (BDV NCP) 
8085 (BVD CP) 	9. Uninfected FLM 
BDV-M (CP) 
Wash - 1 x SSC 42°, 2 x 30' 
A 
- 	 PROBE 
..t2 34567 89 	75 
S 	 50 
1234 567 8 9 
. 	 35 
1 2 3 4 5 6 7 8 
B 
S  
1 2 3 4 5 6 7 8 9 	 75 
.. 
1 2345 6789 
S 
1 2 3 4 5 6 7 B 
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At the lower (25%) formamide concentration all cytopathic 
BVDV strains except Osloss were recognised by all probes. The 
Osloss RNA had presumably been degraded. 
All three probes 
reacted more strongly with CP BVDV strain 8085 than with B816 
implying the former is more similar to the NADL strain. 
Only one of the three BDV strains tested showed a positive 
hybridisation result. 	The NCP strain G2048 reacted with probes 
35 and 50, 	implying it is more similar to BVDV than are the 
other BDV strains. 	The signal was substantially weaker than 
with BVDV for both probes but it was impossible to determine if 
this was due to a difference in specificity or simply in amount 
of viral RNA present, 	since BDV grows to about 10-fold less 
than BVDV. The CP BDV strain showed no reaction with any of the 
probes, 	nor did the NCP strain G1480, which is the strain used 
in cDNA cloning work. 
On raising the hybridisation stringency to standard 
conditions (50% formamide 42°C) several positive reactions were 
lost. The reactions of probe 75 with the CP BVD strains were 
unchanged, but probes 35 and 50 no longer recognised the CP B816 
strain, or any BDV strain except a weak signal between strain 
G2048 and clone 35. 
In summary, at low hybridisation stringency all BVDV strains 
except Osloss were recognised by all three probes and one BDV 
strain was recognised by two of the probes (35 and 50). 	At 
higher (standard) stringency, probes 35 and 50 were almost NADL 
specific, 	showing hybridisation only to one other strain 
(8085). Probe 75, 	however, 	maintained a broader specifity, 
showing the same hybridisation pattern as at 25% formamide. 
Therefore none of these probes was of potential use for 
detecting sequences of the BDV strain G1480 used throughout this 
project. 
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5.4.2 Clones p503 and pN24 
Probes were produced from both clones as described in the 
previous section, and these probes were hybridised under 
standard conditions (42°C, 50% formamide) to dots of RNA from 
cells infected with various pestivirus strains. 	Both probes 
were tested against BVDV-NADL, BVDV Osloss, NCPBD strain G1480 
and uninfected cell RNA. The results are shown in Figure 5.4, 
part A. 
The washing conditions in this experiment were stringent: 
0.1xSSC/0.1% SDS, 60°C for 2 x 30min washes. 	Under these 
conditions both probes pN24 and p503 were specific for the NADL 
strain of BVDV. A further experiment was done in which pN24 was 
hybridised under the same conditions to RNAs of a wider panel of 
virus strains and the filters washed under less stringent 
conditions (1 x SSC 0.1% SDS 42°C 2 x 30mm). 	The results are 
shown in Figure 5.4, 	part B. 	Under these conditions pN24 
recognises all the cytopathic pestivirus strains including 
BDV-CP. 	The strongest signals were obtained with strain C24V 
and BDV-CP. An interesting result is that strain 8085 (CP BVDV) 
reacted less strongly than BDV-CP with probe pN24, 	although in 
the previous experiment strain 8085 gave a very strong signal 
with probe 50 which is derived from sequences adjacent to those 
of pN24. 
p503 was not tested under these less stringent washing 
conditions. 	In summary, probes pN24 and p503 are BVDV-NADL 
specific under standard hybridisation conditions followed by a 
high stringency wash. Probe pN24 recognised three CP viruses 
(two BVDV, one BDV) but no NCP viruses when the washing 
stringency was reduced. 
5.4.3 RNA probes 
Figures 5.5 and 5.6 show the results of hybridising two 
different RNA probes derived from pBV4/p80 to dots of RNA from a 
panel of pestivirus strains. 	In Figure 5.5 a short 192bp 
riboprobe from the downstream end of the p80 region was used. 
Hybridisation took place at 420C 50% formamide and washing was 
Figure 5.4 Autoradiograph showing dot blot hybridisation using 
clones pN24 and p503 to cellular RNA from infected 
cells 
A 1. NADL 	 B 1. C24V 
Osloss 	 2. BDNCP (G1480) 
BDNCP (G1480) 	3. Osloss 
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Figure 5.5 Autoradiograph showing dot blot hybridisation to 
BVDV and BDV strains using the short (192bp) 
riboprobe produced by linearising pBV4/p80 with 
Dral. Dots are total RNA from infected cells. 
BVDV NADL 
	
5. BDV G1480 
BVDV Osloss 
	
6. BDV G2048 
BVDV C24V 
	
7. BDV M(CP) 
BVDV G982 
	
8. Uninfected FLM cells 
Figure 5.6 Autoradiograph showing dot blot hybridisation to 
BVDV and BDV strains using the long (2kb) riboprobe 
produced by linearising pBV4/p80 with HpaI. Dots 
are cellular RNA from infected cells. 
BVDV NADL 
	
5. BDV G1480 
BVDV Osloss 
	
6. BDV G2048 
if C24V 
	
7. 	" M (CP) 
4 	G982 	 8. Uninfected FLM cells 
Era 1 riboprobe 
12345678 
r i bop robe 
1 	23.45:618 
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under low stringency conditions (1 x SSC 0.1% SDS at 42°C for 2 
x lhr washes). 	Higher stringency washes made the probes BVDV 
specific. At the lower stringency the Dral riboprobe appears to 
recognise all of the seven pestivirus strains tested, and gave 
as strong a signal with BD strains as with BVDV strains. 	(The 
lack of signal with NCP BVDV strain C982 was taken to be a false 
negative, due to lack of sample on the membrane, rather than a 
true result). Thus this short riboprobe looked extremely 
promising as a general pestivirus probe. 	When a longer probe 
which spanned the full length of the p80 insert was used, 	the 
specificity became much more rigid. 	This long riboprobe was 
hybridised and the filters washed under the same conditions as 
the short one, 	and the results are shown in Figure 5.6. 	Even 
under the low stringency washing conditions used, this probe 
recognised only the CP strains of virus (BVDV and BDV). 	( A 
positive result was taken as a signal which was greater in 
intensity than that of the negative control). 	Thus the 
increased length of this probe must have introduced areas of low 
homology between strains, whereas the short Dral riboprobe must 
represent a small highly conserved area. 
In a further experiment, this short riboprobe was hybridised 
(under identical conditions) to an extended panel of BDV 
strains, results are shown in Figure 5.7. 	Only one strain of 
the nine tested failed to react (strain L991) strains D861 and 
R2727 showed a faint signal whereas the remaining six strains 
(all NCP) showed an equally strong signal. 
In summary the short riboprobe derived from plasmid pBV4/p80 
was shown to be specific over a broad range of BVDV and BDV 
strains making it potentially an extremely useful tool in the 
detection of pestivirus RNAs. 	The longer probe produced from 
the same clone had restricted specificity. Other lengths of 
riboprobe were not produced and tested, but it could be 
envisaged that a family of probes of differing lengths and 
specificities might be produced from this clone. 
Figure 5.7 Autoradiograph showing dot blot hybridisation of 
the Dral riboprobe to various BDV stains shown. 
Dots are from BDV infected FIN cells. 
JH2876 	 6. G2048 
L991 	 7. G1480 
D861 	 8. 01305 
R2727 	 9. A1870 
"Weybridge" 	10. Uninfected FLM cells 
1 
Dra I 	riboprobe I.' SOIL) 
2 	34 	5 67.8. 9  10 
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5.4.4 Northern hybridisation using riboprobes from pBV4/p80 
Having identified a probe which seemed potentially useful 
over a broad range of virus strains, the next stage was to use 
this probe in Northern blotting experiments to identify the size 
of RNA species to which it hybridised. 
Samples of the same RNAs from infected cells as were used in 
the dot blot experiments were run on denaturing formaldehyde 
gels, the gels were blotted onto a nitrocellulose membrane and 
the blots probed with either the short or long pBV4/p80 
riboprobe. Details of these procedures can be found in Chapter 
2, Sections 5.2 and 6.2 
Figure 5.8A and B shows the results of a Northern blot of 
BVDV-NADL alongside two NCP BDV strains (G2048 and G1480). 	In 
A, the gel has been stained with ethidium bromide to show the 
marker RNAs and to check that the RNA samples were not degraded. 
In B the results are shown on an autoradiograph after 
hybridising the blot to the short Dral riboprobe at 42°C in 50% 
formamide, and washing under stringent conditions (0.1 x SSC 
0.1% SDS at 60°C for 2 x 20mm). 	Under these conditions the 
probe hybridised to a single high molecular weight band in the 
NADL RNA sample and to no RNA species in any of the BD samples. 
The size of the high molecular weight band was approximately 
12kb as expected for the BVDV genomic RNA. 	The lack of signal 
in the BDV samples was not due to lack of RNA, as can be seen in 
the UV photograph, 	the BDV tracks contain as much cellular RNA 
as the BVDV tracks. Nor is it likely to be due to a lack of 
virus RNA in the sample, 	since virus titres were reasonable 
(Table 5.3) and the same sample had given a positive dot blot 
result at a lower washing stringency. 	Therefore at the high 
washing stringency used, 	the Dral riboprobe appears to be BVDV 
specific, the extent of this specificity between different BVDV 
strains was not tested on a Northern blot. 
In the next experiment the above hybridisation using the 
short Dral riboprobe was repeated on a Northern blot of various 
BVDV and BD RNAs but the washing stringency was reduced to 1 x 
SSC 0.1% SDS at 42°C 2 x 30niin, 	in an attempt to detect 
Figure 5.8 A Polaroid photograph of denaturing agarose gel 
containing cellular RNA from BVDV or BDV 
infected cells. 
Track 1. RNA ladder 
	5. BDNCP G1480 
BVDV-NADL 
	
6. BDNCP C2048 
NADL virion RNA* ] 	- 
- 	 8. Uninfected FLM cells 
B Autoradiograph showing results of Northern blot 













hybridisation of the probe to BDV RNA as in the dot blot results 
shown in Figure 5.7. 	The results of this hybridisation are 
shown in Figure 5.9. The decreased wash stringency allowed 
hybridisation of the probe to all RNAs present. 	High molecular 
weight RNA was visible in the BVD-NADL sample but not in any 
other strain. This result throws confusion on the positive dot 
blot results obtained with this probe under the same low 
stringency washing conditions - the negative controls are 
showing less of a signal than the infected samples in both 
cases, but the Northern blot reveals that the signal in the 
infected samples is due to hybridisation to RNA species whose 
size seems to indicate that they are of cellular and not viral 
origin except in the case of BVDV-NADL where an RNA of the 
correct size was detected. 
In summary the Dral riboprobe was BVDV specific at high 
stringency and detected a 12kb band on Northern blots. At low 
stringency the specificity was blurred, all infected samples 
gave positive signals with low molecular weight RNAs but no high 
molecular weight bands were detected from any sample other th" 
BVDV NADL. 
Figure 5.10 A and B shows the results of a Northern blot of 
BVDV NADL and BDNCP (strain G1480) probed with the longer (more 
specific) HpaI riboprobe. 	The hybridisation and washing were 
carried out as in the previous experiment, ie standard 
hybridisation conditions followed by non-stringent washing of 
the blot. Since this probe appeared more specific it was hoped 
that this would eliiinate the apparent non-specific 
hybridisation to cellular RNAs. 	However, as can be seen, this 
was not the case. 	At this stringency, the HpaI riboprobe gave 
exactly the same pattern as the Dral riboprobe, 	ie a strong 
positive signal from a high molecular weight RNA in the 
BVDV-NADL samples but non-specific hybridisation to 28s and 18s 
cellular ribosomal RNA in all other samples. 	This non-specific 
hybridisation was also evident in the NADL sample of RNA from 
infected cells, though not in the NADL sample RNA from purified 
virus, 	a further indication of the cellular origin of these 
lower molecular weight bands. 
Figure 5.9 Autoradiograph 	showing results of Northern 
hybridisation experiment using the Dral riboprobe. 
RNA ladder 
BVDV NADL infected 
BT cell RNA 
Uninfected BT cell 
RNA 
BDV G2048 infected 
FUI cell RNA 
Uninfected FLM cell 
RNA 
BDV-M (CP) infected FU( 
cell RNA 
BDV G1480 infected FLM 
cell RNA 
BVD NCP (C982) infected 
ET cell RNA 
BVD Osloss infected BT 
cell RNA 
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Figure 5.10 A Denaturing agarose gel stained with ethidium 
bromide, showing RNAs from infected and 
uninfected cells as detailed below. 
Uninfected FLM cell RNA 
Uninfected BT cell RNA 
BDNCP (G1480) infected FLM cell RNA 
BVDV-NADL infected BT cell RNA 
BVDV-NADL RNA from purified virus 
B Autoradiograph of a Northern blot of the above 
gel probed with the Hpal riboprobe 
12345 
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1 	 5- 
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In summary, the short Dral riboprobe was used at high 
stringency to demonstrate the 12kb BVDV-.NADL genomic RNA on 
Northern blot, but failed to detect RNA from BDV (NCP strains). 
At lower stringency the positive results obtained on dot blots 
with both short and long riboprobes were shown probably to be 
due to hybridisation of these probes to the ribosomal RNAs of 
infected cells as detected on Northern blots, or to mRNA species 
induced by infections. 
5.5 SUMMARY 
Six BVDV clones were used to produce probes which were tested 
for their hybridisation to various BVDV and BDV strains. 	Few 
positive signals were obtained with any BDV samples although a 
range of BVDV strains were positive. The BDV hybridisation 
results could be summarised as follows: 	Clones 35 and 50 
detected BDNCP G2048, 	Clone pN24 detected cytopathic BDV, and 
the riboprobes derived from pBV4/p80 detected various BDV 
strains on dot blots but failed to reveal high molecular weight 
BDV RNA on Northern blots. 	Thus no probe was obtained with 
which to screen the possible cDNA library produced from the 
BDNCP strain G1480 used in this project. 
This implies that at least over the areas tested nucleic acid 
homology between BVDV and BDV is quite low. 
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CHAPTER 6 
THE POLYMERASE CHAIN REACTION 
6.1 INTRODUCTION 
The polymerase chain reaction (PCR) is an in vitro method for 
primer-directed 	amplification 	of specific DNA sequences. 
Originally developed by Saiki et al (1985), it was designed to 
provide highly efficient amplification and purification of DNA 
sequences of interest. 
PCR relies on the availability of sequence information for 
sites that flank the region to be amplified. Two short 
synthetic oligonucleotides in opposing orientations are prepared 
as primers, complementary to each of these sites. Reiterative 
cycles of DNA denaturation, primer annealing and primer 
extension are then used to generate multiple copies of the 
primer-flanked target sequence. The efficiency and sensitivity 
of the technique is unparalleled, a million copies of a target 
can be produced in a few hours, and amplification can be 
achieved from one target molecule in a single cell (Li et al, 
1990). 	Although originally developed for use with target DNA 
sequences, PCR has been used successfully in conjunction with 
reverse transcription to amplify rare RNA sequences (Doherty et 
al, 1989). PCR has also been used to detect and analyse viral 
sequences in infected cells, for both DNA and RNA viruses (Kwok 
et al, 1987, Gama et al, 1988). 	There is one report in the 
literature describing the use of PCR to amplify sequences from 
the BVDV genomic RNA (Schroeder and Balassu-Chan, 1990). 
PCR is of great potential value in pestivirus research for 
several reasons. Current diagnostic-methods for the detection 
of pestiviruses rely either on virus isolation or immunoassays 
which lack the sensitivity of PCR. PCR is also rapid and can be 
performed on very small amounts of material, amplification is 
readily achieved on RNA prepared from lymphocytes in clinical 
material. It is also an excellent way to detect non-cytopathic 
pestiviruses which can be difficult to detect by other 
diagnostic techniques. 
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This chapter describes the use of PCR to amplify various 
pestivirus sequences as follows: 	Two complete sequences of 
different BVDV strains (Osloss and NADL) were available. 	Based 
on sequence comparisons (for further discussion on sequence 
comparison see Chapter 7) conserved areas of the BVDV genome 
were identified and used to design complementary primers, 
covering various parts of the genome. These primers were tested 
firstly on the NADL strain of BVDV, and then on other BVDV and 
BD strains. 
To perform PCR on pestiviruses, an initial reverse 
transcription step to produce cDNA is necessary. This cDNA 
could be primed using random hexainers as in Chapter 4, or else 
by using the specific anti-sense oligonucleotide primer. Both 
approaches were tried. Once the amplification of cDNA had been 
achieved, the amplified sequences could be used as probes for 
the detection of pestivirus RNA or screening a cDNA library. 
6.2 DESIGN OF PRIMERS FOR PCR ON PESTIVIRUSES 
The design of primers is the first step in any PCR experiment 
and three factors need consideration. Firstly, where to 
position the primers; this depends on where the areas of 
interest occur, the desired length of amplimer and the position 
of conserved stretches of sequence to be used as primers. 
Secondly, the actual sequence of the primers, which may not 
always be a straightforward complement of the target strand, if 
a broader specificity is required. 	Lastly, the physical 
properties of the primer, such as length and C/C content, are 
also important. 
In this work five sets of primer pairs were tested in PCR 
reactions. 	Two of these pairs were kindly supplied by M. 
Sweeney, University of Warwick, and the other three were 
designed specifically. A summary of the primers can be found in 
Figure 6.1 and Table 6.1. 
Primer pair 325C'326C 
These span a target sequence 299bp in length covering most of 
the 5' untranslated region of the genome. This region is highly 
TABLE 6.1 
Oligonucleotide 	Sequence (5' -> 3') 	 Length (bp) 	G/C Content 	Position on NADL RNA 
325c AGAGCCTAGCCATGCCCTTAGT 22 54% 97 - 118 
326c  TCAACTCCATGTGCCATGTAC 21 48% 395 - 375 
NADL2 CTFGrFGACGGGTFGAC 17 53% 1739 - 1755 
NADL2R GGTGCCAAATI'TCCCAGG 18 55% 1994 - 1977 
NADL6 GAAAGCATI'ATGAGCAACT 19 37% 12204 - 12222 
NADL6R TACAGCTAAAGTGGTGTGTGC 21 48% 12523 - 12503 
CCGCTAGGGGGCAA*TArnTC 21 52% 5301 - 5321 
TGCTG*CGTGG*AGTCAT 18 50% 6484- 6467 
928G G'lTFAGTGGCAGCACTCATAGAGCTGAACT 30 46% 4614-4643 
929G TAAGCTCGTAGGGAACCTCACCGGGGCTCT 30 60% 5557 - 5529 


















Figure 6.1 Relative positions of primer pairs used in PCR on 
the BVDV-NADL genome. Not to scale. 
BVDV GENOMIC RNA 
p20 	p62 	p53 	 p54 	 p80 	
11 	
p58 	 p75 
	
FAd FB 	 C 	 r D 
PRIMER PAIRS 
A 	325 / 326c 	 D 	NADL6 / 6, 
B NADL2 / 2R 	 E 	928 / 929, 
C 	718, / 719D 
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conserved, at around 90%, between NADL and Osloss BVDV strains, 
as would be expected, since the control and recognition 
sequences for virus gene expression are likely to occur in this 
region. Thus it would be reasonable to expect these primers to 
have a broad range of specificity. Additionally, the resulting 
amplified sequence should be useful as a general probe for the 
pestiviruSes. 
Primer pair NADL 6/NADL 
These span a target sequence 320bp long covering the last 100 
bases of the p75 coding region and stretching into the 3' 
untranslated region. 	The sequence divergence in this region is 
around 25% mismatch, although this is not an even distribution, 
there are very highly conserved regions interspersed with 
variable regions. 	The 3' untranslated region must contain 
recognition sequences for the viral RNA polymerase, and there 
are other conserved areas in this region. 	In particular, there 
are sets of repeated sequences which are conserved between the 
NADL and Osloss strains (see Chapter 7). 	This target sequence 
then, is also likely to have a broad specificity. 
Primer pair NADL 2/NADL 2R 
These primers flank a region 256bp long in the area coding 
for the p62 glycoprotein. 	They were derived solely from the 
sequence of the NADL strain and should therefore be specific for 
this strain, since their sequences are not conserved in the 
Osloss strain. The target sequence amplified by these primers 
should have some discriminatory uses since there is considerable 
inter-strain variation in this glycoprotein region (71% homology 
between NADL and Osloss strains). 
Primer pair 718D'719D 
These primers flank a sequence of 1184bp in a region of 
considerable interest; the junction between p54 and p80 which is 
cleaved in cytopathic pestivirus strains and not in non-
cytopathic strains. The p54 sequences which make up roughly half 
of the target sequence amplified by these primers are highly 
variable. 	This region includes the insertion of ubiquitin 
116 
sequences which occur only in the Osloss strain. However, the 
p80 sequences are highly conserved - this region is the most 
highly conserved of the entire genome. It would be of great 
interest to use PCR of this region to define differences in the 
sequence of the p54/p8O cleavage site in different virus 
strains. For this reason, primers were needed which would 
anneal to a very broad range of pestivirus strains. 	Since 
sequences were only available for two BVDV strains, flavivirus 
sequences were searched for homologies with these existing BVDV 
sequences, with the rationale thatany such homologies would be 
conserved between most, if not all, pestiviruses. The primer 
719 D is positioned at a region where there is homology with 
flaviviruses at the protein level. 
Primer pair928,,L2-29. _ 
These primers flank a 944bp region of the p54 coding 
sequence, which stops just prior to the p54/p80 processing 
point, 	and which actually overlaps the 
718D719D 
 amplimer, so 
in effect it is a 5' portion of the larger 
718D719D 
 target 
sequence. Again this area is highly variable and includes the 
Osloss ubiquitin insertion. The sequences of these primers were 
kindly recommended by L. Moerlooze, who had achieved success in 
amplifying a cytopathic strain of BDV using them (Moerlooze et 
al, 1990). 
6.3 EXPERIMENTAL 
6.3.1 Preparation of stock solutions 
Because of the extreme sensitivity of the PCR technique, 
several precautions were routinely taken to minimise the chance 
of amplification of contaminating DNA sequences. 
All PCR work was performed wearing gloves, and the assembly 
and analysis of the reactions were carried out using separate 
sets of pipettes. 	Reagents were prepared in a sterile laminar 
flow hood, 	sterilised and aliquoted in small volumes. Aliquots 




Buffers: 	5 x MMLV reverse transcriptase buffer. Supplied with 
enzyme (BRL). 
10 x PCR amplification buffer 	500mM KC1 
100mM Tris Cl pH8.3 
15mM MgC12  
0.1mg/mi Gelatin 
Buffers were prepared using sterile frozen stock solutions as 
described below. 
dNTPs 
dNTPs were used in excess: a final concentration of 200uM in 
the reaction. A stock solution containing 10mM of each dNTP was 
prepared by dilution of commercially available 100mM stocks 
(Pharmacia) in sterile water. 
Oligonucleotide primers 
These were used at luM in the reaction. 	Because of the 
differing lengths of primers and different supply concentrations 
the dilution factor for each primer as supplied was different. 
Table 6.2 shows the dilution of primers used. 
Tag Polymerase 
The enzyme used was "Axnplitaq" supplied by Perkin Elmer 
Cetus. It was used at 5 units per lOOul PCR. 
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Table 6.2 Dilution of oligonucleotide stocks 
Oligo 
Length 








to give 20x 
325 C 22 6.6ug/ml 320ug/ml 132ug/ml 1/2.5 
326 C 21 6.9ug/ml 320ug/ml 138ug/ml 1/2.5 
NADL2 17 5.9ug/ml 500ug/ml 118ug/ml 1/4 
NADL2R 18 6.2ug/ml 500ug/ml 124ug/ml 1/4 
NADL6 19 6.2ug/ml 500ug/ml 124ug/ml 1/4 
NADL6R 21 6.9ug/ml 500ug/ml 138ug/ml 1/3.5 
718 D 21 6.9ug/ml 220ug/ml 138ug/ml 1/1.5 
719 D 18 5.9ug/ml 280ug/ml 118ug/ml 1/2.5 
928 D 30 9.8ug/ml 400ug/ml 198ug/ml 1/2 
929D 
30 8.9ug/ml 300ug/ml 178ug/ml 1/2 
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6.4 METHODS 
The overall strategy for the PCR performed on pestiviruses 
was to use RNA prepared from virus-infected cells as the input 
source of target, to prepare cDNA from this RNA and then 
directly amplify this cDNA in a PCR. 	The cDNA reaction was 
diluted into PCR buffer thereby allowing a one tube reaction 
which minimises losses. 
RNA isolation 
RNA was prepared from virus infected cells using the 
guanidiniuin isothiocyanate method (Chapter 2, Section 4.5) and 
pelleted through a 5.7M CsCl cushion. RNA was routinely 
prepared from two 50m1 cultures of monolayered cells, harvested 
before CPE had become pronounced. 	This RNA was stored under 
ethanol at -20°C, and aliquots removed for PCR as required. 
cDNA synthesis 
The cDNA reactions were standard for all PCR experiments and 
were performed in a 20ul volume. The RNA was mixed with either 
random hexamers at lOug/ml or the specific downstream 
oligonucleotide primer at 25ug/ml (final concentrations). The 
reaction was heated to 96°C for 3 min then cooled to 37°C. 	The 
rest of the reaction components were added as follows: 
4u1 MMLV reverse transcriptase buffer 
lul 10mM dNTP stock 
lul RNA guard (Pharmacia) 
lul MMLV reverse transcriptase* 
* This was the cloned enzyme lacking the ENAse H activity 
supplied by BRL. 	It was vastly superior to the AMV enzyme 
(Anglian Biotech) in producing cDNA from unpurified RNA 
populations (results not shown). 
The cDNA reaction was allowed to proceed at 42°C for 30mm. 
Amplification of first-strand cDNA 
The 20u1 first-strand cDNA reaction was diluted to lOOul 





5u1 each oligonucleotide primer (20 x. stock) 
lOul 10 x PCR buffer 
This mixture was overlaid with lOOul light mineral oil, 
boiled for 3mm, 	then chilled on ice. 	The rest of the 
components were added (through the mineral oil): 
2u1 10mM dNTPs 
0.5ul (5 units) Taq polymerase 
The reaction was amplified through the desired cycles. 
AmDlification Cycles 
The standard cycle used was: 95°C for 90s denaturation 
37°C for 2min annealing 
72°C for 3min extension 
Generally 25-30 cycles were performed 
The cycles used were varied as required. 
Once amplified, 	reactions were frozen at -20°C and the 
mineral oil removed. A sample of the reaction (one fifth - one 
tenth of the volume) was analysed on an agarose gel by ethidium 
bromide staining. 
6.5 RESULTS 
In this work five primer pairs were tested for their ability 
to prime amplification on target cDNA prepared from cells 
infected with BVDV and BDV. 
6.5.1 Primers 325C'326C 
These were firstly tested on RNA from BVDV NADL infected 
cells. 
cDNA synthesis was performed using both random priming and 
specific priming by oligo 326 	The cDNA was amplified by PCR 
by the standard method (see previous section) through 30 cycles. 
One fifth of the reaction volume was run on a 1.5% agarose gel 
and stained with ethidium bromide. 	The results are shown in 
Figure 6.2 
Figure 6.2 Agarose gel (2%) showing PCR result using primers 
325 
C 
 /326 C on NADL-infected ET cell RNA 
Track: 1 1kb ladder 
2 1st strand primed by 326 
3 1st strand primed by random 
hexanucleotides 
4 As track 2 
5 1/20th of the reaction in track 2 
Figure 6.3 Agarose gel (2%) showing PCR result using 3 
different primer sets on NADL-infected BT cell RNA 
Track: 1 1kb ladder 
2 NADL6/NADL6R primers 
3 NADL2/NADL2R  primers 
4 325/326 primers 
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The expected amplimer size was approximately 300bp. Track 2 
shows the result with specific priming and track 3 with random 
priming (Track 4 is the same as track 1 and track 5 is one 
twentieth of the reaction volume loaded). 
A cleanly amplified fragment of the expected size was 
obtained from BVD-NADL sequences using PCR amplification of cDNA 
primed by oligo 326g. 
	
Amplification of random primed cDNA gave 
a fragment of the same size but a "ladder effect" was obtained 
due to non-specific amplification of other sequences. 
Thus, under standard conditions, 30 cycles of amplification 
using primers 325/326 produced the expected 300bp amplified 
fragment from BVD-NADL RNA. 
6.5.2 Primers NADL 
212R 
 and NADL 616R 
In the next experiment, shown in Figure 6.3, two more primer 
pairs were tested on the same BVD-NADL RNA, again under the same 
conditions as above. Track 2 shows amplification by primers 
NADL 
66R' 
 track 3 by primers NADL 
212R 
 and track 4 by primers 
325326C, The expected amplimer sizes were 320bp, 257bp and 
298 bp respectively. One tenth of each reaction was run on the 
gel, which was 1.5% agarose. 
Successful amplification was achieved using all three primer 
sets after 30 cycles. 	The NADL 22R pair appeared least 
efficient, the other two pairs seemed to be of equal efficiency. 
The next stage was to try these two most efficient primers on 
BDV RNA. 	In any case the NADL 
22R 
 primers would be least 
likely of these three sets to prime on BDV RNA, 	since they are 
likely to be the most specific, being derived from a variable 
region of the genome (Figure 6.1). 
Figure 6.4 shows the results of amplification performed on 
oligo-primed cDNA from the RNA of BVDV-NADL and BDV-Cl480 (NCP) 
infected cells. Both primer pairs gave successful amplification 
on the positive control RNA (BVDV-NADL) but unfortunately the 
resulting bands were very faint. 	Neither pair primed 
amplification on the BDV sample. 
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Varying conditions described below were used in an attempt to 
achieve amplification on the BDV RNA template. The following 
changes were made to the standard protocol: 
35 cyles were used as opposed to 30, in case the BDV samples 
had lower numbers of target molecules. 	This had no effect on 
amplification of BDV sequences (result not shown). 
The already non stringent annealing temperature of 37°C was 
decreased to room temperature to see if this allowed primer 
annealing and extension on the BDV samples. This, too, was 
unsuccessful (result not shown). 	This result implies that the 
problem is not due to poor primer annealing, since under such 
non stringent conditions it is unlikely that the primers would 
not anneal especially since these primers are presumed to be 
conserved. 	The problem appears then to be at the extension 
rather than the annealing stage. If there is a mismatch in base 
pairing at or near the priming end of the oligonucleotide, 
priming will not occur even if the rest of the primer is tightly 
bound. It seems to be the case for these primer pairs that one 
or both of the pairs may have such a mismatch with the BDV 
sequence at their priming ends. 
These primers did not seem to be of use as a route to amplify 
BDV sequences. 	At this stage it was decided to design another 
set of primers derived from the most conserved region in BVDV, 












 were used in a PCR on BDV-infected cell 
RNA as follows: 	Primer 
719D 
 was used to specifically prime 
first strand cDNA as discussed in Section 4. 	This cDNA was 
included in a PCR using this primer pair. The standard 
amplification cycle was adjusted to allow a longer extension time 
since the target sequence was 1.2kb long. 	Amplification was 
performed using 35 cycles of 95°C for 90S, 37°C for 2min and 
72°C for 5mm. 	1/10 of the reaction was run on a 1.2% agarose 
gel. 	The results are shown in Figure 6.5. Tracks 2 and 4 are 
negative control samples from uninfected cells, track 3 is BDV 
Figure 6.4 1% Agarose gel showing PCR on BVDV and BDV infected 
cell RNAs using primer pairs 325326C 
 and 
NADL6/6R. 
1 1kb ladder 
2 NADL infected BT cells ; 325 C 
 /326 
 C 
3 NADL infected BT cells + NADL 616R 
4 BDV infected FLM cells + 325c 326C 
5 BDV infected FLM cells + 325 C 
 /326 
 C 
Figure 6.5 1% Agarose gel showing results of PCR using primer 
pair 718D'719D 
 on RNAs from BVDV infected, BDV 
infected and uninfected cells. 
1 1kb ladder 
2 Uninfected FLM cells 
3 BDNCP infected FLM cl1s 
4 Uninfected BT cells 




and track 5 is the BVDV-NADL sample. 	Thus the 718D 
 and 719 D 
primers appear to allow successful amplification on BDV RNA, 
but not on BVDV-NADL RNA. 	This is unexpected, since they were 
derived from the published NADL sequence. 
Figure 6.6 shows a repeat of this experiment, 	this time 
including a positive control using primers 325326C on the NADL 
sample to check that the NADL RNA is viable. 	This figure shows 
that amplification is successful with the primers 325326C 
 on 
NADL RNA (track 2), 	but unsuccessful with primers 718D719D 
(track 3). 	Track 4 shows the successful amplification of BDV 
sequences using primers 	 These primers failed to 
produce specific amplification on the negative control 
(uninfected cell) RNA. 	Thus primers 718D'719D 
 are extremely 
valuable as a route to BD sequences from this area of the 
genome. The failure of these primers on a BVDV NADL template is 
difficult to explain, 	one explanation may be that the NADL RNA 
sample was degraded such that the 	 control amplimer 
remained intact, 	but the 718D719D sequence was destroyed. 
Another explanation could be that secondary structures in the 
NADL RNA prevented amplification over a length of 1.2kb, though 
this does not occur in BDV. 
6.5.4 Primers 928G'929G 
These primers were designed on the basis of unpublished 
observations that they gave successful amplification with RNA 
from cells infected with the Moredun cytopathic strain of BDV 
(L. Moerloose, personal communication). However, in our hands 
they did not achieve successful amplification on either CP or 
NCP BDV strains, though they did give amplification on 
BVDV-NADL. 	Figures 6.7 and 6.8 show this. 	Amplification was 
performed under standard conditions by the methods described in 
Section 4, 	except that the extension time was increased to 4 
min and the number of cycles was 35. 	Figure 6.7 shows PCR 
performed solely on a NADL sample: 	track 2 is the positive 
control with primers 325 C /326CI track 3 is an unsuccessful 
718D719D reaction, track 4 shows a positive result after 





 on NADL and BDNCP infected cell RNA. 
Track: 1 1kb ladder 
2 3251326 primers on NADL (+ve control) 
718/719 on NADL 
718/719 D on BDNCP 
718/719 on uninfected FLM cell RNA 
Figure 6.7 	1% Agarose gel showing PCR result using three 
different primer pairs on BVDV NADL infected cell 
RNA. 
Track: 1 1kb ladder 
2 325326C primers 
718D'719D primers 
928G929G primers 
5 928C929C primers on uninfected cell RNA 
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amplification using primers 928/929, and track 5 shows a 
negative control sample of uninfected BT cells. 
Figure 6.8 shows the results on BDV samples. Track 2 is a 
negative control using uninfected cell RNA, 	track 3 is a 
718D719D reaction on NADL RNA, track 4 is the positive control 
using primers 928 and 929 on NADL, and tracks 5 and 6 show 
the same primers used on BDNCP and BDCP respectively. 
Successful amplification was not achieved using either of the BD 
template RNAs. 	This result was repeated (not shown) altering 
the number of cycles, 	the magnesium concentration and the 
annealing temperature all had no effect (not shown) and NCP 
strains of BDV respectively, neither of which gave successful 
amplification using these primers. 
6.6 CONCLUSIONS 
Five oligonucleotide pairs were tested for their ability to 
prime amplification of BVDV and BDV sequences in PCR. Of these 
pairs, four produced successful amplification from BVDV-NADL and 
one from BDV-G1480. 
It was found that the cDNA synthesis preceding amplification 
was best performed using specific priming from the downstream 
oligonucleotide, rather than using random hexaniers. The 
amplifications were specific, particularly considering the 
relatively low (37°C) annealing temperature used throughout. 
An unexpected result was the lack of amplification on the BDV 
template using primers 325/326 and NADL 
66R• 	
Both these 
pairs are from sequences which occur in the non-coding regions 
of BVDV and are very highly conserved. Lack of amplification 
using these primers was perhaps due to a mismatch at the priming 
end 	of one or both primers. Primer pair 928 
G 
 /929 G also failed 
to amplify BDV sequences. 	These primers had been previously 
shown to do so, 	the reason for their failure in our hands 
remains unclear. 
Figure 6.8 1% Agarose gel showing PCR result of using 
different primer pairs on BDNCP and BDCP infected 
cell RNAs. 
Track: 1 1kb ladder 
2 primers 928G'929c on uninfected cell RNA 
3 primers 718D"719D on BVD NADL 
4 primers 928/929G 
 on BVD NADL 
5 primers 928G'929G 
 on BDCP 





 were the only pair to successfully amplify 
BDV sequences. 	These produced a specific amplification of a 
1.2kb fragment. Unfortunately, time did not permit verification 
of this result by hybridisation of the amplimer to BDV RNA. 
The 	successful 	amplification of BDV sequences is a 
potentially valuable route to obtaining sequence information 
about the virus. 	The amplified fragment could be used as a 
probe to detect different pestivirus strains, as a primer for 
further direct PCR on BD, or as a probe for any cDNA library. 
In addition, amplification of this particular area of the genome 
is of interest, since it spans the processing junction of 
p54/p8O. Unfortunately, because of limited time, these routes 
were not exploited. 
Another potential experiment would be to test the four BVDV 
amplified sequences for their ability to hybridise to BDV-RNA in 
blots. An estimate of the homology between the different areas 
of the genome represented could be obtained in this way. 
Lastly, the failure of four of the primer pairs to amplify 
BDV sequences may be due to a failure of one, rather than both, 
oligonucleotides. 	Different combinations of primers could be 
tried to see if this was the case, for example NADL 
2R 
 with 
325 C could potentially produce an amplified sequence 1900bp long 
encompassing the p20 and p62 coding sequences. 
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Chapter 7 
COMPUTER ASSISTED SEQUENCE ANALYSIS OF PESTIVIRUSES 
7.1 INTRODUCTION 
At the outset of this project there was sequence information 
available for only one pestivirus: BVDV Osloss (Renard et al 
1987c). Soon after, this was followed by the publication of the 
sequence of the RNA of BVDV-NADL (Collett et al, 1988c). The 
availability of two full-length BVDV sequences allowed a 
comparison to be made at both the amino acid and nucleotide 
levels. 
Recently two reports describing the nucleotide sequence of 
HCV strains, Alfort and Brescia, were published (Moorman cC al, 
1990) (Meyers et al, 	1989). 	This allowed further comparisons 
between pestivirus sequences. 
Reports describing the comparison of pestivirus sequences 
have now been published (Moorman et al, 1990; Collett et al, 
1988a). The comparisons undertaken in this thesis agree with the 
findings of these authors. 
The most extensively studied pestivirus was BVDV NADL, for 
which many viral proteins have been mapped (Collett et al, 
1988b), therefore comparisons were made with reference to this 
strain. 
Sequence comparisons were undertaken primarily to find 
conserved stretches of nucleic acid sequence which would be 
useful as probes or primers for use in PCR. 
Hardware and software 
Computer comparison programmes were run on the AFRC Harpenden 
VAX system. 	The programs used were the University of Wisconsin 
package for analysis of sequence data (Devereux et al, 1984). 
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Sequence data 
The BVDV-Osloss sequence was entered into a file directly 
from the published sequence, by M. 	Sweeney, University of 
Warwick, who kindly supplied us with a copy of the sequence on 
disk. 
The BVDV NADL sequence was obtained on disk from M.S. 
Collett, Molecular Genetics Inc, Minnesota, USA. The HCV 
(Brescia) sequence was obtained on disk from R. Moorman, CVL, 
The Netherlands. 
All sequences were transferred from disk to files in the VAX 
system for analysis. 
7.2 ANALYSIS AND COMPARISON OF TWO BVDV SEQUENCES 
7.2.1 Identifying open reading frames 
Both NADL and Osloss sequences were searched for open reading 
frames (ORFs). The program "FRAMES" would have been ideal for 
this but it could not be used due to our lack of graphics 
facilities. Instead the program "MAP" was used. This programme 
finds and translates all reading frames on the + and - strands, 
as well as displaying restriction enzyme sites on the sequences 
covered. 	The option to translate only open reading frames from 
the + strand was chosen. 	This revealed one major ORF in the 
NADL sequence and two major ORFs in the Osloss sequence. 	The 
NADL ORF ran from position 386 to position 12352, and the Osloss 
ORFs from positions 384 to 4244 and 4396 to 12494. There are 
also several minor ORFs in both NADL and Osloss sequences. 
Since one long ORF is present in NADL and two in Osloss the 
expression of proteins from the RNA of these viruses must be by 
a process similar to that established for picorna-viruses - ie 
production of a giant polyprotein which is co- and post-
translationally cleaved to produce the mature viral proteins. 
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7.2.2 Translating open reading frames and alignment of the 
two sequences 
The program "TRANSlATE" was used. 	This program translates 
any nucleotide sequence into its corresponding amino acid 
sequence. For the Osloss sequence, the two ORFs were translated 
into separate files then joined head to tail to form a 
contiguous protein sequence. This protein sequence was aligned 
with the translated NADL ORF using the comparison program "GAP". 
The amino acid sequences of Osloss and NADL are3q7/and 3988 
residues long respectively. 	These were aligned using the 
comparison program GAP, 	which aligns two sequences to find the 
best match, inserting gaps where necessary in order to achieve 
this. 	GAP can only allow a comparison where the product of the 
characters is less than 1 x 106, 	eg 1000 x 1000 or 10 x 
1000,000. 	The comparison of the two sequences was therefore 
split into sections of 1000 residues long. 
The overall homology between NADL and Osloss at the protein 
level is about 90%. However, this homology was not evenly 
distributed: individual proteins and parts of proteins had 
different homologies, which are discussed below. 
p116 is the precursor protein of the two putative structural 
glycoproteins p62 and p53. 	This region is one of the most 
variable, 	although the variation is localised mainly in p53, 
while p62 is 95% conserved. 	p53 is only 82% conserved. 	The 
number and position of the N-linked glycosylation sites (motif = 
Asn-X-Thr/Ser) are conserved. 	p62 possesses ten such sites and 
p53 possesses four. 	That p53 is the most variable of the 
pestivirus-coded proteins is not surprising since this protein 
has been identified as being invo1vd in virus neutralisation. 
The C-terminus of p53 marks the end of the proposed structural 
proteins and also the end of the first ORF in Osloss. 
(Following p53 and before the first non-structural protein, 
there is an extremely hydrophobic stretch of 150 amino acids to 
which no protein has been assigned. 
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The proteins encoded C-terminally of p53 are considered non- 
structural. 	This region begins with the p125 precursor which, 
in NADL, and presumably Osloss, is processed to yield p54 and 
P80. 	The sequence of p54 is well conserved overall but both 
NADL and Osloss contain unique inserts at slightly different 
sites in this region. NADL contains a 90 residue insertion 
between amino acids 199 and 200 of the second Osloss ORF, while 
0s1ss contains a unique insertion between residues 1679 and 
1680 of the NADL genome. This insertion in the Osloss strain is 
identical in protein sequence to human ubiquitin, with one 
mismatch. Insertions in this region have now been demonstrated in another BVDV 
strain, CPI, and are correlated with cytopathogenicity (see discussion). 
In p80, there are blocks of sequences which are conserved 
between flaviviruses, pestiviruses and eukaryotic helicase 
proteins. 	There are five such regions in p80. 	Bazan et al 
(1989) have in addition detected a trypsin-like serine protease 
domain in p80, the sequences making up this domain are highly 
conserved. 
The final coding domain of NADL is represented by p133, 	a 
precursor processed to yield p58 and p75. 	p58 begins with good 
homology which becomes less evident as we approach the 
C-terminus. Within this region, 	however, 	there is a short 
stretch of amino acids which are also conserved in flaviviruses. 
At the start of p75, there is a region of 40 amino acids 
which are variable, followed by a conserved region of 300 
residues, another 60 residue variable region and a reasonably 
well conserved C-terminal sequence 	There are two short 
stretches of homology with flaviviruses in p75. 
7.2.3 Comparison of BVDV NADL and Osloss at the nucleic acid 
level 
The entire 12kb of nucleotide sequences of the two strains 
were compared (in 12 x 1000 segments) using the program GAP. 
The overall homology was 75% and the distribution of conserved 
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areas followed the pattern of the amino acid sequence. The 
longest stretch of nucleotide homology was a 125bp segment 
spanning the 5' untranslated region and the N-terminal of p20. 
Other particuarly conserved stretches were seen in regions 
corresponding to p62 (35bp long) and p80 (42bp long). 
7.2.4 Comparison of the untranslated regions (UTRs) 
The 5' UTRs of NADL and Osloss show a homology of 90%, 	as 
opposed to the overall homology of 75%. 	This probably reflects 
the fact that these sequences have a functional role in 
recognition and control, 	for example, 	in replication and 
translation of the +-stranded genomic RNA. 	In both strains 
there appears to be a pseudo-start codon followed 4bp later by 
the authentic ATG. 	Interestingly, 	a similar pattern is also 
found in picornaviruses, though not in flaviviruses. 
The 3' UTRs are also 90% conserved for the last half of their 
length, but the first section (up to 12390) is only 70% 
conserved. 	This section includes an insertion in NADL of 38bp 
relative to Osloss. 	The largest totally conserved sequence in 
the 3' region is a 35bp stretch. 
7.2.5 Repeat seguences 
The programme "REPEAT" was used to define direct and inverted 
repeat sequences in the UTRs of the two strains. There is a 
conserved direct repeat motif GGGTAG-4bp-CAGTGGT 42bp apart in 
the 5' UTR of both strains. 	There are other, shorter, direct 
repeats conserved whose spacing varies between the two strains. 
There was also an inverted repeat sequence in the 5' and 3' UTRs 
as follows: ATA GGC TCC TGC AGA GC, which was fully conserved 
in both strains. 	This sequence is likely to be involved in the 
replication of the RNA. 
The sequence TGTATATA is repeated 28bp apart in the 3' UTR of 
NADL and 19bp apart in the 3' UTR of Osloss. 
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7.3 COMPARISON OF BVDV SEQUENCES WITH HCV AND FLAVIVIRUSES 
With the availability of the HCV Brescia sequence further 
comparisons with the BVDV sequences became possible. 	Reports 
have since been published (Moorman et al, 1990) of such a 
comparison. The sequence of yellow fever virus (YFV) was used as 
a flavivirus sequence (Rice et al, 1985). 
7.3.1 Amino acid comparison 
NADL, Osloss and HCV Brescia all share a high degree of 
homology and a very similar arrangement of the coding regions. 
The sequence of proteins is the same for HCV as for BVDV. There 
is about 70% homology between NADL or Osloss and HCV Brescia. 
The most notable differences between the HCV protein sequence 
and the two BVDV sequences was that HCV lacked any insertions in 
the p54/p8O region. The regions in p80 which were identified as 
motifs found in helicases and those forming the serine protease 
domain were also conserved between HCV and BVDV. 
In the non-coding regions of HCV, the inverted repeat 
described for Osloss and NADL is also fully conserved lending 
further credence to the possibility that it is involved in RNA 
replication. 
The protein sequences of pestiviruses have been compared to 
those of flaviviruses (Collett et al, 1989) and therefore this 
thesis did not include such comparisons. 	However, the small 
areas of homology which were described in the above report, 
were checked for homology with BVDV Osloss. 	These were 
completely conserved, 	and in fact the longest stretch of 
flavivirus homology in the BVDV strains forms part of the most 
conserved region in the p80 protein (-corresponding to flavivirus 
protein NS3). 
Comparison of the UTR regions revealed no similarities 
between pestiviruses and flaviviruses. 
Flaviviruses have a similar arrangement of proteins to 
pestiviruses but when hydrophobicity plots were performed there 
was virtually no similarity. 
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7.4 CONCLUSIONS 
The molecular features of BVDV were examined at the protein 
and nucleic acid level by using computer-assisted analysis. Two 
strains of BVDV, NADL and Osloss, were compared with each other, 
with HCV and with flaviviruses. 
Homology at the protein level was very good between BVDV and 
HCV, about 70%, and of course, higher (87%) between the two BVDV 
strains. Sequence homology was virtually non-existent between 
pestiviruses and flaviviruses although a common protein 
arrangement seemed to occur. Both flaviviruses and pestiviruses 
would seem to share the same mechanism of gene expression, 
proteins being co- and post-translationally processed from a 
giant polyprotein transcribed from the single polycistronic 
mRNA. This processing may be done in part by cellular protease 
enzymes and in part by virus-encoded proteases. There have been 
putative protease cleavage sites identified (Moorman et al, 
1990). 	These occur between amino acids 267/268, 	560/561 and 
689/690. These sites are conserved between the four 
pestiviruses (two BVDV, 	two HCV) so far examined. 	They 
correspond to the C termini of p20, p48  and p25 respectively. 
The cleavage point in the non-structural precursor p125 
occurs around position 5630 in BVDV (NADL). 	This precursor is 
only cleaved in cytopathic pestivirus strains and remains intact 
in non-cytopathic strains (Donis and Dubovi, 1987). 	The fact 
that p80 itself contains likely sequences for serine protease 
activity raises the possibility that it is a self-cleaving 
protein, which also contains a helicase activity. 	There is 
speculation as to whether the inserts observed in cytopathic 
virus strains around the cleavage point of p54/p8O are relevant 
to the way in which the p125 protein is processed, although 
there is no sound evidence as yet on which to base this. 
Collett et al (1988a) have proposed, on the basis of sequence 
organisation and protein arrangement of the pestiviruses, 	to 
incorporate these viruses into the Flaviviridae family as a 
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separate genus. 	They argue that the alignment of proteins is 
sufficiently distinct to distinguish pestiviruses from the 
Togaviridae where they are currently classified. Both groups 
which have reported HCV sequences argue against the inclusion of 
pestiviruses in the Flaviviridae, due to the almost complete 
lack of sequence homology between the two groups, although they 
would accept such a reclassification were functional 
similarities found between pestivirus and flavivirus proteins. 
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CHAPTER 8 
GENERAL DISCUSSION AND CONCLUSIONS 
This thesis has presented work done at the molecular level on 
BD and BVD viruses. 
At the beginning of this project, 	there was only one report 
in the literature describing the molecular cloning of a 
pestivirus sequence (Renard et al, 	1985). 	This published 
sequence was for the Osloss strain of BVDV. During the course 
of this work, the interest and expertise in pestivirus molecular 
biology have gathered momentum, 	and there now exists sequence 
data for two BVDV strains, Osloss and NADL, and two HCV strains, 
Brescia and Alfort (Renard et al, 	1985; Collett et al, 1988c; 
Meyers et al, 1989; Moorman et al, 1990). The organisation of 
the coding regions of the NADL strain (Collett et al, 	1988b) 
was deduced, and proteins mapped to regions of the genome. This 
was a major step forward in terms of molecular knowledge of 
these viruses. 	Sequences of the four pestiviruses have been 
compared with each other and with flaviviruses (Moorman, 1990). 
A portion of the BDV-CP genome has been sequenced (Moerlooze et 
al, 1990). These workers used the PCR technique to sequence the 
carboxy-terminal portion of the 54K protein of eight pestivirus 
strains, including the BD-CP strain. The region sequenced was a 
conserved cysteine-rich area very similar to sequences found in 
proteins which have the zinc-finger configuration of nucleic 
acid binding proteins. 
In this area at least, Border disease virus (CP strain) does 
not differ significantly from the NADL strain of BVDV (13 
changes in 225) and was in fact more similar to BVDV-NADL than 
was BVDV Osloss (28/225) or HCV Alfort (61/225). 
In addition, no significant differences were found between CP 
and NCP pestivirus strains, thus indicating that other areas of 
the genome must contribute to the cytopathic phenotype of these 
viruses. 
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The initial aim of this work was to produce a cDNA library 
from purified BDV RNA. This was attempted, as will be discussed 
shortly, but, in the course of this work other approaches were 
exploited, which gave results in areas not envisaged in the 
initial project plan. 	Such areas included studies on BDV 
replication, PCR work and computer-assisted analysis of existing 
pestivirus sequences. 
The main aim initially, though, was to generate cDNA clones 
from the genome of BDV. This required growth and purification 
of large amounts of virus, isolation and purification of the 
viral RNA for use as a template, a method of priming cDNA 
synthesis on the template, a cloning system for cDNA thus 
generated, and a suitable method for screening clones for BDV 
sequences. 	In addition to the usual criteria to be satisfied, 
there were also special considerations and problems associated 
with pestiviruses in general, one probable reason for the dearth 
of reports on pestivirus molecular biology. 
Pestiviruses are notoriously difficult to obtain in large 
purified amounts. They grow poorly and unpredictably in tissue 
culture, a fact borne out by results reported in Chapter 3, 
where titres of cultures of BDV could vary by 3 logs for no 
apparent reason. This meant that it was impossible to achieve a 
consistently efficient virus growth programme. In retrospect, 
it was realised that the scaling up of virus growth was not 
necessarily the best approach to large amounts of virus; BDV 
seemed to grow far better, and more consistently, in sealed 
plastic tissue culture flasks than in the large glass roller 
bottle cultures used in this work. 	Using glass, titres ranged 
between 103 106  TCID 50 /ml, but in plastic flasks they averaged 
between 10 and 10 /ml. 	Experiments described in Chapter 3 
covered attempts to increase viral growth by using the drug 
Actinomycin D, which had been proposed to enhance the growth of 
BVDV NCP strains (Nuttall, 1980). The results reported in 
this chapter show an effect interesting in its own right, that 
AcD enhanced the growth of NCP and CP strains of BDV during the 
early stages of infection, but the effect was transient and 
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could not be utilized to increase yields of virus on a bulk 
scale. 	This difficulty in producing a high quality stock of 
virus for cloning purposes was undoubtedly the key factor in the 
failure to produce cDNA clones of BDV as described in Chapter 4. 
The purification and handling of BDV genomic RNA was also an 
area of potential difficulty, firstly because it was available 
in such tiny amounts, and secondly because its length makes it 
extremely liable to attack by RNAases. 
Various methods have been tried to minimise or circumvent 
these problems by the groups who have cloned pestivirus 
sequences. 	In the earliest report (Renard et al, 1985), BVD 
virus was purified from tissue culture supernatant. This group 
reported that the virus was present in the tissue culture fluid 
at a titre of 108pfu/ml and they used 3 litres of such fluid. 
Since this was the only published method for cDNA synthesis on 
pestiviruses available at the beginning of this work, we 
committed ourselves to a virus growth programme based on this 
report. This meant our target volume was at least 30L, since BD 
virus was known to grow to 1 log less than BVD virus. 
A different approach entirely was taken by the group who 
sequenced BVDV-NADL (Collett et al, 	1989). 	They found it 
impossible to purify enough high quality BVDV RNA from 
supernatant virus, 	so they isolated total RNA from virus- 
infected cells and purified the virus RNA fraction by 
precipitation in 2M Lid 2, exploiting the fact that, because of 
areas of secondary structure, 	the viral RNA remained in the 
soluble fraction. 	Using this approach, 	enough pure viral 
genomic RNA was obtained to be visible on an ethidium bromide 
stained gel. 	In retrospect, 	this seems a better approach to 
obtain BDV RNA, assuming it has the same properties as the BVDV 
RNA. 
The HCV cDNA cloning was also performed using intracellular 
viral RNA as a template. This group reported that HCV grew to a 
titre of 3 x 10 TCID50/ml, and the cellular RNA fraction was 
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enriched for HCV sequences by centrifugation in a denaturing 
sucrose gradient. 
Thus, if further attempts were to be made to construct a cDNA 
library from BDV, the method of choice would seem to be growth 
of virus in large plastic tissue culture flasks and isolation of 
total RNA from the infected cell monolayers followed by 
enrichment of the viral RNA fraction either by gradient 
centrifugation or LiCl2 precipitation. 
It would be extremely interesting to obtain sequence data 
from BD virus, since this is the only remaining pestivirus for 
which there is not complete molecular information. 	We can 
speculate that the overall organisation of the genome will be 
similar to BVDV and HCV, 	but the degree of sequence homology 
would be interesting to know. 	Antigenically all three 
pestiviruses are quite closely related, 	sharing a common 
soluble antigen. Neutralisation tests have shown BDV to be more 
related to BVDV- NADL than to HCV (Laude and Gelfi, 	1979). 
Epitope mapping of the 53K glycoprotein allowed separation of 
BVDV strains into groups, 	NADL being the sole member of its 
group. 
When BVDV and HCV protein sequences were compared, the two 
HCV sequences were 93% similar, the two BVDV sequences were 87% 
similar. 	HCV Alfort is also 85% similar to BVDV-NADL, not much 
more divergence than between BVDV strains. However, the Brescia 
strain of HCV is only 70% similar to either NADL or Osloss. 	It 
would be intriguing to know how similar BDV is to the BVDV and 
HCV strains. Areas of homology could be used to predict many 
features of the proteins from their sequences, 	for example, 
structural and functional domains, 	tertiary structures and 
active sites. Preliminary studies of this type have already been 
performed on BVDV sequences. 	Linear sequence motifs have been 
identified which strongly suggest the function of particular 
proteins, or domains within proteins. 	The amino acid sequence 
CDD is conserved amongst all RNA-dependent RNA polymerases so 
far sequenced, and this sequence is present uniquely within the 
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BVDV genome in the p75 protein (Collett et al, 1988b). 	This 
sequence also occurs in the HCV p75 protein (although it is not 
unique in the HCV genome), 	therefore there is a strong 
possibility that p75 is the viral RNA polymerase, or a part of 
it. 	Other predictions have been made on the basis of BVDV 
protein sequence data; 	the motif G X S G X P has been found in 
the N-terminal portion of p125, this sequence is similar to the 
motif conserved around catalytic serine residues of 
chymoptrypsin-like proteases. 	This has been taken one step 
further, comparison of the linear sequence of the p125 protein 
and the corresponding flavivirus N$3 protein has allowed a 
tentative prediction that the substrate-binding pocket involves 
conserved sequences downstream from the catalytic site. 	In the 
C-terminal section of p125, 	there are sequences similar to 
helicase (triphosphate-binding protein) sequences from a number 
of prokayotic and eukaryotic proteins. 	Thus, 	p125 appears to 
consist of two functional domains which can be cleaved to 
produce two separate proteins in cytopathic virus strains 
(Gorbalenya et al, 	1989). 
The p54 protein of pestiviruses (the N-terminal section of p125) 
has been shown to possess a conserved cysteine-rich stretch of 
amino acids very similar to the "zinc-finger" sequences of 
nucleic acid binding proteins. These sequences are 
characteristic of proteins which interact directly with nucleic 
acid, and have been described for non-structural proteins of 
other positive-stranded RNA viruses. Helical prediction showed a 
conserved helix following the zinc- finger sequence. 	This 
conformation is found only in the cleaved p54 protein, and not 
in the intact p125, 	ie only in cytopathic virus strains 
(Moerlooze et al, 1990). 
The experiments reported in Chapter 4 show preliminary 
results that the BDV genomic RNA is, like the other pestivirus 
RNAs, around 12kb long. It was also seen that the proportion of 
viral RNA in infected cells is very small. This is in 
accordance with observations on the other pestiviruses. 
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The replication mechanism of pestivirus RNAs in the infected 
cell is an area which remains unelucidated. No subgenomic RNAs 
have ever been detected in Northern blots either in this work or 
with BVDV (Renard et al, 1985). 	The degree of secondary 
structure present in the large genomic RNA would make it 
difficult to distinguish replicative forms or replicative 
intermediates. Since pestivirus replication is uninhibited by 
AcD, they do not rely on host cell enzymes for their RNA 
synthesis. They must, therefore, encode an RNA-dependent RNA 
polymerase which is translated directly from the +-stranded 
genomic/messenger RNA. The replication strategy for the 
+-stranded pestivirus RNA is unknown, but they would appear more 
similar in this respect to both flaviviruses and picorna 
viruses, neither of which synthesise sub-genomic RNA during 
replication. Alphaviruses on the other hand synthesis two sub-
genomic RNAs, and three replicative intermediate (RI) molecules 
are clearly identifiable. 	Picornavirus replication has been 
well defined by both in vivo and in vitro studies (for review 
see Winuuer and Kuhn (1987)). The positive template strand after 
a few rounds of translation switches to being used as a template 
for minus strand RNA synthesis. 	Plus and minus strands are 
synthesised throughout the replication cycle, 	the former at 
about 10-fold excess. 	There have been RI molecules identified 
which are involved in plus strand synthesis. 	These molecules 
consist of template RNA with several nascent RA chains 
attached. The mechanism for plus and minus strand synthesis may 
be different, 	as they appear to be under separate control. An 
important aspect of picornavirus repliction is that host cell 
proteins unrelated to nucleic acid metabolism may be recruited 
by the virus during RNA replication (see above review). 
Flavivirus replication has also been well studied although 
not as thoroughly. 	For review see Brinton (1987). 	Like 
picornavirus there are no subgenomic RNAs detectable, and the 
polymerase gene maps to the 3' end. 	The ratio of plus to minus 
strand RNA is again about 10:1. Both RI and replicative form 
(RF) structures have been detected. 	RNA synthesis is biphasic, 
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with synthesis peaking 6hrs after infection then a steady 
increase starting 13hrs after infection. Again it was suggested 
that minus strand synthesis may be under different control from 
plus strand synthesis. 
Pestiviruses probably have a replication strategy very 
similar to picorna- and flaviviruses, 	ie a few rounds of 
translation, then synthesis of minus strand RNA followed by plus 
strand synthesis to produce mRNA and genomic RNA. 	The 
involvement of host cell factors is not unlikely, as has been 
observed for picornaviruses. 
The results reported in Chapter 3 demonstrate that BD viral 
RNA synthesis has commenced by 4.5hrs post infection. 
Preliminary results showed a dramatic drop in RNA synthesis 
after this time, 	a phenomenon also reported by Nuttall (1980) 
for BVDV. 	This result would need to be repeated to assess its 
significance. If it is a true effect, it could be due to either 
release of labelled genomic RNA as free virus, or to 
incorporation of the label into a negative template RNA fraction 
on which the genomic RNA would be transcribed, and which would 
later be degraded. 	Further experiments designed to study the 
timing and partitioning of radiolabelled precursors could help 
shed light on the replication mechanisms of this virus. 
The polymerase chain reaction (PCR) is a new technology which 
became available during this project. The primary requirement 
for a successful PCR is sequence information for making 
oligonucleotide primers. Several such primers were obtained and 
tested on BD virus, 	the sequences had been deduced by finding 
conserved areas on the BVDV NADL and Osloss sequences. 	The 
results of PCR are reported in Chapter 6. Consistent results 
were not obtained on BD virus RNA but some amplification was 
achieved. 	Amplification was excellent using BVDV RNA. 	This 
seems the most promising way to obtain sequence information on 
BD virus. Once a segment has been amplified and sequenced it can 
then be used as a probe to screen a cDNA library for adjacent 
sequences, and in this way, various amplified fragments could be 
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used to obtain sequence information either directly or by their 
subsequent use as probes. 
This is one area where PCR could possibly be used to 
investigate replication kinetics. 	Primers designed to amplify 
either the plus strand sequence or the corresponding minus 
strand sequence could be used to quantify the amounts of each 
strand at any given time during virus infection, hence strand-
specific primers could therefore be used to obtain ratios of 
plus strand to minus strand during the course of virus 
infection, 	which would help elucidate the mechanism of virus 
replication. 
One intriguing question which could be tackled with the 
availability of sequence data for BD viruses is that of 
cytopathogenicity and the pathogenesis of mucosal disease in 
sheep. 	In cattle, a model for the onset of mucosal disease has 
been established, ie that the trigger for MD seems to be 
superinfection of a persistently infected animal with a CP virus 
which is antigenically similar to the persistently infecting 
strain (Howard et al, 1987). 	If pairs of viruses (CP and NCP) 
could be isolated from experimentally infected cases of mucosal 
disease and regions involved in antigenic variation (for 
instance the p53 region) were amplified and sequenced by PCR 
then sequences of different strains of CP and NCP viruses could 
be compared very quickly and the combinations giving rise to 
mucosal disease identified. 
Another area where PCR sequencing would be useful is to 
compare sequences of the p125 protein in CP and NCP strains of 
BDV. 	Like BVDV, 	BDV possesses a protein which is cleaved to 
80K in CP strains but is unprocessed in NCP strains (Dutia et 
al, 	1990). 	It has been noted that the three CP BVDV strains 
sequenced so far have an insert in the p80 region, although the 
inserts differ in sequence and position. It would be interesting 
to compare CP and NCP BDV strains to determine if an insert in 
p80 was always associated with cytopathogenicity. This approach 
has already been taken by Meyers 	et al (199) who found that 
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in addition to the insertions already discussed, a BVDV strain CP1 had an insertion of 
a complete p80 gene plus ubiquitin sequences, while its NCP "partner" had no 
insertions. Furthermore, they showed that p80 was expressed from this duplicated gene 
and not from p125, which was not processed in this strain. 
In summary, this thesis describes work carried out at the 
molecular level on BDV and BD viruses. BD virus was grown in 
bulk and RNA produced from it. Attempts to synthesis cDNA from 
this template were unsuccessful and in that respect the original 
objective of the work has not been achieved. However, the work 
allowed a full insight into the problems associated with 
pestivirology on the practical level. 	We now have a much 
clearer idea of the limitations of the approaches tried, 	and 
where problems may be avoided in the future. Other work carried 
out during the project was more fruitful. 	The growth and 
replication of BDV was studied and a time course produced. 
Radiolabelled BDV genomic RNA was isolated from infected cells 
and shown to be 12kb long, 	in agreement with other data 
presented from ethidium bromide stained gels. 	Hybridisation 
studies were carried out using BVDV clones, one of which seemed 
promising in dot blot hybridisations. 	Finally PCR was used, a 
technique which holds much promise for elucidation of sequences, 
the ultimate aim of this work on BD virus. 
With the current acceleration of pestiviral molecular biology 
many of the previously unanswered questions may now become 
accessible to being tackled at the molecular level. 	The more 
strains for which sequence data becomes available, the easier 
it will be to assign functions to proteins and to deduce 
replication mechanisms. 	The pivotal question of the mechanisms 
operating in mucosal disease may become clearer as more 
pestiviruses are defined at the molecular level. 
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